<SEC-DOCUMENT>0001213900-21-034344.txt : 20210628
<SEC-HEADER>0001213900-21-034344.hdr.sgml : 20210628
<ACCEPTANCE-DATETIME>20210628091810
ACCESSION NUMBER:		0001213900-21-034344
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20210613
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210628
DATE AS OF CHANGE:		20210628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Avalon GloboCare Corp.
		CENTRAL INDEX KEY:			0001630212
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				471685128
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38728
		FILM NUMBER:		211050247

	BUSINESS ADDRESS:	
		STREET 1:		4400 ROUTE 9
		STREET 2:		SUITE 3100
		CITY:			FREEHOLD
		STATE:			NJ
		ZIP:			07728
		BUSINESS PHONE:		(646) 762-4517

	MAIL ADDRESS:	
		STREET 1:		4400 ROUTE 9
		STREET 2:		SUITE 3100
		CITY:			FREEHOLD
		STATE:			NJ
		ZIP:			07728

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Avalon Globocare Corp.
		DATE OF NAME CHANGE:	20161018

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLOBAL TECHNOLOGIES CORP
		DATE OF NAME CHANGE:	20150108
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>ea143147-8ka1_avalonglob.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amendment No. 1 to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
June 13, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AVALON GLOBOCARE CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding: 0.5pt 0.5pt 1.5pt; text-align: center">Delaware</TD>
    <TD STYLE="width: 2%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding: 0.5pt 0.5pt 1.5pt; text-align: center">000-55709</TD>
    <TD STYLE="width: 2%; padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding: 0.5pt 0.5pt 1.5pt; text-align: center">47-1685128</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.5pt; text-align: center">(State or Other Jurisdiction<BR>
of Incorporation)</TD>
    <TD STYLE="padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.5pt; text-align: center">(Commission File Number)</TD>
    <TD STYLE="padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.5pt; text-align: center">(IRS Employer <BR>
Identification Number)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4400 Route 9 South, Suite 3100, Freehold, New
Jersey 07728</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">732-780-4400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&rsquo;s telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding: 0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="width: 98%; padding: 0.5pt; text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding: 0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD>
    <TD STYLE="width: 98%; padding: 0.5pt; text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding: 0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="width: 98%; padding: 0.5pt; text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2%; padding: 0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="width: 98%; padding: 0.5pt; text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.25pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
Emerging growth company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding: 0.5pt 0.5pt 1.5pt; text-align: center">Title of each class</TD>
    <TD STYLE="width: 2%; padding: 0.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding: 0.5pt 0.5pt 1.5pt; text-align: center">Trading Symbols</TD>
    <TD STYLE="width: 2%; padding: 0.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding: 0.5pt 0.5pt 1.5pt; text-align: center">Name of each exchange on which registered</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding: 0.5pt; text-align: center">Common Stock, $0.0001 par value per share</TD>
    <TD STYLE="padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.5pt; text-align: center">AVCO</TD>
    <TD STYLE="padding: 0.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.5pt; text-align: center">The Nasdaq Capital Market</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>









<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Amendment No. 1 to Form 8-K (&ldquo;Form 8-K/A&rdquo;) amends
the Current Report on Form 8-K filed by Avalon GloboCare Corp. (the &ldquo;Company&rdquo;), with the Securities and Exchange Commission
(&ldquo;SEC&rdquo;) on June 14, 2021 (the &ldquo;Original Filing&rdquo;). This Form 8-K/A is being filed solely for the purposes of (i)
filing with the SEC (a) the audited financial statements of Lonlon Biotech Ltd. (&ldquo;Sen Lang&rdquo;) and related auditors&rsquo; report
and consent for the year ended December 31, 2020, (b) the unaudited financial statements of Sen Lang for the quarter ended March 31, 2021
and (c) the unaudited pro forma financial information of the Company and Sen Lang with respect to the Acquisition (as defined in the Original
Filing), and (ii) correcting the percentage of the equity of the OpCo (as defined in the Original Filing) disclosed as being purchased
in the Equity Financing (as defined in the Original Filing) and filing with the SEC an amendment to the Exchange Agreement (as defined
in the Original Filing). This Form 8-K/A does not change any of the other information contained in the Original Filing except as specifically
set forth herein. This Form 8-K/A continues to speak as of the date of the Original Filing and we have not updated or amended any disclosures,
except as specifically set forth herein, contained in the Original Filing to reflect events that have occurred since the time of the Original
Filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 1.01 Entry into a Material Definitive Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Equity Financing</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Acquisition, on June 13,
2021, an institutional investor (the &ldquo;Investor&rdquo;) entered into an agreement with the OpCo related to the purchase of registered
capital of the OpCo (the &ldquo;<U>OpCo Capital Increase Agreement</U>&rdquo;) pursuant to which the Investor will acquire an aggregate
of up to 13.5% of the equity ownership of the OpCo for an aggregate purchase price (the &ldquo;Subscription Amount&rdquo;) of approximately
US$30,000,000 (represented by an actual investment of RMB200,000,000) (the &ldquo;Equity Financing&rdquo;), which funds will be invested
in the OpCo in three equal installments of approximately US$10,000,000, at a fixed price, the first to be upon the closing of the Acquisition,
the second to be within three months after the closing and the third to be within six months after the closing. In addition, pursuant
to a Securities Exchange Agreement (the &ldquo;Exchange Agreement&rdquo;), by and among the Company, Sen Lang, the OpCo and the Investor,
dated June 13, 2021, the Investor has the right, exercisable between the six-month and five year-anniversaries of the respective initial
closing and installment closings, to elect to exchange, from time to time, all or part of its then-owned equity ownership of the OpCo
for shares (the &ldquo;Exchange Shares&rdquo;) of Avalon Common Stock at a fixed exchange price of US$1.21 per share of Avalon Common
Stock, which was the market price of the Avalon Common Stock as of the date of the Exchange Agreement under Nasdaq rules. In addition,
the Exchange Agreement provides that the Investor may only exchange up to 10% of its total investment amount in any 30 day period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 24, 2021, the Company, Sen Lang, the
OpCo and the Investor entered into Amendment No. 1 to Securities Exchange Agreement (&ldquo;Amendment No. 1&rdquo;) to clarify that the
percentage of the OpCo&rsquo;s capital being purchased by the Investor is approximately 13.5% (rather than the 15.6% previously reported).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summary of Amendment No. 1 does
not purport to be complete and is qualified in its entirety by reference to the actual agreement, which is filed as Exhibit 10.2 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 3.02 Unregistered Sales of Equity Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information with respect to the Acquisition
and the Equity Financing, including the Purchase Agreement and the Exchange Agreement, as amended, is incorporated into this Item 3.02
by reference. The Acquisition Shares and the Exchange Shares have not been, and will not be, registered under the Securities Act, and
instead will be issued pursuant to the exemption provided in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item 7.01
Regulation FD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">On June 28,
2021, Avalon issued a press release and letter to stockholders with information regarding the Acquisition and the Equity Financing. A
copy of the press release is attached hereto as Exhibit 99.5. The information in this Current Report on Form 8-K under Item 7.01, including
the information contained in Exhibit 99.5, is being furnished to the Securities and Exchange Commission, and shall not be deemed to be
&ldquo;filed&rdquo; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under
the&nbsp;Securities Act of 1933, as amended, or the&nbsp;Exchange Act, except as shall be expressly set forth by a specific reference
in such filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
8.01 Other Events.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Stock Ownership of Avalon Officers and Directors</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Currently, the officers and directors of Avalon own
in the aggregate approximately 64.1% of the outstanding shares of Avalon Common Stock and are expected to vote in favor of the issuance
of the Acquisition Shares pursuant to Nasdaq rules.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Sen Lang Financial Statements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sen Lang&rsquo;s audited consolidated financial
statements for the year ended December 31, 2020, and the notes related thereto, filed herewith and attached as Exhibit 99.2, are incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sen Lang&rsquo;s unaudited condensed consolidated
financial statements for the quarter ended March 31, 2021, and the notes related thereto, filed herewith and attached as Exhibit 99.3,
are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Pro Forma Financial Information</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s unaudited pro forma consolidated
combined statements of operations and comprehensive loss for the year ended December 31, 2020 and the three months ended March 31, 2021,
the unaudited pro forma consolidated combined balance sheet as of March 31, 2021, and the notes related thereto, are filed as Exhibit
99.4 to this Form 8-K/A and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Additional
Information about the Proposed Acquisition Transaction and Where to Find It</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This communication
relates to the proposed Acquisition and may be deemed to be solicitation material in respect of the Acquisition. In connection with the
Acquisition, Avalon will file relevant materials with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;), including a
proxy statement on Schedule 14A (the &ldquo;Proxy Statement&rdquo;). This communication is not a substitute for the Proxy Statement or
for any other document that Avalon may file with the SEC or send to Avalon&rsquo;s stockholders in connection with the Acquisition. BEFORE
MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS OF AVALON ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR
SUPPLEMENTS THERETO) AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL
CONTAIN IMPORTANT INFORMATION ABOUT AVALON, THE ACQUIRED COMPANIES, THE ACQUISITION AND RELATED MATTERS. The Acquisition will be submitted
to Avalon&rsquo;s stockholders for their consideration. Investors and security holders will be able to obtain free copies of the Proxy
Statement (when available) and other documents filed by Avalon with the SEC through the website maintained by the SEC at http://www.sec.gov.
Copies of the documents filed by Avalon with the SEC will also be available free of charge on Avalon&rsquo;s website at&nbsp;www.avalon-globocare.com&nbsp;or
by contacting Avalon&rsquo;s Investor Relations contact at PR@Avalon-GloboCare.com.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Participants
in the Solicitation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Avalon and
its directors and certain of its executive officers and employees may be deemed to be participants in the solicitation of proxies from
Avalon&rsquo;s stockholders with respect to the Acquisition under the rules of the SEC. Information about the directors and executive
officers of Avalon and their ownership of shares of Avalon&rsquo;s common stock is set forth in its Annual Report on Form&nbsp;10-K&nbsp;for
the year ended December 31, 2020, which was filed with the SEC on March 30, 2021 and in subsequent documents filed with the SEC, including
the Proxy Statement. Additional information regarding the persons who may be deemed participants in the proxy solicitations and a description
of their direct and indirect interests in the Acquisition, by security holdings or otherwise, will also be included in the Proxy Statement
and other relevant materials to be filed with the SEC when they become available. You may obtain free copies of this document as described
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Cautionary
Statement Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This communication
contains &ldquo;forward-looking statements&rdquo; within the meaning of the Private Securities Litigation Reform Act of 1995. Avalon generally
identifies forward-looking statements by terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expects,&rdquo;
&ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;could,&rdquo; &ldquo;intends,&rdquo; &ldquo;target,&rdquo; &ldquo;projects,&rdquo;
&ldquo;contemplates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo; &ldquo;potential&rdquo; or &ldquo;continue&rdquo;
or the negative of these terms or other similar words. These statements are only predictions. Avalon has based these forward-looking statements
largely on its then-current expectations and projections about future events and financial trends as well as the beliefs and assumptions
of management. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances
that are beyond Avalon&rsquo;s control. Avalon&rsquo;s actual results could differ materially from those stated or implied in forward-looking
statements due to a number of factors, including but not limited to: (i) risks associated with Avalon&rsquo;s ability to obtain the stockholder
approval required to consummate the Acquisition in accordance with Nasdaq rules and the timing of the closing of the Acquisition, including
the risks that a condition to closing would not be satisfied within the expected timeframe or at all or that the closing of the Acquisition
will not occur; (ii) the outcome of any legal proceedings that may be instituted against the parties and others related to the Purchase
Agreement; (iii) the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the
Purchase Agreement, (iv) unanticipated difficulties or expenditures relating to the Acquisition, the response of business partners and
competitors to the announcement of the Acquisition; and (v) those risks detailed in Avalon&rsquo;s most recent Annual Report on Form&nbsp;10-K&nbsp;and
subsequent reports filed with the SEC, as well as other documents that may be filed by Avalon from time to time with the SEC. Accordingly,
you should not rely upon forward-looking statements as predictions of future events. Avalon cannot assure you that the events and circumstances
reflected in the forward-looking statements will be achieved or occur, and actual results could differ materially from those projected
in the forward-looking statements. The forward-looking statements made in this communication relate only to events as of the date on which
the statements are made. Except as required by applicable law or regulation, Avalon undertakes no obligation to update any forward-looking
statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated
events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01 Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) <I>Exhibits</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt"><B>Exhibit<BR>
    Number</B></TD>
    <TD STYLE="width: 1%; padding: 0.25pt 0.25pt 1.75pt">&nbsp;</TD>
    <TD STYLE="width: 89%; border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; text-align: center"><B>Description</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt">10.2</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><A HREF="ea143147ex10-2_avalonglob.htm">Amendment No. 1 to Securities Exchange Agreement, dated June 24, 2021, among Avalon GloboCare Corp, Lonlon Biotech Ltd., Senlang Biotechnology Co. Ltd. and Yueyin Datong (Tianjin) Asset Management Co. Ltd.</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0.25pt">23.1</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><A HREF="ea143147ex23-1_avalonglob.htm">Consent of Friedman LLP.</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt">99.2</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><A HREF="ea143147ex99-2_avalonglob.htm">Sen Lang&rsquo;s audited consolidated financial statements for the year ended December 31, 2020, and the notes related thereto.</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0.25pt">99.3</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><A HREF="ea143147ex99-3_avalonglob.htm">Sen Lang&rsquo;s unaudited condensed consolidated financial statements for the quarter ended March 31, 2021, and the notes related thereto</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt">99.4</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><A HREF="ea143147ex99-4_avalonglob.htm">The Company&rsquo;s unaudited pro forma consolidated combined statements of operations and comprehensive loss for the year ended December 31, 2020 and the three months ended March 31, 2021, the unaudited pro forma consolidated combined balance sheet as of March 31, 2021, and the notes related thereto.</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0.25pt">99.5</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><A HREF="ea143147ex99-5_avalonglob.htm">Press Release dated June 28, 2021.</A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0.25pt"><B>AVALON GLOBOCARE CORP.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt 0.25pt 1.75pt">Dated: June 28, 2021</TD>
    <TD STYLE="padding: 0.25pt 0.25pt 1.75pt">By:&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">/s/ Luisa Ingargiola</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 6%; padding: 0.25pt">Name:&nbsp;</TD>
    <TD STYLE="width: 30%; padding: 0.25pt">Luisa Ingargiola</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">Title: </TD>
    <TD STYLE="padding: 0.25pt">Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>ea143147ex10-2_avalonglob.htm
<DESCRIPTION>AMENDMENT NO. 1 TO SECURITIES EXCHANGE AGREEMENT, DATED JUNE 24, 2021, AMONG AVALON GLOBOCARE CORP, LONLON BIOTECH LTD., SENLANG BIOTECHNOLOGY CO. LTD. AND YUEYIN DATONG (TIANJIN) ASSET MANAGEMENT CO. LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>amendment
no. 1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>to
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SECURITIES
exchange AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Amendment No. 1 to Securities Exchange Agreement (this &ldquo;<U>Amendment No. 1</U>&rdquo;) is dated as of June 24, 2021, among Avalon
GloboCare Corp., a Delaware corporation (the &ldquo;Company&rdquo;), Lonlon Biotech Ltd., a company incorporated in the British Virgin
Islands (&ldquo;Sen Lang&rdquo;), Senlang Biotechnology Co. Ltd. (&#27827;&#21271;&#26862;&#26391;&#29983;&#29289;&#31185;&#25216;&#26377;&#38480;&#20844;&#21496;
in Chinese), a company with limited liability organized and existing under the laws of the PRC (the &ldquo;<U>OpCo</U>&rdquo;), and Yueyin
Datong (Tianjin) Asset Management Co. Ltd. (in Chinese, &#32422;&#21360;&#22823;&#36890;&#65288;&#22825;&#27941;&#65289;&#36164;&#20135;&#31649;&#29702;&#26377;&#38480;&#20844;&#21496;),
a limited liability company organized and existing under the laws of the People&rsquo;s Republic of China (including its successors
and assigns, &ldquo;<U>Purchaser</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Parties have entered into that certain Securities Exchange Agreement dated as of June 13, 2021 (the &ldquo;<B>Securities Exchange
Agreement</B>&rdquo;), pursuant to which Purchaser agrees to subscribe to RMB200,000,000 of the OpCo&rsquo;s registered capital in exchange
of, at Purchaser&rsquo;s option, Common Stock of the Company or Capital Stock of Sen Lang, under the terms and conditions of the <B>Securities
Exchange Agreement</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Parties desire to enter into this Amendment No. 1 to amend, modify and supplement the <B>Securities Exchange Agreement</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;Section
2.2 of the <B>Securities Exchange Agreement</B> shall be amended and restated in its entirety to read as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Purchase of Registered Capital</U>. Upon the terms and subject to the conditions set forth in the OpCo Capital Increase Agreement,
the OpCo agrees to sell, and Purchaser agrees to purchase, equity interests of the OpCo, representing in the aggregate of 13.5302%<SUP>1
</SUP>of the OpCo&rsquo;s total registered capital (the &ldquo;<U>Registered Capital</U>&rdquo;) pursuant to the Capital Increase Agreement
with the excess of the payment amount over the Registered Capital as the OpCo&rsquo;s &ldquo;capital excess&rdquo;. The effectiveness
of each of this Agreement and the OpCo Capital Increase Agreement is contingent upon, and its closing will be substantially concurrent
with the closing of the transactions contemplated by the Acquisition Agreement (the &ldquo;<U>Acquisition Closing</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;Except
as specifically amended and supplemented herein, all aspects of <B>the Securities Exchange Agreement </B>shall remain in full force and
effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
percentage registered capital to be inserted at the date of execution of this Agreement and the OpCo Capital Increase Agreement shall
be calculated as follows: (a) the Subscription Amount in RMB paid by the Purchasers pursuant to the OpCo Capital Increase Agreement converted
to USD at the Exchange Rate of 6.3856 (the Exchange Rate on June 11, 2021), divided by (b) the total of (i) the sum of (x) the outstanding
shares of Common Stock of the Company (84,425,564 shares) plus (y) 81,000,000 (the number of shares of Common Stock of the Company to
be issued pursuant to the Acquisition Agreement), multiplied by the Per Share Exchange Price, plus (ii) the Subscription Amount. Such
percentage of OpCo&rsquo;s registered capital shall only applicable in the event of that the Purchaser has paid up the Total Subscription
Amount to OpCo, and the final and acutal percentage of the registered capital of the OpCo held by the Purchaser shall be adjusted based
on the actual Subcription Amount paid by the Purchaser pursuant to the OpCo Capital Increase Agreement.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Exchange Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>AVALON
    GLOBOCARE CORP. </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Dr. David Jin</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. David
    Jin</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">With a copy to (which shall not constitute notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Lowenstein
Sandler LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1251 Avenue of the Americas</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">New York, New York 10021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Attn: Steven M. Skolnick, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
sskolnick@lowenstein.com </FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Exchange Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SENLANG
    BIOTECHNOLOGY CO. LTD.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Ding Wei</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ding Wei</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">With a copy to (which shall not constitute notice):</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">JunHe LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">26/F HKRI Centre One, HKRI Taikoo Hui 288</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Shimen Road (No.1), Shanghai 200041, P. R. China</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Attn: Frank Zhou</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Email: zhouf@junhe.com</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Exchange Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LONLON
    BIOTECH LTD.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 0.75pt; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Ding Wei</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ding Wei</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">With a copy to (which shall not constitute notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lowenstein
Sandler LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1251 Avenue of the Americas</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">New York, New York 10021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Attn: Steven M. Skolnick, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
sskolnick@lowenstein.com </FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO SECURITIES EXCHANGE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Exchange Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: Yueyin Datong (Tianjin) Asset Management Co. Ltd. (in Chinese, <B>&#32422;&#21360;&#22823;&#36890;&#65288;&#22825;&#27941;&#65289;&#36164;&#20135;&#31649;&#29702;&#26377;&#38480;&#20844;&#21496;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: __/s/ Xiong Shuirou____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Seal)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ________ Xiong Shuirou ______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________President, Partner_____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: ______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-708,
Chuangzhi Building, 482 Dongmanzhong Road, Sino-Singapore Tianjin Eco-city, Binhai New Area, Tianjin City, P.R. China</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#20013;&#22269;&#22825;&#27941;&#24066;&#28392;&#28023;&#26032;&#21306;&#20013;&#26032;&#22825;&#27941;&#29983;&#24577;&#22478;&#21160;&#28459;&#20013;&#36335;482&#21495;&#21019;&#26234;&#22823;&#21414;1-708)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Shares to Purchaser upon an Exchange (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
A</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDMENT
1 TO CAPITAL INCREASE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OF</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SENLANG
BIOTECHNOLOGY CO. LTD. (&#27827;&#21271;&#26862;&#26391;&#29983;&#29289;&#31185;&#25216;&#26377;&#38480;&#20844;&#21496;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea143147ex23-1_avalonglob.htm
<DESCRIPTION>CONSENT OF FRIEDMAN LLP.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><IMG SRC="ex23-1_001.jpg" ALT="">&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT ACCOUNTANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the inclusion by reference in the registration statements on Form S-3 (File No. 333-229118) and Form S-8 (File No.
333-251196) of Avalon GloboCare Corp. of our report dated June 24, 2021, with respect to our audits of the consolidated financial statements
of Lonlon Biotech Ltd. as of December 31, 2020 and 2019 and for the years then ended, which included an explanatory paragraph as to Lonlon
Biotech Ltd.&rsquo;s ability to continue as a going concern, which appears in this Current Report on Form 8-K of Avalon GloboCare Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Friedman LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
25, 2021</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ea143147ex99-2_avalonglob.htm
<DESCRIPTION>SEN LANG'S AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2020, AND THE NOTES RELATED THERETO
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="text-align: right; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">E<B>xhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>LONLON BIOTECH LTD. AND SUBSIDIARIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>December 31, 2020 and 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">December 31, 2020 and 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONTENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%"><A HREF="#a_001">Report of Independent Registered Public Accounting Firm</A></TD>
    <TD STYLE="text-align: center; width: 10%">F-2</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Consolidated Financial Statements:</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><A HREF="#a_002">Consolidated Balance Sheets - As of December 31, 2020 and 2019</A></TD>
    <TD STYLE="text-align: center">F-3</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><A HREF="#a_003">Consolidated Statements of Operations and Comprehensive Loss - For the Years Ended December 31, 2020 and 2019</A></TD>
    <TD STYLE="text-align: center">F-4</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><A HREF="#a_004">Consolidated Statements of Changes in Shareholders&rsquo; Equity - For the Years Ended December 31, 2020 and 2019</A></TD>
    <TD STYLE="text-align: center">F-5</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><A HREF="#a_005">Consolidated Statements of Cash Flows &ndash; For the Years Ended December 31, 2020 and 2019</A></TD>
    <TD STYLE="text-align: center">F-6</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><A HREF="#a_006">Notes to Consolidated Financial Statements</A></TD>
    <TD STYLE="text-align: center">F-7</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_001"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Board of Directors and<BR>
Stockholders of Lonlon Biotech Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Opinion on the Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying balance sheets
of Lonlon Biotech Ltd. and its subsidiaries (collectively the Company) as of December 31, 2020 and 2019, and the related statements of
operations and comprehensive loss, changes in shareholders&rsquo; equity, and cash flows for each of the years in the two-year period
ended December 31, 2020, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements
present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its
operations and its cash flows for each of the years in the two-year period ended December 31, 2020, in conformity with accounting principles
generally accepted in the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Basis for Opinion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements are the responsibility
of the Company&rsquo;s management. Our responsibility is to express an opinion on the Company&rsquo;s financial statements based on our
audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding
of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s
internal control over financial reporting. Accordingly, we express no such opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Going Concern Matter</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements,
the Company has suffered significant losses from operations and had significant working capital deficit and accumulated deficit that raises
substantial doubt about its ability to continue as a going concern. Management&rsquo;s plans in regard to these matters are also described
in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">/s/ Friedman LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">We have served as the Company&rsquo;s auditor
since 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">New York, New York</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">June 24, 2021 </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A NAME="a_002"></A>LONLON BIOTECH LTD. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
BALANCE SHEETS</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSETS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT ASSETS:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,935</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">164,994</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,271</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,528</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverable VAT</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">335,150</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">320,247</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,962</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,355</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,017</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,007</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">546,335</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">649,131</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT ASSETS:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security deposit and other long-term assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,012</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,843</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use assets, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">320,123</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">487,797</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,567,522</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,110,094</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Non-current Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,937,657</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,673,734</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,483,992</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,322,865</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITIES AND SHAREHOLDERS&rsquo; EQUITY</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT LIABILITIES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">918,752</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable - related party</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">310,330</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79,439</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,810</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,014</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued leasehold improvements liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,583</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,428</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities and other payables</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,432</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,329</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,508</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,821</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred grant income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,679</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,074</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease obligation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">155,470</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,133</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,437,564</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">554,238</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT LIABILITIES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred grant income - noncurrent portion</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">351,677</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">495,651</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease obligation - noncurrent portion</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,566</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,235</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Non-current Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457,243</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">795,886</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,894,807</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,350,124</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments and Contingencies</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHAREHOLDERS&rsquo; EQUITY:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Ordinary shares, $1.00 par value; 50,000
    shares authorized;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001 shares issued and
    outstanding at December 2020 and 2019 *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional paid-in capital</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,946,197</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,946,197</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated deficit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,380,014</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,937,651</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated other comprehensive income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,001</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(45,806</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total shareholders&rsquo; equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">589,185</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,972,741</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities and Shareholders&rsquo; Equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,483,992</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,322,865</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The shares amounts are presented on a retroactive basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_003"></A>LONLON
BIOTECH LTD. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years Ended</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUES</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General laboratory testing</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">649,932</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,594</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immunology and hematology testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,183</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,736</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Revenues</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,090,115</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,330</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST OF REVENUES</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General laboratory testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">343,794</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,972</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immunology and hematology testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,444</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,269</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Cost of Revenues</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">541,238</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,241</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GROSS PROFIT</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General laboratory testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">306,138</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,622</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immunology and hematology testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">242,739</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,467</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Gross Profit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">548,877</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,089</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPERATING EXPENSES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,813,250</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,624,879</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and marketing expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">163,145</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">925,438</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,020,825</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(929,505</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(612,769</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Operating Expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,972,328</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,032,935</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS FROM OPERATIONS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,423,451</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,985,846</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER (EXPENSE) INCOME</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,397</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense - related party</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,169</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,654</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,942</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Other (Expense) Income, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,912</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,942</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS BEFORE INCOME TAXES</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,442,363</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,978,904</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCOME TAXES</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET LOSS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,442,363</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,978,904</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPREHENSIVE LOSS:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET LOSS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,442,363</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,978,904</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER COMPREHENSIVE INCOME (LOSS)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized foreign currency translation gain (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,807</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50,204</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPREHENSIVE LOSS</FONT></TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,383,556</FONT></TD>
    <TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,029,108</FONT></TD>
    <TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET LOSS PER ORDINARY SHARE:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(244.21)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(297.86)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WEIGHTED AVERAGE ORDINARY SHARES OUTSTANDING:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The shares and per share amounts are presented on a retroactive
basis.</TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A NAME="a_004"></A>LONLON BIOTECH LTD. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CONSOLIDATED STATEMENTS OF CHANGES IN SHAEHOLDERS&rsquo; EQUITY </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For the Years Ended December 31, 2020 and 2019</FONT></P>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Accumulated</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Ordinary Shares *</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Additional</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Other</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Paid-in<BR>
Capital</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Accumulated<BR>
Deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Comprehensive<BR>
Income (Loss)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Shareholders&rsquo;<BR>
Equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%">Balance as of December 31, 2018</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">10,001</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">10,001</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,946,197</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(2,958,747</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4,398</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,001,849</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Foreign currency translation adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(50,204</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(50,204</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss for the year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,978,904</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,978,904</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Balance as of December 31, 2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,946,197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,937,651</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(45,806</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,972,741</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Foreign currency translation adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,807</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,807</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Net loss for the year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,442,363</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,442,363</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Balance as of December 31, 2020</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">10,001</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">10,001</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,946,197</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(8,380,014</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">13,001</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">589,185</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The shares amounts are presented on a retroactive basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><A NAME="a_005"></A>LONLON BIOTECH LTD. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CONSOLIDATED STATEMENTS OF CASH FLOWS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2020</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2019</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">CASH FLOWS FROM OPERATING ACTIVITIES:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Net loss</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,442,363</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,978,904</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Adjustments to reconcile net loss to net cash used in operating activities:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt">Depreciation</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,147,115</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">889,410</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Amortization of right-of-use assets</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">189,283</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">169,451</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Loss on disposal of property and equipment</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12,855</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">406</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Changes in operating assets and liabilities:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Accounts receivable</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(41,306</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,540</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Recoverable VAT</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,973</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(93,654</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt">Inventory</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(13,907</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(92,778</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Prepaid expenses and other current assets</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">38,647</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">124,134</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Security deposit and other long-term assets</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,116</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Accounts payable</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">213,553</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">34,799</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Salary payable</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(7,849</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">50,441</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Accrued liabilities and other payables</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(24,445</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">34,546</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Deferred revenue</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">80,924</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,842</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 20pt">Deferred grant income</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(93,261</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(157,859</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Operating lease obligation</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(190,279</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(173,647</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">NET CASH USED IN OPERATING ACTIVITIES</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,121,944</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,192,353</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">CASH FLOWS FROM INVESTING ACTIVITIES:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Purchase of property and equipment</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(128,109</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(870,110</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prepayment for property and equipment</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(11,578</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">NET CASH USED IN INVESTING ACTIVITIES</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(128,109</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(881,688</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">CASH FLOWS FROM FINANCING ACTIVITIES</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Proceeds from borrowings</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">869,578</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Proceeds from related party&rsquo;s borrowings</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">608,704</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Repayments for related party&rsquo;s borrowings</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(376,817</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">NET CASH PROVIDED BY FINANCING ACTIVITIES</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,101,465</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">EFFECT OF EXCHANGE RATE ON CASH</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,529</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(16,066</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">NET DECREASE IN CASH</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(146,059</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,090,107</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">CASH&nbsp;&nbsp;- beginning of year</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">164,994</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,255,101</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">CASH - end of year</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">18,935</TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">164,994</TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Cash paid for:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; padding-left: 20pt">Interest</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">20,782</TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">NON-CASH INVESTING AND FINANCING ACTIVITIES:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 10pt">Property and equipment acquired on credit as payable</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">297,251</TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,439</TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 10pt">Property and equipment acquired by decreasing prepayment for long-term assets</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">26,087</TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of these consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="a_006"></A>LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>NOTE 1 &ndash; <U>ORGANIZATION AND NATURE OF OPERATIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lonlon Biotech Ltd. (&ldquo;Senlang&rdquo; or
the &ldquo;Company&rdquo;) is a holding company incorporated in the British Virgin Islands (&ldquo;BVI&rdquo;) on October 15, 2020. The
Company is mainly engaged in the business of research and development in relation to CAR-T cell therapy, immune cell therapy and related
drug development in the People&rsquo;s Republic of China (&ldquo;PRC&rdquo; or &ldquo;China&rdquo;), through a variable interest entity
(&ldquo;VIE&rdquo; as defined in Note 4), Hebei Senlang Biotechnology Co., Ltd. (&ldquo;SenlangBio&rdquo;), which was established on January
29, 2016, and subsidiary of the VIE. <FONT STYLE="background-color: white">SenlangBio also provides immunology and hematology testing
services, mainly related to cell therapy, including tumor biomarkers and immunophenotyping. On February 9, 2018, SenlangBio formed a wholly
owned subsidiary, Shijiazhuang Senlang Medical Laboratory Co., Ltd. (&ldquo;SenlangBio Clinical Laboratory&rdquo;), in China, which focuses
on general laboratory testing for patients and other customers, including genomics, proteomics, routine blood/urine testing, COVID-19
PCR/antibody testing etc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 2, 2020, Senlang established a wholly
owned subsidiary in Hong Kong, Lonlon Biotech Investment Limited (&ldquo;Senlang HK&rdquo;), which is a holding company. On November 20,
2020, Senlang HK established a Wholly Foreign-Owned Enterprise in China, Beijing Langlang Runfeng Biotechnology Co., Ltd. (&ldquo;Senlang
BJ&rdquo; or &ldquo;WFOE&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 26, 2021, Senlang BJ entered into a series
of contractual arrangements, or VIE agreements with SenlangBio and 13 equity holders of SenlangBio, through which the Company obtained
control and became the primary beneficiary of SenlangBio, hereinafter referred to as the Reorganization. As a result, SenlangBio became
the Company&rsquo;s VIE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 26, 2021, the Company completed its reorganization
of the entities under the common control of 13 majority shareholders through their 100% controlled entities incorporated in the British
Virgin Islands, and indirectly owned a majority of the equity interests of the Company, its subsidiaries, its VIE and the VIE&rsquo;s
subsidiary prior to and after the Reorganization. The Company was established as a holding company of Senlang BJ. Senlang BJ is the primary
beneficiary of SenlangBio, and all of these entities are under common control of the Company&rsquo;s ultimate controlling shareholders
before and after the Reorganization, which results in the consolidation of the Company and has been accounted for as a reorganization
of entities under common control at carrying value and for accounting purpose, the reorganization was accounted for as a recapitalization.
The consolidated financial statements are prepared on the basis as if the Reorganization became effective as of the beginning of the first
period presented in the accompanying consolidated financial statements of the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following chart illustrates the Company&rsquo;s
corporate structure, including its subsidiaries, consolidated variable interest entity and VIE&rsquo;s subsidiary as of the issuance
date of this report:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-2_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 1 &ndash; <U>ORGANIZATION AND NATURE OF
OPERATIONS (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>VIE Agreements with SenlangBio</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Upon the
completion of the reorganization, the Company, through the WFOE, entered into the following contractual arrangements with the VIE and
the VIE&rsquo;s 13 shareholders that enabled the Company to (1) have power to direct the activities that most significantly affects the
economic performance of the VIE, and (2) receive the economic benefits of the VIE that could be significant to the VIE. Accordingly, the
WFOE was considered the primary beneficiary of the VIE and had consolidated the VIE and the VIE&rsquo;s subsidiary&rsquo; financial results
of operations, assets and liabilities in the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><U>Contracts
that give the Company effective control of the VIE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Equity Pledge Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Equity Pledge Agreement between Senlang
BJ, SenlangBio and SenlangBio&rsquo;s shareholders, SenlangBio&rsquo;s shareholders agree to pledge all of their equity interests in SenlangBio
to Senlang BJ to guarantee the performance of SenlangBio and SenlangBio&rsquo;s shareholders&rsquo; obligations under the Exclusive Technical
Consultation and Service Agreement, the Exclusive Purchase Option Agreement, the Shareholder&rsquo;s Rights Proxy Agreement, and the Spousal
Consent (&ldquo;Transaction Agreements&rdquo;). Under the terms of the Equity Pledge Agreement, in the event that SenlangBio or SenlangBio&rsquo;s
shareholders breach their respective contractual obligations under the Transaction Agreements or the Equity Pledge Agreement, Senlang
BJ, as pledgee, is entitled to directly exercise the pledge right and to notify SenlangBio&rsquo;s shareholders to immediately repay or
pay the loans or other payables under the Transaction Agreements. SenlangBio&rsquo;s shareholders further agreed not to dispose of the
pledged equity interests without prior written consent from Senlang BJ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The pledge is effective on the date when the registration
of the equity pledge is completed with the competent administration for industry and commerce, and the term of validity of the pledge
is the same as the longest term of validity in the Transaction Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purposes of the Equity Pledge Agreement are
to (1)&nbsp;guarantee the performance of SenlangBio and SenlangBio&rsquo;s shareholders&rsquo; obligations under the Transaction Agreements,
(2)&nbsp;make sure SenlangBio&rsquo;s shareholders do not transfer or assign the pledged equity interests, or create or allow any encumbrance
that would prejudice interests of Senlang BJ without prior written consent from Senlang BJ, and (3)&nbsp;provide Senlang BJ control over
SenlangBio.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event SenlangBio or SenlangBio&rsquo;s
shareholders breaches their contractual obligations under the Transaction Agreements or Equity Pledge Agreement, Senlang BJ will be entitled
to (1) be compensated on a preferential basis with the proceeds from the conversion, auction or sale of the pledged equity, and (2) notify
SenlangBio&rsquo;s shareholders to immediately repay the loans or other payables under the Transaction Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exclusive Purchase Option Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Exclusive Purchase Option Agreement,
SenlangBio&rsquo;s shareholders irrevocably grants Senlang BJ (or its designee) an exclusive right to purchase the equity held by SenlangBio&rsquo;s
shareholders in the SenlangBio in whole or in part at any time during the term of the Agreement; SenlangBio also irrevocably grants Senlang
BJ (or its designee) an exclusive right to purchase the assets owned by SenlangBio in whole or in part at any time during the term of
the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to consideration for equity purchase,
Senlang BJ has the right to purchase all or part of the equity held by SenlangBio&rsquo;s shareholders in SenlangBio at the lowest price
permitted by the PRC laws. With respect to the price for asset purchase, Senlang BJ has the right to purchase SenlangBio&rsquo;s assets
at a price equivalent of the net book value of the purchased assets; provided that if the minimum price permitted by the PRC law is higher
than the net book value, the minimum price permitted by the PRC laws will prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Exclusive Purchase Option Agreement,
Senlang BJ may purchase all or part of the equity held by SenlangBio&rsquo;s shareholders in SenlangBio and all or part of the assets
owned by SenlangBio at any time to the extent permitted by PRC laws. The Exclusive Purchase Option Agreement, together with the Equity
Pledge Agreement, Exclusive Technical Consultation and Service Agreement, and the Proxy Agreement, enable Senlang BJ to exercise effective
control over SenlangBio. The Exclusive Purchase Option Agreement will become effective upon the affixation of signatures or corporate
seals by the Senlang BJ, SenlangBio and SenlangBio&rsquo;s shareholders, and will remain in effect, unless terminated by Senlang BJ by
giving a thirty (30) day advance written notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 1 &ndash; <U>ORGANIZATION AND NATURE OF
OPERATIONS (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><U>Contracts
that give the Company effective control of the VIE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Shareholder&rsquo;s Rights Proxy Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Shareholder&rsquo;s Rights Proxy Agreement,
SenlangBio&rsquo;s shareholders authorize any entity or individual designated by Senlang BJ to act on their behalf as their exclusive
agent to exercise all shareholder&rsquo;s rights under the PRC laws and the Articles of Association, including but not limited to: (a)
to convene, attend and vote on all the matters during shareholders&rsquo; meetings; (b) to transfer, pledge or dispose of, or create encumbrance
on the equity; (c) to receive dividends; (d) to participate in judicial proceedings or execute legal documents in relation to shareholders&rsquo;
rights; (e) to appoint legal representatives, directors and officers of SenlangBio; and (f) to enter into contracts and exercise the Exclusive
Purchase Option Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Shareholder&rsquo;s Rights Proxy Agreement
shall remain effective until the earlier of: (a) the date on which SenlangBio&rsquo;s shareholders are no longer the nominee or actual
shareholders of Senlang BJ; (b) the date on which Senlang BJ requests the proxy to be terminated in writing; or (c) the date on which
the assets and licenses of SenlangBio have been fully transferred to Senlang BJ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><U>Contracts
that enable the Company to receive substantially all of the economic benefits from the VIE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exclusive Technical Consultation and Service
Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Exclusive Technical Consultation
and Service Agreement between Senlang BJ and SenlangBio, Senlang BJ provides SenlangBio with technical consultation and services, including
conducting market research, assisting with developing management and sales plans, implementing relevant technology application, and providing
other consultation services for computer network, finance, business, legal affairs, operation, human resources, and other aspects of SenlangBio.
Additionally, Senlang BJ agrees to grant SenlangBio its trademarks, software copyrights, management systems, management methods and other
intellectual property in relation to its services on a chargeable and revocable basis, but such grant shall not result in the transfer
of any intellectual property or create any restriction on Senlang BJ&rsquo;s full ownership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For services rendered to SenlangBio under this
agreement, Senlang BJ is entitled to collect a service fee calculated based on the complexity of services rendered, time required by Senlang
BJ, and the exact contents and commercial value of services rendered. During the term of this agreement, Senlang BJ shall enjoy all the
economic benefits derived from SenlangBio&rsquo;s operation, and in the event of serious difficulties in SenlangBio&rsquo;s operations,
Senlang BJ may provide SenlangBio with financial support, and Senlang BJ has the right to request SenlangBio to cease operation. The Exclusive
Technical Consultation and Service Agreement shall remain in effect for ten (10) years and shall be automatically renewed unless it is
terminated earlier by Senlang BJ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the foregoing VIE Agreements, Senlang
BJ has effective control of SenlangBio which enables Senlang BJ to receive all of the expected residual returns and absorb the expected
losses of the VIE and its subsidiary.&nbsp;<FONT STYLE="background-color: white">Management therefore concludes that the Company, through
the above contractual arrangements, has the power to direct the activities that most significantly impact the VIE&rsquo;s economic performance,
bears the risks of and enjoys the rewards normally associated with ownership of the VIE, and therefore the Company is the ultimate primary
beneficiary of the VIE. Consequently,&nbsp;</FONT>the Company consolidates the accounts of SenlangBio and its subsidiary for the periods
presented herein, in accordance with&nbsp;<FONT STYLE="background-color: white">Accounting Standards Codification (&ldquo;</FONT>ASC&rdquo;)
810-10, Consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
reflect the activities of Senlang and each of the following entities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 19%">Name</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 56%; text-align: center">Background</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 23%; text-align: center">Ownership</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><B>Subsidiaries:</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Senlang HK</TD>
    <TD>&nbsp;</TD>
    <TD>A Hong Kong company</TD>
    <TD>&nbsp;</TD>
    <TD>100% owned by Senlang</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated on November 2, 2020</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Senlang BJ</TD>
    <TD>&nbsp;</TD>
    <TD>A PRC limited liability company and a wholly foreign owned enterprise</TD>
    <TD>&nbsp;</TD>
    <TD>100% owned by Senlang HK</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated on November 20, 2020</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><B>VIE:</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>SenlangBio</TD>
    <TD>&nbsp;</TD>
    <TD>A PRC limited liability company</TD>
    <TD>&nbsp;</TD>
    <TD>VIE</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated on January 29, 2016 Immunology and hematology testing service provider</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><B>VIE&rsquo;s subsidiary:</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>SenlangBio</TD>
    <TD>&nbsp;</TD>
    <TD>A PRC limited liability company</TD>
    <TD>&nbsp;</TD>
    <TD>100% owned by SenlangBio</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Clinical Laboratory</TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated on February 9, 2018</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>General laboratory testing service provider</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white"><B>NOTE
2 &ndash; <U>BASIS OF PRESENTATION AND GOING CONCERN AND LIQUIDITY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Basis of Presentation </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (&ldquo;U.S.
GAAP&rdquo;) and with the rules and regulations of the U.S. Securities and Exchange Commission for financial information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s consolidated financial statements
include the accounts of the Company and its subsidiaries, VIE and subsidiary of VIE over which the Company exercises control and, when
applicable, entity for which the Company has a controlling financial interest or is the primary beneficiary. All significant intercompany
accounts and transactions have been eliminated in consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Going Concern and Liquidity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company currently has limited operations.
Currently, the Company&rsquo;s operations are focused on <FONT STYLE="background-color: white">utilizing cell and gene engineering technologies
to generate innovative and transformative cellular immunotherapies for solid and hematologic cancers. The Company provides </FONT>general
laboratory testing and <FONT STYLE="background-color: white">immunology and hematology testing services</FONT> for patients and other
customers in China. These consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As reflected in the accompanying consolidated
financial statements, the Company had <FONT STYLE="background-color: white">a working capital deficit and accumulated deficit of $1,891,229
and $8,380,014, respectively</FONT>, at December 31, 2020, has incurred net loss of $2,442,363 and $2,978,904, respectively, for the years
ended December 31, 2020 and 2019, and generated negative cash flow from operating activities of $1,121,944 and $2,192,353, respectively,
for the year ended December 31, 2020 and 2019. The Company has a limited operating history and its continued growth is dependent upon
the continuation of providing general laboratory testing and <FONT STYLE="background-color: white">immunology and hematology testing services,</FONT>
and obtaining additional financing to fund future obligations and pay liabilities arising from normal business operations. In addition,
the current cash balance cannot be projected to cover the operating expenses for the next twelve months from the release date of this
report. These matters raise substantial doubt about the Company&rsquo;s ability to continue as a going concern. The ability of the Company
to continue as a going concern is dependent on the Company&rsquo;s ability to raise additional capital, implement its business plan, and
generate significant revenues. There are no assurances that the Company will be successful in its efforts to generate significant revenues,
maintain sufficient cash balance or report profitable operations or to continue as a going concern. The Company plans on raising capital
through bank and other borrowings to implement its business plan. However, there is no assurance these plans will be realized and that
any additional financings will be available to the Company on satisfactory terms and conditions, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The occurrence of an uncontrollable event such
as the COVID-19 pandemic could negatively impact the Company&rsquo;s operations even though the pandemic did not significantly impact
the Company&rsquo;s operation in 2020. However, given the dynamic nature of these circumstances, the uncertainty around the potential
resurgence of the COVID-19 cases in China, and the instability of local policies and restrictions, the COVID-19 impact over the Company&rsquo;s
business in the year of 2021 cannot be reasonably estimated at this time. If COVID-19 cases resurged in the area the Company conducted
its business and local government implemented new restrictions in the effort to contain the spread, it is expected the Company&rsquo;s
business will be negatively impacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification
of liabilities that may result should the Company be unable to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Use of Estimates and
Assumptions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The preparation of the
consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates
during the years ended December 31, 2020 and 2019 include the useful lives of property and equipment, assumptions used in assessing impairment
of long-term assets, and valuation of deferred tax assets and the associated valuation allowances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Fair Value of Financial Instruments and
Fair Value Measurements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">The
Company adopted the guidance of Accounting Standards Codification (&ldquo;ASC&rdquo;) 820 for fair value measurements which clarifies
the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs
used <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in measuring fair value as follows</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            <FONT STYLE="background-color: white">1-Inputs are unadjusted quoted prices in active markets
                                            for identical assets or liabilities available at the measurement date.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            <FONT STYLE="background-color: white">2-Inputs are unadjusted quoted prices for similar assets
                                            and liabilities in active markets, quoted prices for identical or similar assets and liabilities
                                            in markets that are not active, inputs other than quoted prices that are observable, and
                                            inputs derived from or corroborated by observable market data.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            <FONT STYLE="background-color: white">3-Inputs are unobservable inputs which reflect the
                                            reporting entity&rsquo;s own assumptions on what assumptions the market participants would
                                            use in pricing the asset or liability based on the best available information.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying values of current assets and current liabilities in the Company&rsquo;s consolidated balance sheets approximated their fair
values as of December 31, 2020 and 2019 due to their short-term nature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
825-10 &ldquo;Financial Instruments&rdquo;, allows entities to voluntarily choose to measure certain financial assets and liabilities
at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless
a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should
be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding
instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Cash
consists of cash on hand and cash in the bank. The Company maintains cash with financial institutions in the PRC. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Credit
Risk and Uncertainties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s cash is maintained with state-owned banks within the PRC. Balances at state-owned banks within the PRC are covered by
insurance up to RMB 500,000 (approximately $77,000) per bank. Any balance over RMB 500,000 per bank in PRC will not be covered. At December
31, 2020, cash balances held in the PRC are RMB 123,659 (approximately $19,000). The Company has not experienced any losses in such accounts
and believes it is not exposed to any risks on its cash in bank accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s operations are carried out in PRC. Accordingly, the Company&rsquo;s business, financial condition and results of operations
may be influenced by the political, economic and legal environment in the PRC, and by the general state of the PRC&rsquo;s economy. The
Company&rsquo;s operations in PRC are subject to specific considerations and significant risks not typically associated with companies
in North America. The Company&rsquo;s results may be adversely affected by changes in governmental policies with respect to laws and
regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments which potentially subject the Company to concentrations of credit risk consist principally of trade accounts receivable.
A portion of the Company&rsquo;s sales are credit sales which is to the customer whose ability to pay is dependent upon the industry
economics prevailing in Hebei province, China; however, concentrations of credit risk with respect to trade accounts receivable is limited
due to short term payment terms. The Company also performs ongoing credit evaluations of its customers to help further reduce credit
risk.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounts
Receivable and Allowance for Doubtful Accounts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are presented net of an allowance for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated
losses. The Company reviews the accounts receivable on a periodic basis and makes general and specific allowances when there is doubt
as to the collectability of individual balances. In evaluating the collectability of individual receivable balances, the Company considers
many factors, including the age of the balance, a customer&rsquo;s payment history, its current credit-worthiness and current economic
trends. Accounts are written off after exhaustive efforts at collection.&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
believes that the accounts receivable are fully collectable. Therefore, no allowance for doubtful accounts is deemed to be required on
its accounts receivable at December 31, 2020 and 2019. The Company historically has not experienced significant uncollectible accounts
receivable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inventory</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Inventory
consists of raw materials. Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out
(FIFO) method.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;A reserve is established when management
determines that certain inventory may not be saleable. If inventory costs exceed expected net realizable value due to obsolescence or
quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the estimated net realizable
value. The Company did not record any inventory reserve at December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prepaid
Expenses and Other Current Assets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
expenses and other current assets primarily consist of prepaid utilities and prepaid internet service fees, which are recognized as expenses
over the related service periods. As of December 31, 2020 and 2019, prepaid expenses and other current assets amounted to $21,017 and
$58,007, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property
and Equipment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are carried at cost and are depreciated on a straight-line basis over the estimated useful lives of the assets. The estimated
useful lives are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Useful Life</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Estimated Residual Value Rate</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 53%; font: 10pt Times New Roman, Times, Serif; text-align: left">Laboratory equipment</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 25%; font: 10pt Times New Roman, Times, Serif; text-align: center">3 - 5 Years</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif; text-align: center">5%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Office equipment and furniture</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">3 - 5 Years</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">5%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Vehicles</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">4 - 5 Years</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">5%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left">Leasehold improvements</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Shorter of the remaining lease terms or estimated useful life</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">0%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Software</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">1 - 2 Years</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">0%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired
or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in
income or loss in the period of disposition. The Company examines impairment of fixed assets when events or changes in circumstances
reflect the fact that their recorded value may not be recoverable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impairment
of Long-lived Assets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC Topic 360, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate
that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss
when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured
as the difference between the asset&rsquo;s estimated fair value and its book value. There were no triggering events requiring assessment
of impairment as of December 31, 2020 and 2019. For the years ended December 31, 2020 and 2019, no impairment of long-lived assets was
recognized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Government
Grants and Deferred Grant Income</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
grants related to purchased long-live assets, most of which are laboratory equipment for research and development, are recorded as deferred
grant income initially and recognized as grant income on a systematic basis over the useful lives of the assets. Government grants that
are to compensate incurred costs, expenses or losses are recognized in the current period. The Company applies the presentation method
consistently to the similar government grants in the consolidated financial statements. Government grants that are related to operating
activities are included in operating income (loss), otherwise, they are recorded in other income (expense).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grants
and subsidies received from Chinese government are recognized when the proceeds are received or collectible and related milestones have
been reached and all contingencies have been resolved. For the years ended December 31, 2020 and 2019,&nbsp;grant income&nbsp;amounted
to $929,505 and $612,769, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
grant income represents grants collected but not earned as of each of the balance sheet date. This is primarily composed of receipts
of the government subsidies for acquisition of lab equipment and reimbursement on office rent and research and development expense. Deferred
grant income was recognized as grant income in accordance with aforementioned methodology. As of December 31, 2020 and 2019, deferred
grant income amounted to $612,356 and $666,725, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Value
Added Tax</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to value added tax (&ldquo;VAT&rdquo;) on revenues earned for services provided in the PRC. The amount of VAT liability
is determined by applying the applicable tax rates to the invoiced amount of services provided (output VAT) less VAT paid on purchases
made with the relevant supporting invoices (input VAT). The Company reports revenue net of PRC&rsquo;s value added tax for all the periods
presented in the consolidated statements of operations and comprehensive loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accrued
Liabilities and Other Payables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
liabilities and other payables primarily consist of accrued and unpaid interest related to notes payable, taxes payable, and accrued
liabilities for other miscellaneous items. As of December 31, 2020 and 2019, accrued liabilities and other payables amounted to $37,432
and $59,329, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Deferred
Revenue</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Payments
received prior to services being performed are recorded as deferred revenue until such time as the services are performed. As of December
31, 2020 and 2019, deferred revenue amounted to $88,508 and $2,821, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revenue
Recognition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2018, the Company began recognizing revenue under Accounting Standards Codification (&ldquo;ASC&rdquo;)&nbsp;Topic 606,&nbsp;Revenue
from Contracts with Customers&nbsp;(&ldquo;ASC 606&rdquo;), using the modified retrospective transition method. The&nbsp;impact of adopting
the new revenue standard was not material to the Company&rsquo;s consolidated financial statements and there was no adjustment to beginning
accumulated deficit on January 1, 2018.&nbsp;&nbsp;&nbsp;The core principle of the revenue standard is that a company should recognize
revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company
expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
                                            1: Identify the contract with the customer</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
                                            2: Identify the performance obligations in the contract</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
                                            3: Determine the transaction price</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
                                            4: Allocate the transaction price to the performance obligations in the contract</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
                                            5: Recognize revenue when the company satisfies a performance obligation</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revenue
Recognition (continued)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
order to identify the performance obligations in a contract with a customer, a company must assess the promised goods or services in
the contract and identify each promised goods or service that is distinct. A performance obligation meets ASC 606&rsquo;s definition
of a &ldquo;distinct&rdquo; goods or service (or bundle of goods or services) if both of the following criteria are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            customer can benefit from the goods or service either on its own or together with other resources
                                            that are readily available to the customer (i.e., the goods or service is capable of being
                                            distinct).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            entity&rsquo;s promise to transfer the goods or service to the customer is separately identifiable
                                            from other promises in the contract (i.e., the promise to transfer the goods or service is
                                            distinct within the context of the contract).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a goods or service is not distinct, the goods or service is combined with other promised goods or services until a bundle of goods or
services is identified that is distinct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). The consideration
promised in a contract with a customer may include fixed amounts, variable amounts, or both. Variable consideration is included in the
transaction price only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will
not occur when the uncertainty associated with the variable consideration is subsequently resolved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is allocated to each performance obligation on a relative standalone selling price basis. The transaction price allocated
to each performance obligation is recognized when that performance obligation is satisfied, at a point in time or over time as appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s revenues are derived from providing general laboratory testing services and immunology and hematology testing services
for patients and other customers. Revenues related to its service offerings are recognized at a point in time when service is rendered.
<FONT STYLE="background-color: white">Any payments received in advance of the performance of services are recorded as&nbsp;deferred revenue&nbsp;until
such time as the services are performed. Except for deferred revenue, the Company did not have any other contract liability nor contract
asset as of December 31, 2020 and 2019.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not offer promotional payments, customer coupons, rebates or other cash redemption offers to its customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has concluded that its government grants are not within the scope of ASC Topic 606 as they do not meet the definition of a contract
with a customer. The Company has concluded that the grants meet the definition of a contribution and are non-reciprocal transactions,
and has also concluded that Subtopic 958-605, Not-for-Profit-Entities-Revenue Recognition does not apply, as it is a business entity
and the grants are with governmental agencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the absence of applicable guidance under US GAAP, effective January 1, 2018, the Company developed a policy for the recognition of grant
revenue when the related costs are incurred or the related long-live assets are purchased, and the right to payment is realized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes this policy is consistent with the overarching premise in ASC Topic 606, to ensure that revenue recognition reflects
the transfer of promised goods or services to customers in an amount that reflects the consideration that it expects to be entitled to
in exchange for those goods or services, even though there is no exchange as defined in ASC Topic 606.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes the recognition of revenue as costs are incurred or long-live assets are purchased, and amounts become realizable is
analogous to the concept of transfer of control of a service over time under ASC Topic 606.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disaggregation
of Revenues</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the following table, revenues are disaggregated by segment for the years ended December 31, 2020 and 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Revenue Stream</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2019</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Revenue Stream Detail</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: left">General laboratory testing</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">649,932</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">77,594</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif; text-align: justify">Providing general laboratory testing services, including genomics, proteomics, routine blood/urine testing, COVID-19 PCR/antibody testing etc., to patients and other customers.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">440,183</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,736</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Providing immunology and hematology testing services, mainly related to cell therapy, including tumor biomarkers and immunophenotyping, to customers.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total revenue</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,090,115</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">93,330</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operating
Lease</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, the Financial Accounting Standards Board (the &ldquo;FASB&rdquo;) issued Accounting Standards Update (&ldquo;ASU&rdquo;)
2016-02, Leases (Topic 842). Lessees are required to recognize a right-of-use asset and a lease liability for virtually all of their
leases (other than leases that meet the definition of a short-term lease). The liability is equal to the present value of lease payments.
The asset is based on the liability, subject to certain adjustments, such as for initial direct costs. For income statement purposes,
a dual model was retained, requiring leases to be classified as either operating or finance leases. Operating leases result in straight-line
expense (similar to operating leases under the prior accounting standard) while finance leases result in a front-loaded expense pattern
(similar to capital leases under the prior accounting standard). Lessor accounting is similar to the prior model but updated to align
with certain changes to the lessee model (e.g., certain definitions, such as initial direct costs, have been updated) and the new revenue
standard, ASU 2014-9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted this new accounting standard on January 1, 2018 on a modified retrospective basis and applied the new standard to leases
through a cumulative-effect adjustment to beginning accumulated deficit. As a result, comparative financial information has not been
restated and continues to be reported under the accounting standards in effect for those periods. The Company elected to adopt both the
transition relief provided in ASU 2018-11 and the package of practical expedients which allowed it, among other things, to retain historical
lease classifications and accounting for any leases that existed prior to adoption of the standard. Additionally, the Company elected
the practical expedients allowing it not to separate lease and non-lease components and not record leases with an initial term of twelve
months or less (&ldquo;short-term leases&rdquo;) on the balance sheets across all existing asset classes. The new standard had a material
impact on the consolidated balance sheets but did not materially impact the Company&rsquo;s consolidated operating results and had no
impact on the Company&rsquo;s beginning accumulated deficit and cash flows. The following is a discussion of the Company&rsquo;s lease
policy under the new lease accounting standard:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&rsquo;s
right to use an underlying asset for the lease term and lease liabilities represent the Company&rsquo;s obligation to make lease payments
arising from the lease. Right-of- use assets and lease liabilities are recognized at the commencement date based on the present value
of the remaining future minimum lease payments. As the interest rate implicit in the Company&rsquo;s leases is not readily determinable,
the Company utilizes its borrowing rates set by the Central Bank of the People&rsquo;s Republic of China, determined by class of underlying
asset, to discount the lease payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases premises for offices under non-cancellable operating leases. Operating lease payments are expensed over the term of lease.
The Company leases do not include options to extend nor any restrictions or covenants. The Company has historically been able to renew
its office leases. Under the terms of the lease agreements, the Company has no legal or contractual asset retirement obligations at the
end of the lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Impact
of New Lease Standard on Balance Sheet Line Items</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of applying the new lease standard using a modified retrospective method, the Company recognized operating lease right-of-use
assets of $799,983, current portion of operating lease liabilities of $150,985, and long-term operating lease liabilities of $648,998
as of January 1, 2018. There is no impact on equity as of January 1, 2018, the date of adoption. See Note 13.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General
Laboratory Testing Services Costs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
of general laboratory testing services include the cost of inventory, labor and related benefits, depreciation, and other overhead costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Immunology
and Hematology Testing Services Costs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
of immunology and hematology testing services include the cost of inventory, labor and related benefits, depreciation, and other overhead
costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employee
Benefits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
full-time employees of the Company are entitled to staff welfare benefits including medical care, housing fund, pension benefits, unemployment
insurance and other welfare, which are government mandated defined contribution plans. The Company is required to accrue for these benefits
based on certain percentages of the employees&rsquo; respective salaries, subject to certain ceilings, in accordance with the relevant
PRC regulations, and make cash contributions to the state-sponsored plans out of the amounts accrued. Total expenses for the plans were
$135,231 and $221,232 for the years ended December 31, 2020 and 2019, respectively, which were charged to the same accounts as the related
salary costs in the same period as the related salary costs incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research
and Development</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures
for research and product development costs are expensed as incurred. The Company incurred research and development expense of $2,813,250
and $2,624,879 in the years ended December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Income
Taxes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes using the asset/liability method prescribed by ASC 740, &ldquo;Income Taxes.&rdquo; Under this method,
deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and
liabilities using enacted tax rates that will be in effect in the period in which the differences are expected to reverse. The Company
records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not
that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is
recognized as income or loss in the period that includes the enactment date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 &ldquo;Income Taxes&rdquo;. Using
that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position
will be sustained upon examination by the tax authorities. As of December 31, 2020 and 2019, the Company had no significant uncertain
tax positions that qualify for either recognition or disclosure in the financial statements. Tax year that remains subject to examination
is the years ended December 31, 2016 through December 31, 2020. The Company recognizes interest and penalties related to significant
uncertain income tax positions in income tax expense. However, no such interest and penalties were recorded as of December 31, 2020 and
2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Loss per share</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company computes
loss per share in accordance with ASC 260, &ldquo;Earnings per Share&rdquo; (&ldquo;ASC 260&rdquo;). ASC 260 requires companies with complex
capital structures to present basic and diluted earnings per share (&ldquo;EPS&rdquo;). Basic EPS is measured as net income divided by
the weighted average common shares outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of potential
common shares (e.g. convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e. those that increase income per share or decrease
loss per share) are excluded from the calculation of diluted EPS. As of December 31, 2020 and 2019, there were no dilutive shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
Currency Translation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency of the Company is U.S. Dollars. The functional currency of the parent company, Senlang, and Senlang HK, is the U.S.
dollar and the functional currency of Senlang BJ, SenlangBio, and SenlangBio Clinical Laboratory is the Chinese Renminbi (&ldquo;RMB&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monetary
assets and liabilities denominated in currencies other than the reporting currency are translated into the reporting currency at the
rates of exchange prevailing at the balance sheet date. Revenue and expenses are translated using average rates during each reporting
period, and shareholders&rsquo; equity is translated at historical exchange rates. Cash flows are also translated at average translation
rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding
balances on the consolidated balance sheet. Translation adjustments resulting from the process of translating the local currency financial
statements into U.S. dollars are included in determining comprehensive income/loss. Transactions denominated in foreign currencies are
translated into the functional currency at the exchange rates prevailing on the transaction dates. Assets and liabilities denominated
in foreign currencies are translated into the functional currency at the exchange rates prevailing at the balance sheet date with any
transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional
currency are included in the results of operations as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
Currency Translation (continued)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Company&rsquo;s revenue transactions are transacted in the functional currency of the Company. The Company does not enter into
any material transaction in foreign currencies. Transaction gains or losses have not had, and are not expected to have, a material effect
on the results of operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset
and liability accounts at December 31, 2020 and 2019 were translated at 6.5306 RMB and 6.9632 RMB to $1.00, respectively, which were
the exchange rates on the balance sheet dates. Equity accounts were stated at their historical rates. The average translation rates applied
to the statements of operations for the years ended December 31, 2020 and 2019 were 6.8999 RMB and 6.9099 RMB to $1.00, respectively.
Cash flows from the Company&rsquo;s operations are calculated based upon the local currencies using the average translation rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Comprehensive
Loss</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
loss is comprised of net loss and all changes to the statements of equity, except those due to investments by shareholders, changes in
paid-in capital and distributions to shareholders. For the Company, comprehensive loss for the years ended December 31, 2020 and 2019
consisted of net loss and unrealized gain/loss from foreign currency translation adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commitment
and Contingencies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of business, the Company is subject to contingencies, such as legal proceedings and claims arising out of its business,
that cover a wide range of matters. Liabilities for such contingencies are recorded when it is probable that a liability has been incurred
and the amount of the assessment can be reasonably estimated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Segment
Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The&nbsp;Company
uses &ldquo;the management approach&rdquo; in determining reportable operating segments. The management approach considers the internal
organization and reporting used by the Company&rsquo;s chief operating decision maker for making operating decisions and assessing performance
as the source for determining the Company&rsquo;s reportable segments. The Company&rsquo;s chief operating decision maker is its Chief
Executive Officer (&ldquo;CEO&rdquo;), who reviews operating results to make decisions about allocating resources and assessing performance
for the entire Company. The Company has determined that it has two reportable business segments: general laboratory testing segment,
and immunology and hematology testing segment. These reportable segments offer different types of services and products, have different
types of revenue, and are managed separately as each requires different operating strategies and management expertise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are
controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management,
members of the immediate families of principal owners of the Company and its management and other parties with which the Company may
deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one
of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all significant related
party transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Accounting Standards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the FASB issued ASU No. 2018-13,&nbsp;<I>Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure
Requirements for Fair Value Measurement</I>. The objective of ASU 2018-13 is to improve the effectiveness of disclosures in the notes
to the financial statements by removing, modifying, and adding certain fair value disclosure requirements to facilitate clear communication
of the information required by generally accepted accounting principles. The amendments are effective for all entities for fiscal years,
and interim periods within those fiscal years, beginning after December 15, 2019 with early adoption permitted upon issuance of this
ASU. The adoption of ASU 2018 &ndash; 13 did not have a material impact on the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Accounting Standards (continued)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued&nbsp;ASU 2016-13,&nbsp;<I>Financial Instruments - Credit Losses (&ldquo;Topic 326&rdquo;).&nbsp;</I>The ASU
introduces a new accounting model, the Current Expected Credit Losses model (&ldquo;CECL&rdquo;), which requires<I>&nbsp;</I>earlier
recognition of credit losses and additional disclosures related to credit risk.&nbsp;The CECL model utilizes a lifetime expected credit
loss measurement objective for the recognition of credit losses at the time the financial asset is originated or acquired. ASU 2016-13
is effective for annual period beginning after December 15, 2022, including interim reporting periods within those annual reporting periods.
The Company expects that the adoption will not have a material impact on the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU 2019-12, <I>Simplifying the Accounting for Income Taxes, as part of its Simplification Initiative
to reduce the cost and complexity in accounting for income taxes. </I>This standard removes certain exceptions related to the approach
for intra period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax
liabilities for outside basis differences. It also amends other aspects of the guidance to help simplify and promote consistent application
of GAAP. The guidance is effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. The
Company is evaluating the effects that the adoption of this guidance will have its consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are
not anticipated to have an impact on or are unrelated to its consolidated financial condition, results of operations, cash flows or disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
4 &ndash;&nbsp;<U>VARIABLE INTEREST ENTITY AND OTHER CONSOLIDATION MATTERS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 26, 2021, Senlang BJ entered into VIE Agreements with SenlangBio and 13 shareholders of SenlangBio. The key terms of these VIE
Agreements are summarized in &ldquo;NOTE 1 &ndash; ORGANIZATION AND NATURE OF OPERATIONS&rdquo; above. As a result of the VIE Agreements,
the Company classifies SenlangBio as a VIE.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without
additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such
as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of
the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary
and must consolidate the VIE. Senlang BJ is deemed to have a controlling financial interest and be the primary beneficiary of SenlangBio,
because it has both of the following characteristics:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
                                            to direct activities of a VIE that most significantly impact the entity&rsquo;s economic
                                            performance, and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligation
                                            to absorb losses of the entity that could potentially be significant to the VIE or right
                                            to receive benefits from the entity that could potentially be significant to the VIE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the VIE Agreements, SenlangBio pays service fees equal to all of its net income to Senlang BJ. At the same time, Senlang BJ is entitled
to receive all of SenlangBio&rsquo;s expected residual returns. The VIE Agreements are designed so that SenlangBio operates for the benefit
of the Company. Accordingly, the accounts of SenlangBio are consolidated in the accompanying financial statements pursuant to ASC 810-10,
Consolidation. In addition, its financial positions and results of operations are included in the Company&rsquo;s consolidated financial
statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as all of these VIE agreements are governed by PRC law and provide for the resolution of disputes through arbitration in the
PRC, they would be interpreted in accordance with PRC law and any disputes would be resolved in accordance with PRC legal procedures.
The legal environment in the PRC is not as developed as in other jurisdictions, such as the United States. As a result, uncertainties
in the PRC legal system could further limit the Company&rsquo;s ability to enforce these VIE agreements. Furthermore, these contracts
may not be enforceable in China if PRC government authorities or courts take a view that such contracts contravene PRC laws and regulations
or are otherwise not enforceable for public policy reasons. In the event the Company is unable to enforce these VIE agreements, it may
not be able to exert effective control over SenlangBio and its ability to conduct its business may be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
4 &ndash;&nbsp;<U>VARIABLE INTEREST ENTITY AND OTHER CONSOLIDATION MATTERS (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Company&rsquo;s main current operations are conducted through SenlangBio and subsidiary of SenlangBio. Current regulations in
China permit SenlangBio to pay dividends to the Company only out of its accumulated distributable profits, if any, determined in accordance
with its article of association and PRC accounting standards and regulations. The ability of SenlangBio to make dividends and other payments
to the Company may be restricted by factors including changes in applicable foreign exchange and other laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following consolidated financial information of the VIE and VIE&rsquo;s subsidiary as a whole as of December 31, 2020 and 2019 and for
the years ended December 31, 2020 and 2019 was included in the accompanying consolidated financial statements of the Company. Transactions
between the VIE and VIE&rsquo;s subsidiary are eliminated in the financial information presented below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December&nbsp;31,</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif">Cash</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">18,935</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">164,994</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">45,271</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,528</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Recoverable VAT</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">335,150</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">320,247</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Inventory</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">125,962</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">104,355</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">21,017</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">58,007</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Security deposit and other long-term assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">50,012</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">75,843</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating lease right-of-use assets, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">320,123</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">487,797</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Property and equipment, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,567,522</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,110,094</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total Assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,483,992</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,322,865</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Notes payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">918,752</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Notes payable - related party</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">245,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">310,330</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">79,439</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Salary payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">105,810</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">107,014</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued leasehold improvements liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">315,583</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,428</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued liabilities and other payables</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,432</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">59,329</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred revenue</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">88,508</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,821</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred grant income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">260,679</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">171,074</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating lease obligation</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">155,470</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">133,133</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred grant income - noncurrent portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">351,677</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">495,651</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Operating lease obligation - noncurrent portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">105,566</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">300,235</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total Liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,894,807</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,350,124</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Net Assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">589,185</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,972,741</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended December&nbsp;31,</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 76%">Revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1,090,115</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">93,330</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from operations</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,423,451</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,985,846</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,442,363</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,978,904</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
5 &ndash;&nbsp;<U>SECURITY DEPOSIT AND OTHER LONG-TERM ASSETS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2020 and 2019, security deposit and other long-term assets consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December&nbsp;31, <BR>
2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December&nbsp;31, <BR>
2019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Security deposit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">50,012</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">49,993</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Prepayment for leasehold improvements</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">25,850</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">50,012</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">75,843</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
6 &ndash;&nbsp;<U>PROPERTY AND EQUIPMENT, NET</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2020 and 2019, property and equipment consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December&nbsp;31, <BR> 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December&nbsp;31, <BR> 2019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Laboratory equipment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">2,268,929</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">2,092,112</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Electronic equipment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">234,212</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">216,132</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Tools and furniture</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">198,361</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">131,475</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Vehicles</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">63,317</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">59,384</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Leasehold improvements</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,252,449</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,784,437</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Software</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">26,858</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">25,162</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,044,126</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,308,702</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,476,604</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,198,608</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Property and equipment, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,567,522</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,110,094</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2020 and 2019, depreciation expense of property and equipment amounted to $1,147,115 and $889,410, respectively,
of which, $28,787 and $0 was included in cost of revenue, $411,986 and $391,602 was included in research and development expenses, and
$706,342 and $497,808 was included in general and administrative expense, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
7 &ndash; <U>NOTES PAYABLE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2020, from time to time, the Company acquires loans from various entities to fund its operations. These loans are due within one year
and are unsecured and uncollateralized. The Company did not incur any borrowing activity in 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">At
December 31, 2020, short-term borrowings consisted of the following</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31, <BR>
2020</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: justify">Loan from China Construction Bank, due on February 17, 2021 with annual interest rate of 4.1025%, extended through May 2021 (See Note 15)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">459,376</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Loan from a third-party company, due on February 8, 2021 with annual interest rate of 4.35%, extended through October 2021 (See Note 15)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">459,376</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">918,752</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2020, interest expense related to these borrowings amounted to $12,397 and has been included in interest
expense on the accompanying consolidated statements of operations and comprehensive loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As&nbsp;of
December 31, 2020, the related accrued and unpaid interest for these borrowings was $2,942 and has been included in accrued liabilities
and other payables on the accompanying consolidated balance sheets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
8 &ndash;&nbsp;<U>RELATED PARTY TRANSACTIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
Payable - Related Party</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">During 2020, from time to time, the Company acquired loans from Hebei
Senlang Taihe Biological Technology Co. Ltd. (&ldquo;Taihe&rdquo;) to fund its operations. These loans are due within one year and are
unsecured and uncollateralized. The annual interest rate for these loans is 4.35%. SenlangBio&rsquo;s largest shareholder is the former
executive director of Taihe. The Company did not incur any related party borrowing activity in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the outstanding principal amounted to $245,000 and was recorded as &ldquo;Notes payable &ndash; related party&rdquo;
on the accompanying consolidated balance sheets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2020, interest expense related to related party borrowings amounted to $11,169 and has been included in interest
expense &ndash; related party on the accompanying consolidated statements of operations and comprehensive loss. As&nbsp;of December 31,
2020, the related interest for related party borrowings was paid in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
9 &ndash;&nbsp;<U>INCOME TAXES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>British
Virgin Islands </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the current laws of BVI, Senlang is not subject to tax on income or capital gain. In addition, payments of dividends by the Company to
its shareholders are not subject to withholding tax in the BVI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hong
Kong</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senlang
HK is incorporated in Hong Kong and is subject to Hong Kong Profits Tax on the taxable income as reported in its statutory financial
statements adjusted in accordance with relevant Hong Kong tax laws. The applicable tax rate is 16.5% on its taxable income generated
from operations in Hong Kong. The Company did not make any provisions for Hong Kong profit tax as there were no assessable profits derived
from or earned in Hong Kong since inception. Additionally, payments of dividends by the subsidiary incorporated in Hong Kong to the Company
are not subject to any Hong Kong withholding tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>United
States</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its subsidiaries have no presence in the United States and does not conduct business in the United States, therefore no United
States income tax should be imposed upon the Company and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senlang
BJ, SenlangBio and SenlangBio Clinical Laboratory are subject to PRC Enterprise Income Tax (&ldquo;EIT&rdquo;) on the taxable income
in accordance with the relevant PRC income tax laws. The EIT rate for companies operating in the PRC is 25%. <FONT STYLE="background-color: white">In
the years ended December 2020 and 2019, Senlang BJ, SenlangBio and SenlangBio Clinical Laboratory were each recognized as small low-profit
enterprise and received a preferential income tax rate of 10%.</FONT> The Company did not have any income taxes expense for the years
ended December 31, 2020 and 2019 since it incurred losses in the periods. As of December 31, 2020, income tax returns for the tax years
ended December 31, 2016 through December 31, 2020 remain open for statutory examination by PRC tax authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is a reconciliation of the statutory tax rate to the effective tax rate for the years ended December 31, 2020 and 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years Ended December 31,</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">PRC statutory income tax rate</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">25.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">25.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Effect of income tax exemptions and reliefs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(15.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(15.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Effect of non-deductible expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.1</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.6</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(10.1</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(10.6</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Effective tax rate</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
9 &ndash;&nbsp;<U>INCOME TAXES (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRC
(continued)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s approximate net deferred tax assets as of December 31, 2020 and 2019 were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">Deferred tax assets:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR>
 2020</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR>
 2019</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left">Net operating loss carryforward</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,340,709</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">806,933</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,340,709</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(806,933</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Net deferred tax assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company provided a valuation allowance equal to the deferred income tax assets for the years ended December 31, 2020 and 2019 because
it was not known whether future taxable income will be sufficient to utilize the loss carryforward. The potential tax benefit arising
from the loss carryforward will begin to expire in 2023. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and 2019, the Company had no significant uncertain tax positions that qualify for either recognition or disclosure
in the financial statements. As of December 31, 2020, income tax returns for the tax years ended December 31, 2016 through December 31,
2020 remain open for statutory examination by PRC tax authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
uncertain tax positions are related to tax years that remain subject to examination by the relevant tax authorities. Based on the outcome
of any future examinations, or as a result of the expiration of statute of limitations for specific jurisdictions, it is reasonably possible
that the related unrecognized tax benefits for tax positions taken regarding previously filed tax returns, might materially change from
those recorded as liabilities for uncertain tax positions in the Company&rsquo;s consolidated financial statements as of December 31,
2020 and 2019. In addition, the outcome of these examinations may impact the valuation of certain deferred tax assets (such as net operating
losses) in future periods. The Company&rsquo;s policy is to recognize interest and penalties accrued on any unrecognized tax benefits,
if any, as a component of income tax expense. The Company does not anticipate any significant increases or decreases to its liability
for unrecognized tax benefit within the next twelve months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the PRC Tax Administration and Collection Law, the statute of limitations is three years if the underpayment of income taxes is due
to computational errors made by the taxpayer. The statute of limitations will be extended to five years under special circumstances,
which are not clearly defined, but an underpayment of income tax liability exceeding RMB100,000 (approximately $15,000) is specifically
listed as a special circumstance. In the case of a transfer pricing related adjustment, the statute of limitations is ten years. There
is no statute of limitations in the case of tax evasion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounting
for Uncertainty in Income Taxes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax authority of the PRC government conducts periodic and ad hoc tax filing reviews on business enterprises operating in the PRC after
those enterprises complete their relevant tax filings. Therefore, the Company&rsquo;s tax filings results are subject to change. It is
therefore uncertain as to whether the PRC tax authority may take different views about the Company&rsquo;s tax filings, which may lead
to additional tax liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 requires recognition and measurement of uncertain income tax positions using a &ldquo;more-likely-than-not&rdquo; approach. The management
evaluated the Company&rsquo;s tax positions and concluded that no provision for uncertainty in income taxes was necessary as of December
31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>NOTE 10 &ndash;&nbsp;<U>EQUITY</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The equity structures
as of December 31, 2020 was presented after giving retroactive effect to the reorganization of the Company that was completed in April
2021. Immediately before and after the reorganization, the shareholders of SenlangBio controlled Senlang. Therefore, the reorganization
is accounted for as a transaction of entities under common control at carrying value and for accounting purpose, the reorganization was
accounted for as a recapitalization. The consolidated financial statements are prepared on the basis as if the Reorganization became effective
as of the beginning of the first period presented in the accompanying consolidated financial statements of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 15, 2020, Senlang was incorporated
in the British Virgin Islands. As of the date of this report, its authorized share capital consists of 50,000 ordinary shares with a par
value of $1.00 per share. As of the date of this report, 10,001 ordinary shares were issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Statutory Reserve</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senlang
BJ, SenlangBio and SenlangBio Clinical Laboratory operate in the PRC and are required to reserve 10% of their net profit after income
tax, as determined in accordance with the PRC accounting rules and regulations. Appropriation to the statutory reserve by the Company
is based on profit arrived at under PRC accounting standards for business enterprises for each year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The&nbsp;profit
arrived at must be set off against any accumulated losses sustained by the Company in prior years, before allocation is made to the statutory
reserve. Appropriation to the statutory reserve must be made before distribution of dividends to shareholders. The appropriation is required
until the statutory reserve reaches 50% of the registered capital. This statutory reserve is not distributable in the form of cash dividends.
Senlang BJ, SenlangBio and SenlangBio Clinical Laboratory did not make any appropriation to statutory reserve during the years ended
December 31, 2020 and 2019 as they incurred net losses in the periods.&nbsp;As of December 31, 2020 and 2019, the Company did not have
any statutory reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
11 -&nbsp;<U>CONCENTRATIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Customers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information as to each customer that accounted for 10% or more of the Company&rsquo;s revenues for the years
ended December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Years Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">Customer</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left">A</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">15</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
than 10%</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
customer, whose outstanding receivable accounted for 10% or more of the Company&rsquo;s total outstanding accounts receivable at December
31, 2020, accounted for 98.1% of the Company&rsquo;s total outstanding accounts receivable at December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
customer, whose outstanding receivable accounted for 10% or more of the Company&rsquo;s total outstanding accounts receivable at December&nbsp;31,
2019, accounted for 100.0% of the Company&rsquo;s total outstanding accounts receivable at December&nbsp;31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suppliers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information as to each supplier that accounted for 10% or more of the Company&rsquo;s purchase for the years
ended December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years Ended December 31,</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">Supplier</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2019</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 76%">A</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">21</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">B</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">16</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
than 10%</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
suppliers, whose outstanding payable accounted for 10% or more of the Company&rsquo;s total outstanding accounts payable at December
31, 2020, accounted for 77.8% of the Company&rsquo;s total outstanding accounts payable at December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
suppliers, whose outstanding payable accounted for 10% or more of the Company&rsquo;s total outstanding accounts payable at December&nbsp;31,
2019, accounted for 61.1% of the Company&rsquo;s total outstanding accounts payable at December&nbsp;31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>NOTE
12 &ndash;&nbsp;<U>SEGMENT INFORMATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2020 and 2019, the Company operated in two reportable business segments - (1) general laboratory testing
segment, and (2) immunology and hematology testing segment. The Company&rsquo;s reportable segments are strategic business units that
offer different services and products. They are managed separately based on the fundamental differences in their operations. Information
with respect to these reportable business segments for the years ended December 31, 2020 and 2019 was as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years Ended December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">649,932</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">77,594</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">440,183</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,736</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,090,115</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">93,330</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Cost of revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">343,794</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">35,972</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">197,444</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10,269</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">541,238</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">46,241</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Gross profit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">306,138</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">41,622</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">242,739</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,467</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">548,877</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">47,089</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">331,209</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">168,380</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,641,119</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,864,555</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,972,328</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,032,935</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Other (expense) income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Interest expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(23,566</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(23,566</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Other income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,213</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,544</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,441</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,398</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,654</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,942</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total other (expense) income, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(18,912</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,942</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">23,858</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">124,214</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,418,505</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,854,690</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,442,363</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,978,904</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Depreciation</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,193</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">907</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,139,922</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">888,503</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,147,115</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">889,410</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Capital expenditure</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">60,688</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,091</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">67,421</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">876,597</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">128,109</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">881,688</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>NOTE
12 &ndash;&nbsp;<U>SEGMENT INFORMATION (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Identifiable long-lived tangible assets at December 31, 2020 and 2019</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, <BR> 2020</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,<BR> 2019</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">62,447</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">14,056</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,505,075</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,096,038</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,567,522</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,110,094</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">Total assets at December 31, 2020 and 2019</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">General laboratory testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">163,560</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">71,234</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,320,432</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,251,631</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,483,992</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,322,865</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have long-lived assets located outside the PRC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
13 &ndash;&nbsp;<U>COMMITMENTS AND CONTINCENGIES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contingencies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">From
time to time, the Company may be subject to certain legal proceedings, claims and disputes that arise in the ordinary course of business.
Although the outcomes of these legal proceedings cannot be predicted, the Company does not believe these actions, in the aggregate, will
have a material adverse impact on its financial position, results of operations or liquidity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operating
Leases Commitment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a party to leases for office space. Rent expense under all operating leases amounted to approximately $208,000 and $213,000
for the years ended December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
cash flow information related to leases for the&nbsp;years ended December 31, 2020&nbsp;and 2019 is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Years Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Cash paid for amounts included in the measurement of lease liabilities:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left">Operating cash flows paid for operating lease</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">209,413</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">217,484</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Right-of-use assets obtained in exchange for lease obligation:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Operating lease</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the lease term and discount rate for the Company&rsquo;s operating lease as of December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Operating Lease</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining lease term (in years)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">1.27</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Weighted average discount rate</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4.75</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
13 &ndash;&nbsp;<U>COMMITMENTS AND CONTINCENGIES (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operating
Leases Commitment (continued)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the maturity of lease liabilities under operating lease as of December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">For the Year Ending December 31:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Operating Lease</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: left">2021</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">169,963</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2022</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">106,357</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">2023 and thereafter</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total lease payments</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">276,320</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Amount of lease payments representing interest</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(15,284</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total present value of operating lease liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">261,036</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">155,470</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Long-term portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">105,566</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">261,036</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Variable
Interest Entity Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, (i) the corporate structure of the Company is in compliance with existing PRC laws and regulations; (ii) the
Contractual Arrangements are valid and binding, and do not result in any violation of PRC laws or regulations currently in effect; and
(iii) the business operations of WFOE, VIE and VIE&rsquo;s subsidiary are in compliance with existing PRC laws and regulations in all
material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
there are substantial uncertainties regarding the interpretation and application of current and future PRC laws and regulations. Accordingly,
the Company cannot be assured that PRC regulatory authorities will not ultimately take a contrary view to the foregoing opinion of its
management. If the current corporate structure of the Company or the Contractual Arrangements is found to be in violation of any existing
or future PRC laws and regulations, the Company may be required to restructure its corporate structure and operations in the PRC to comply
with changing and new PRC laws and regulations. In the opinion of management, the likelihood of loss in respect of the Company&rsquo;s
current corporate structure or the VIE Agreements is remote based on current facts and circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
14 &ndash;&nbsp;<U>RESTRICTED NET ASSETS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company&rsquo;s operations are conducted through its PRC subsidiary, VIE and VIE&rsquo;s subsidiary, which
can only pay dividends out of their retained earnings determined in accordance with the accounting standards and regulations in the PRC
and after they have met the PRC requirements for appropriation to statutory reserve. In addition, most of the Company&rsquo;s businesses
and assets are denominated in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place
either through the People&rsquo;s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted
by the People&rsquo;s Bank of China. Approval of foreign currency payments by the People&rsquo;s Bank of China or other regulatory institutions
requires submitting a payment application form together with suppliers&rsquo; invoices, shipping documents and signed contracts. These
currency exchange control procedures imposed by the PRC government authorities may restrict the ability of the Company&rsquo;s PRC subsidiary
to transfer their net assets to the Lonlon Biotech Ltd. (the &ldquo;Parent Company&rdquo;) through loans, advances or cash dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
I of Article 5-04 of Regulation S-X requires the condensed financial information of the parent company to be filed when the restricted
net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal
year. For purposes of this test, restricted net assets of consolidated subsidiaries shall mean that amount of the registrant&rsquo;s
proportionate share of net assets of its consolidated subsidiaries (after intercompany eliminations) which as of the end of the most
recent fiscal year may not be transferred to the parent company in the form of loans, advances or cash dividends without the consent
of a third party. The restricted net assets of the Company&rsquo;s PRC subsidiary amounted to approximately $589,000 and $2,973,000 as
of December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s PRC subsidiary&rsquo; net assets as of December 31, 2020 and 2019 exceeded 25% of the Company&rsquo;s consolidated net
assets. Accordingly, Parent Company&rsquo;s condensed financial statements have been prepared in accordance with Rule 5-04 and Rule 12-04
of SEC Regulation S-X, and are as follows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
14 &ndash;&nbsp;<U>RESTRICTED NET ASSETS (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Financial Information of the Parent Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Parent Company&rsquo;s condensed financial statements have been prepared using the same accounting principles and policies described
in the notes to the consolidated financial statements, with the only exception being that the Parent Company accounts for its subsidiaries
using the equity method. Refer to the consolidated financial statements and notes presented above for additional information and disclosures
with respect to these financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent Company&rsquo;s Condensed Balance Sheets</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <BR>
2020</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <BR>
2019</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSETS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT ASSETS:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in subsidiaries</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">589,185</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,972,741</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Non-current Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">589,185</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,972,741</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">589,185</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,972,741</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITIES AND SHAREHOLDERS&rsquo; EQUITY</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments and Contingencies</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHAREHOLDERS&rsquo; EQUITY:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>
    <P STYLE="text-indent: -0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Ordinary shares, $1.00 par value; 50,000 shares authorized;
    10,001 shares issued and outstanding at December 31, 2020 and 2019 *</P></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional paid-in capital</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,946,197</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,946,197</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulative deficit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,380,014</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,937,651</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated other comprehensive income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,001</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(45,806</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Shareholders&rsquo; Equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">589,185</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,972,741</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities and Shareholders&rsquo; Equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">589,185</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,972,741</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The shares amounts are presented on a retroactive basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Parent Company&rsquo;s Condensed Statements of Operations and Comprehensive Loss</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
December 31,</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Revenue</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Operating expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Income attributable to Parent Company only</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Share of loss from investment in subsidiaries</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,442,363</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,978,904</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,442,363</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,978,904</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other comprehensive income (loss)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Unrealized foreign currency translation gain (loss)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">58,807</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(50,204</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Comprehensive loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,383,556</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,029,108</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
14 &ndash;&nbsp;<U>RESTRICTED NET ASSETS (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Financial Information of the Parent Company (continued)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Parent Company&rsquo;s Condensed Statements of Cash Flows</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
December 31,</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">CASH FLOWS FROM OPERATING ACTIVITIES:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,442,363</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,978,904</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Adjustments to reconcile net loss to net cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">provided by operating activities:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Share of loss from investment in subsidiaries</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,442,363</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,978,904</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">NET CASH PROVIDED BY OPERATING ACTIVITIES</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">NET INCREASE IN CASH</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">CASH - beginning of year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">CASH - end of year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
of Preparation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
condensed financial information of the Parent Company has been prepared using the same accounting policies as set out in the consolidated
financial statements except that the Company used the equity method to account for investment in its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
information and footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally
accepted in the United States of America have been condensed or omitted. The Parent Company only financial information has been derived
from the Company&rsquo;s consolidated financial statements and should be read in conjunction with the Company&rsquo;s consolidated financial
statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
in Subsidiaries</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its subsidiaries were included in the consolidated financial statements where the inter-company balances and transactions
were eliminated upon consolidation. For purpose of the Parent Company&rsquo;s stand-alone financial statements, its investments in subsidiaries
were reported using the equity method of accounting.&nbsp;Such investment is presented as &ldquo;Investment in subsidiaries&rdquo; on
the condensed balance sheets and the subsidiaries&rsquo; loss is presented as &ldquo;Share of loss from investment in subsidiaries&rdquo;
in the condensed statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
15 &ndash; <U>SUBSEQUENT EVENTS</U>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2021, the Company renewed its lease agreement to rent office space in Hebei province, China, with a third party (the &ldquo;Office
Lease&rdquo;). Pursuant to the renewed Office Lease, the daily rent is RMB 382.9 (approximately $59) with a required security deposit
of RMB 9,936 (approximately $1,500). The term of the Office Lease is 12 months commencing on January 1, 2021 and expires on December
31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">In January 2021, the Company
borrowed a short-term loan from a third-party company in the principal amount of $</FONT>459,376<FONT STYLE="background-color: white">.
The new loan bears interest rate at 4.35% per annum and is due on October 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2021, the Company signed an extension with <FONT STYLE="background-color: white">China Construction Bank</FONT> and the borrowing
with principal amount of $459,376 was extended through May 17 ,2021. The principal amount was fully repaid on the due date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2021, the Company signed an extension with a third-party lender and the borrowing with principal amount of $459,376 was extended
through October 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
May 2021, the Company borrowed a short-term loan from a related party company in the principal amount of $763,044. The new loan
bears interest rate at 4.35% per annum and is due on October 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
15 &ndash; <U>SUBSEQUENT EVENTS (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 26, 2021, Senlang BJ entered into a series of contractual arrangements, or VIE agreements with SenlangBio and 13 equity holders
of SenlangBio, through which the Company obtained control and became the primary beneficiary of SenlangBio. As a result, SenlangBio became
the Company&rsquo;s VIE.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 13, 2021, the Company entered into a Share Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;), by and among the Company,
Avalon GloboCare Corp., a Delaware corporation (&ldquo;Avalon&rdquo;), the holders of the share capital of Senlang (the &ldquo;Senlang
Shareholders&rdquo;), the ultimate beneficial owners of the Senlang Shareholders (the &ldquo;Senlang Beneficial Shareholders&rdquo; and,
together with the Senlang Shareholders, the &ldquo;Senlang Owners&rdquo;) and a representative of the Senlang Owners (the &ldquo;Senlang
Representative&rdquo;). Pursuant to the Purchase Agreement, Avalon will acquire all of the issued and outstanding share capital of the
Company in consideration of 81 million shares of the common stock, par value $0.0001 per share, of Avalon (the &ldquo;Acquisition&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In connection with the Acquisition, on June 13, 2021, an institutional
investor (the &ldquo;Investor&rdquo;) entered into an agreement with the related to the purchase of registered capital of the SenlangBio
(the &ldquo;SenlangBio Capital Increase Agreement&rdquo;) pursuant to which the Investor will acquire an aggregate of up to 13.5% of the
equity ownership of the SenlangBio for an aggregate purchase price of RMB 200,000,000 (approximately $30 million) (the &ldquo;Equity Financing&rdquo;),
which funds will be invested in the SenlangBio in three installments of RMB 67,000,000 (approximately $10 million), RMB 67,000,000 (approximately
$10 million) and RMB 66,000,000 (approximately $10 million), the first to be upon the closing of the Acquisition, the second to be within
three months after the closing and the third to be within six months after the closing. In addition, pursuant to a Securities Exchange
Agreement (the &ldquo;Exchange Agreement&rdquo;), by and among the Company, SenlangBio, Avalon and the Investor, dated June 13, 2021,
the Investor has the right, exercisable between the six-month and five year-anniversaries of the respective initial closing and installment
closings, to elect to exchange, from time to time, all or part of its then-owned equity ownership of SenlangBio for shares (the &ldquo;Exchange
Shares&rdquo;) of Avalon Common Stock at a fixed exchange price of US$1.21 per share of Avalon Common Stock, which was the market price
of the Avalon Common Stock as of the date of the Exchange Agreement under Nasdaq rules. In addition, the Exchange Agreement provides that
the Investor may only exchange up to 10% of its total investment amount in any 30-day period.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">F-29</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>ea143147ex99-3_avalonglob.htm
<DESCRIPTION>SEN LANG'S UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2021, AND THE NOTES RELATED THERETO
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 99.3</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LONLON BIOTECH LTD. AND SUBSIDIARIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>March 31, 2021 and 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">March 31, 2021 and 2020&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><BR>
<BR>
</FONT><BR>
CONTENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in; width: 90%">Consolidated Financial Statements (Unaudited):</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#ex3_001">Condensed Consolidated Balance Sheets - As of March 31, 2021 and December 31, 2020</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-2</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#ex3_002">Condensed Consolidated Statements of Operations and Comprehensive Loss - For the Three Months Ended March 31, 2021 and 2020</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-3</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#ex3_003">Condensed Consolidated Statements of Changes in Shareholders&rsquo; Equity - For the Three Months Ended March 31, 2021 and 2020</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-4</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#ex3_004">Condensed Consolidated Statements of Cash Flows &ndash; For the Three Months Ended March 31, 2021 and 2020</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-5</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#ex3_005">Notes to Condensed Consolidated Financial Statements</A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-6</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="ex3_001"></A>LONLON BIOTECH LTD.
AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED BALANCE SHEETS</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSETS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT ASSETS:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,887</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,935</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">636,746</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,271</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverable VAT</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">343,755</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">335,150</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,743</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,962</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,949</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,017</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,336,080</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">546,335</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT ASSETS:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security deposit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,843</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,012</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use assets, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,406</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">320,123</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,268,076</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,567,522</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Non-current Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,584,325</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,937,657</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,920,405</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,483,992</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITIES AND SHAREHOLDERS&rsquo; EQUITY</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT LIABILITIES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,373,480</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">918,752</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable - related party</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,174</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">564,192</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">310,330</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,329</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,810</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued leasehold improvements liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">261,106</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">315,583</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities and other payables</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,938</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,432</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,201</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,508</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred grant income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,496</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,679</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease obligation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,167</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">155,470</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,110,083</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,437,564</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT LIABILITIES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred grant income - noncurrent portion</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">304,617</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">351,677</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease obligation - noncurrent portion</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,377</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,566</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Non-current Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">356,994</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457,243</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,467,077</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,894,807</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments and Contingencies</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHAREHOLDERS&rsquo; EQUITY:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Ordinary shares, $1.00 par value; 50,000 shares authorized;</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">10,001 shares issued and outstanding at March 31, 2021 and December 31, 2020 *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional paid-in capital</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,946,197</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,946,197</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated deficit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,515,294</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,380,014</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated other comprehensive income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,424</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,001</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total shareholders&rsquo; equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">453,328</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">589,185</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities and Shareholders&rsquo; Equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,920,405</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,483,992</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The shares amounts are presented on a retroactive basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of these unaudited
condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center"><A NAME="ex3_002"></A>LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS AND COMPREHENSIVE LOSS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">(Unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three Months Ended</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUES</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General laboratory testing</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">945,648</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,887</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immunology and hematology testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301,857</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Revenues</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,247,505</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,887</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST OF REVENUES</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General laboratory testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">347,911</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,117</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immunology and hematology testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">89,498</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Cost of Revenues</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">437,409</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,117</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GROSS PROFIT</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General laboratory testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">597,737</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,770</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immunology and hematology testing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212,359</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Gross Profit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">810,096</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,770</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPERATING EXPENSES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">565,331</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">410,893</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">406,188</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">344,252</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and marketing expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,707</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,584</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(123,467</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(526,703</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Operating Expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,759</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">237,026</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS FROM OPERATIONS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(90,663</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(208,256</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER (EXPENSE) INCOME</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13,647</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense - related party</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,683</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,860</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">226</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,444</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Other Expense, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16,104</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(416</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS BEFORE INCOME TAXES</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(106,767</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(208,672</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCOME TAXES</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,513</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET LOSS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(135,280</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(208,672</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPREHENSIVE LOSS:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET LOSS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(135,280</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(208,672</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER COMPREHENSIVE LOSS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized foreign currency translation loss</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(577</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(47,085</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPREHENSIVE LOSS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(135,857</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(255,757</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NTE LOSS PER ORDINARY SHARE:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis and diluted *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13.53)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20.87)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WEIGHTED AVERAGE ORDINARY SHARES OUTSTANDING:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis and diluted *</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The shares and per share amounts are presented on a retroactive
basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of these unaudited
condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="ex3_003"></A>LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN
SHAEHOLDERS&rsquo; EQUITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR THE THREE MONTHS ENDED MARCH 31, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Unaudited)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"></TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Accumulated</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"></TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Ordinary Shares *</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Additional</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Other</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Number of</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Paid-in</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Accumulated</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Comprehensive</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Shareholders&rsquo;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"> Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Capital</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 28%">Balance as of December 31, 2020</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">10,001</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">10,001</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,946,197</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(8,380,014</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">13,001</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">589,185</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency translation adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(577</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(577</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt">Net loss for the three months ended March 31, 2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(135,280</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(135,280</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">Balance as of March 31, 2021 (unaudited)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">10,001</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">10,001</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,946,197</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(8,515,294</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">12,424</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">453,328</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The shares amounts are presented on a retroactive basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN
SHAEHOLDERS&rsquo; EQUITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR THE THREE MONTHS ENDED MARCH 31, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Unaudited)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Accumulated</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"></TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Ordinary Shares*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Other</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Number of</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Paid-in</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Accumulated</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Comprehensive</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Shareholders&rsquo;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"> Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Capital</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 28%">Balance as of December 31, 2019</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">10,001</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">10,001</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,946,197</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(5,937,651</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(45,806</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,972,741</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency translation adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,085</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,085</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt">Net loss for the three months ended March 31, 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(208,672</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(208,672</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">Balance as of March 31, 2020 (unaudited)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">10,001</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">10,001</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,946,197</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(6,146,323</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(92,891</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,716,984</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The shares amounts are presented on a retroactive basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of these unaudited condensed
consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center"><A NAME="ex3_004"></A>LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">CONDENSED CONSOLIDATED STATEMENTS OF
CASH FLOWS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">FOR THE TRHEE MONTHS ENDED MARCH 31,
2021 AND 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center">(Unaudited)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">For the Three Months Ended</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>CASH FLOWS FROM OPERATING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 0.125in">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(135,280</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(208,672</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Adjustments to reconcile net loss to net cash (used in) provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in">Depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">297,458</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">252,099</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Amortization of right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,193</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,912</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(597,869</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,232</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Recoverable VAT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,838</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,661</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,002</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,015</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Prepaid expenses and other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(40,425</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,917</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Security deposit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,432</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">257,598</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,052</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Salary payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,157</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,788</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accrued liabilities and other payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,902</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(22,052</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Interest payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,860</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">79,824</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Deferred grant income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(123,467</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(42,622</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Operating lease obligation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(57,208</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(45,556</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0in">NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(233,267</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,809</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0in">CASH FLOWS FROM INVESTING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Purchase of property and equipment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(57,581</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(18,665</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0in">NET CASH USED IN INVESTING ACTIVITIES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(57,581</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(18,665</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Proceeds from borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">462,656</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Proceeds from related party&rsquo;s borrowings</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">214,829</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0in">NET CASH PROVIDED BY FINANCING ACTIVITIES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">462,656</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">214,829</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0in">EFFECT OF EXCHANGE RATE ON CASH</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,856</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(5,744</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">NET INCREASE IN CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">169,952</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">204,229</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 0in">CASH - beginning of period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,935</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">164,994</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; padding-left: 0in">CASH - end of period</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">188,887</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">369,223</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Cash paid for:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; padding-left: 0.25in">Interest</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">10,292</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of these unaudited
condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="ex3_005"></A>LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt">(Unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 1 &ndash; <U>ORGANIZATION AND NATURE OF OPERATIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lonlon Biotech Ltd. (&ldquo;Senlang&rdquo; or
the &ldquo;Company&rdquo;) is a holding company incorporated in the British Virgin Islands (&ldquo;BVI&rdquo;) on October 15, 2020. The
Company is mainly engaged in the business of research and development in relation to CAR-T cell therapy, immune cell therapy and related
drug development in the People&rsquo;s Republic of China (&ldquo;PRC&rdquo; or &ldquo;China&rdquo;), through a variable interest entity
(&ldquo;VIE&rdquo; as defined in Note 4), Hebei Senlang Biotechnology Co., Ltd. (&ldquo;SenlangBio&rdquo;), which was established on January
29, 2016, and subsidiary of the VIE. <FONT STYLE="background-color: white">SenlangBio also provides immunology and hematology testing
services, mainly related to cell therapy, including tumor biomarkers and immunophenotyping. On February 9, 2018, SenlangBio formed a wholly
owned subsidiary, Shijiazhuang Senlang Medical Laboratory Co., Ltd. (&ldquo;SenlangBio Clinical Laboratory&rdquo;), in China, which focuses
on general laboratory testing for patients and other customers, including genomics, proteomics, routine blood/urine testing, COVID-19
PCR/antibody testing etc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 2, 2020, Senlang established a wholly
owned subsidiary in Hong Kong, Lonlon Biotech Investment Limited (&ldquo;Senlang HK&rdquo;), which is a holding company. On November 20,
2020, Senlang HK established a Wholly Foreign-Owned Enterprise in China, Beijing Langlang Runfeng Biotechnology Co., Ltd. (&ldquo;Senlang
BJ&rdquo; or &ldquo;WFOE&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 26, 2021, Senlang BJ entered into a series
of contractual arrangements, or VIE agreements with SenlangBio and 13 equity holders of SenlangBio, through which the Company obtained
control and became the primary beneficiary of SenlangBio, hereinafter referred to as the Reorganization. As a result, SenlangBio became
the Company&rsquo;s VIE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 26, 2021, the Company completed its reorganization
of the entities under the common control of 13 majority shareholders through their 100% controlled entities incorporated in the British
Virgin Islands, and indirectly owned a majority of the equity interests of the Company, its subsidiaries, its VIE and the VIE&rsquo;s
subsidiary prior to and after the Reorganization. The Company was established as a holding company of Senlang BJ. Senlang BJ is the primary
beneficiary of SenlangBio, and all of these entities are under common control of the Company&rsquo;s ultimate controlling shareholders
before and after the Reorganization, which results in the consolidation of the Company and has been accounted for as a reorganization
of entities under common control at carrying value and for accounting purpose, the reorganization was accounted for as a recapitalization.
The consolidated financial statements are prepared on the basis as if the Reorganization became effective as of the beginning of the first
period presented in the accompanying consolidated financial statements of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following chart illustrates the Company&rsquo;s
corporate structure, including its subsidiaries, consolidated variable interest entity and VIE&rsquo;s subsidiary as of the issuance date
of this report:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-3_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 1 &ndash; <U>ORGANIZATION AND NATURE OF
OPERATIONS (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>VIE Agreements with SenlangBio</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Upon the
completion of the reorganization, the Company, through the WFOE, entered into the following contractual arrangements with the VIE and
the VIE&rsquo;s 13 shareholders that enabled the Company to (1) have power to direct the activities that most significantly affects the
economic performance of the VIE, and (2) receive the economic benefits of the VIE that could be significant to the VIE. Accordingly, the
WFOE was considered the primary beneficiary of the VIE and had consolidated the VIE and the VIE&rsquo;s subsidiary&rsquo; financial results
of operations, assets and liabilities in the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><U>Contracts
that give the Company effective control of the VIE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Equity Pledge Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Equity Pledge Agreement between Senlang
BJ, SenlangBio and SenlangBio&rsquo;s shareholders, SenlangBio&rsquo;s shareholders agree to pledge all of their equity interests in SenlangBio
to Senlang BJ to guarantee the performance of SenlangBio and SenlangBio&rsquo;s shareholders&rsquo; obligations under the Exclusive Technical
Consultation and Service Agreement, the Exclusive Purchase Option Agreement, the Shareholder&rsquo;s Rights Proxy Agreement, and the Spousal
Consent (&ldquo;Transaction Agreements&rdquo;). Under the terms of the Equity Pledge Agreement, in the event that SenlangBio or SenlangBio&rsquo;s
shareholders breach their respective contractual obligations under the Transaction Agreements or the Equity Pledge Agreement, Senlang
BJ, as pledgee, is entitled to directly exercise the pledge right and to notify SenlangBio&rsquo;s shareholders to immediately repay or
pay the loans or other payables under the Transaction Agreements. SenlangBio&rsquo;s shareholders further agreed not to dispose of the
pledged equity interests without prior written consent from Senlang BJ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The pledge is effective on the date when the registration
of the equity pledge is completed with the competent administration for industry and commerce, and the term of validity of the pledge
is the same as the longest term of validity in the Transaction Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purposes of the Equity Pledge Agreement are
to (1)&nbsp;guarantee the performance of SenlangBio and SenlangBio&rsquo;s shareholders&rsquo; obligations under the Transaction Agreements,
(2)&nbsp;make sure SenlangBio&rsquo;s shareholders do not transfer or assign the pledged equity interests, or create or allow any encumbrance
that would prejudice interests of Senlang BJ without prior written consent from Senlang BJ, and (3)&nbsp;provide Senlang BJ control over
SenlangBio.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event SenlangBio or SenlangBio&rsquo;s
shareholders breaches their contractual obligations under the Transaction Agreements or Equity Pledge Agreement, Senlang BJ will be entitled
to (1) be compensated on a preferential basis with the proceeds from the conversion, auction or sale of the pledged equity, and (2) notify
SenlangBio&rsquo;s shareholders to immediately repay the loans or other payables under the Transaction Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exclusive Purchase Option Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Exclusive Purchase Option Agreement,
SenlangBio&rsquo;s shareholders irrevocably grants Senlang BJ (or its designee) an exclusive right to purchase the equity held by SenlangBio&rsquo;s
shareholders in the SenlangBio in whole or in part at any time during the term of the Agreement; SenlangBio also irrevocably grants Senlang
BJ (or its designee) an exclusive right to purchase the assets owned by SenlangBio in whole or in part at any time during the term of
the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to consideration for equity purchase,
Senlang BJ has the right to purchase all or part of the equity held by SenlangBio&rsquo;s shareholders in SenlangBio at the lowest price
permitted by the PRC laws. With respect to the price for asset purchase, Senlang BJ has the right to purchase SenlangBio&rsquo;s assets
at a price equivalent of the net book value of the purchased assets; provided that if the minimum price permitted by the PRC law is higher
than the net book value, the minimum price permitted by the PRC laws will prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Exclusive Purchase Option Agreement,
Senlang BJ may purchase all or part of the equity held by SenlangBio&rsquo;s shareholders in SenlangBio and all or part of the assets
owned by SenlangBio at any time to the extent permitted by PRC laws. The Exclusive Purchase Option Agreement, together with the Equity
Pledge Agreement, Exclusive Technical Consultation and Service Agreement, and the Proxy Agreement, enable Senlang BJ to exercise effective
control over SenlangBio. The Exclusive Purchase Option Agreement will become effective upon the affixation of signatures or corporate
seals by the Senlang BJ, SenlangBio and SenlangBio&rsquo;s shareholders, and will remain in effect, unless terminated by Senlang BJ by
giving a thirty (30) day advance written notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 1 &ndash; <U>ORGANIZATION AND NATURE OF
OPERATIONS (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><U>Contracts
that give the Company effective control of the VIE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Shareholder&rsquo;s Rights Proxy Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Shareholder&rsquo;s Rights Proxy Agreement,
SenlangBio&rsquo;s shareholders authorize any entity or individual designated by Senlang BJ to act on their behalf as their exclusive
agent to exercise all shareholder&rsquo;s rights under the PRC laws and the Articles of Association, including but not limited to: (a)
to convene, attend and vote on all the matters during shareholders&rsquo; meetings; (b) to transfer, pledge or dispose of, or create encumbrance
on the equity; (c) to receive dividends; (d) to participate in judicial proceedings or execute legal documents in relation to shareholders&rsquo;
rights; (e) to appoint legal representatives, directors and officers of SenlangBio; and (f) to enter into contracts and exercise the Exclusive
Purchase Option Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Shareholder&rsquo;s Rights Proxy Agreement
shall remain effective until the earlier of: (a) the date on which SenlangBio&rsquo;s shareholders are no longer the nominee or actual
shareholders of Senlang BJ; (b) the date on which Senlang BJ requests the proxy to be terminated in writing; or (c) the date on which
the assets and licenses of SenlangBio have been fully transferred to Senlang BJ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><U>Contracts
that enable the Company to receive substantially all of the economic benefits from the VIE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exclusive Technical Consultation and Service
Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Exclusive Technical Consultation
and Service Agreement between Senlang BJ and SenlangBio, Senlang BJ provides SenlangBio with technical consultation and services, including
conducting market research, assisting with developing management and sales plans, implementing relevant technology application, and providing
other consultation services for computer network, finance, business, legal affairs, operation, human resources, and other aspects of SenlangBio.
Additionally, Senlang BJ agrees to grant SenlangBio its trademarks, software copyrights, management systems, management methods and other
intellectual property in relation to its services on a chargeable and revocable basis, but such grant shall not result in the transfer
of any intellectual property or create any restriction on Senlang BJ&rsquo;s full ownership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For services rendered to SenlangBio under this
agreement, Senlang BJ is entitled to collect a service fee calculated based on the complexity of services rendered, time required by Senlang
BJ, and the exact contents and commercial value of services rendered. During the term of this agreement, Senlang BJ shall enjoy all the
economic benefits derived from SenlangBio&rsquo;s operation, and in the event of serious difficulties in SenlangBio&rsquo;s operations,
Senlang BJ may provide SenlangBio with financial support, and Senlang BJ has the right to request SenlangBio to cease operation. The Exclusive
Technical Consultation and Service Agreement shall remain in effect for ten (10) years and shall be automatically renewed unless it is
terminated earlier by Senlang BJ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the foregoing VIE Agreements, Senlang
BJ has effective control of SenlangBio which enables Senlang BJ to receive all of the expected residual returns and absorb the expected
losses of the VIE and its subsidiary.&nbsp;<FONT STYLE="background-color: white">Management therefore concludes that the Company, through
the above contractual arrangements, has the power to direct the activities that most significantly impact the VIE&rsquo;s economic performance,
bears the risks of and enjoys the rewards normally associated with ownership of the VIE, and therefore the Company is the ultimate primary
beneficiary of the VIE. Consequently,&nbsp;</FONT>the Company consolidates the accounts of SenlangBio and its subsidiary for the periods
presented herein, in accordance with&nbsp;<FONT STYLE="background-color: white">Accounting Standards Codification (&ldquo;</FONT>ASC&rdquo;)
810-10, Consolidation. The accompanying consolidated financial statements reflect the activities of Senlang and each of the following
entities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; width: 19%; vertical-align: top">Name</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 55%; text-align: center">Background</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 24%; text-align: center">Ownership</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; vertical-align: top"><B>Subsidiaries:</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">Senlang HK</TD>
    <TD>&nbsp;</TD>
    <TD>A Hong Kong company</TD>
    <TD>&nbsp;</TD>
    <TD>100% owned by Senlang</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated on November 2, 2020</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">Senlang BJ</TD>
    <TD>&nbsp;</TD>
    <TD>A PRC limited liability company and a wholly foreign owned enterprise</TD>
    <TD>&nbsp;</TD>
    <TD>100% owned by Senlang HK</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated on November 20, 2020</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top"><B>VIE:</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">SenlangBio</TD>
    <TD>&nbsp;</TD>
    <TD>A PRC limited liability company</TD>
    <TD>&nbsp;</TD>
    <TD>VIE</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Incorporated on January 29, 2016</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Immunology and hematology testing service provider</P></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top"><B>VIE&rsquo;s subsidiary:</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">SenlangBio </TD>
    <TD>&nbsp;</TD>
    <TD>A PRC limited liability company</TD>
    <TD>&nbsp;</TD>
    <TD>100% owned by SenlangBio</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">Clinical Laboratory</TD>
    <TD>&nbsp;</TD>
    <TD>Incorporated on February 9, 2018</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>General laboratory testing service provider</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white"><B>NOTE
2 &ndash; <U>BASIS OF PRESENTATION AND GOING CONCERN AND LIQUIDITY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Basis of Presentation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These&nbsp;interim condensed consolidated financial
statements of the Company and its subsidiary are unaudited. In the opinion of management, all adjustments (consisting of normal recurring
accruals) and disclosures necessary for a fair presentation of these interim condensed consolidated financial statements have been included.
The results reported in the condensed consolidated financial statements for any interim periods are not necessarily indicative of the
results that may be reported for the entire year. The accompanying condensed consolidated financial statements have been prepared in accordance
with the rules and regulations of the Securities and Exchange Commission and do not include all information and footnotes necessary for
a complete presentation of financial statements in conformity with accounting principles generally accepted in the United States (&ldquo;U.S.
GAAP&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s condensed consolidated financial
statements include the accounts of the Company and its subsidiaries, VIE and subsidiary of VIE over which the Company exercises control
and, when applicable, entity for which the Company has a controlling financial interest or is the primary beneficiary. All significant
intercompany accounts and transactions have been eliminated in consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain&nbsp;information and footnote disclosures
normally included in the annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted.
These condensed consolidated financial statements should be read in conjunction with the Company&rsquo;s audited consolidated financial
statements and notes thereto included in <FONT STYLE="background-color: white">elsewhere in this 8K/A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Going Concern and Liquidity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company currently has limited operations.
Currently, the Company&rsquo;s operations are focused on <FONT STYLE="background-color: white">utilizing cell and gene engineering technologies
to generate innovative and transformative cellular immunotherapies for solid and hematologic cancers. The Company provides </FONT>general
laboratory testing and <FONT STYLE="background-color: white">immunology and hematology testing services</FONT> for patients and other
customers in China. These consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As reflected in the accompanying condensed consolidated
financial statements, the Company had <FONT STYLE="background-color: white">a working capital deficit of $1,774,003 </FONT>at March 31,
2021, and has incurred net loss and negative cash flow from operating activities of $135,280 and $233,267, respectively, for the three
months ended March 31, 2021. The Company has a limited operating history and its continued growth is dependent upon the continuation of
providing general laboratory testing and <FONT STYLE="background-color: white">immunology and hematology testing services,</FONT> and
obtaining additional financing to fund future obligations and pay liabilities arising from normal business operations. In addition, the
current cash balance cannot be projected to cover the operating expenses for the next twelve months from the release date of this report.
These matters raise substantial doubt about the Company&rsquo;s ability to continue as a going concern. The ability of the Company to
continue as a going concern is dependent on the Company&rsquo;s ability to raise additional capital, implement its business plan, and
generate significant revenues. There are no assurances that the Company will be successful in its efforts to generate significant revenues,
maintain sufficient cash balance or report profitable operations or to continue as a going concern. The Company plans on raising capital
through bank and other borrowings to implement its business plan. However, there is no assurance these plans will be realized and that
any additional financings will be available to the Company on satisfactory terms and conditions, if any. These condensed consolidated
financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things,
the realization of assets and the satisfaction of liabilities in the normal course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The occurrence of an uncontrollable event such
as the COVID-19 pandemic could negatively impact the Company&rsquo;s operations even though the pandemic did not significantly impact
the Company&rsquo;s operation in the first quarter of 2021. However, given the dynamic nature of these circumstances, the uncertainty
around the potential resurgence of the COVID-19 cases in China, and the instability of local policies and restrictions, the COVID-19 impact
over the Company&rsquo;s business in the rest of year 2021 cannot be reasonably estimated at this time. If COVID-19 cases resurged in
the area the Company conducted its business and local government implemented new restrictions in the effort to contain the spread, it
is expected the Company&rsquo;s business will be negatively impacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying condensed consolidated financial
statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and
classification of liabilities that may result should the Company be unable to continue as a going concern.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Use of Estimates and
Assumptions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The preparation of the
condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant
estimates during the three months ended March 31, 2021 and 2020 include the useful lives of property and equipment, assumptions used in
assessing impairment of long-term assets, and valuation of deferred tax assets and the associated valuation allowances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Fair Value of Financial Instruments and
Fair Value Measurements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">The
Company adopted the guidance of Accounting Standards Codification (&ldquo;ASC&rdquo;) 820 for fair value measurements which clarifies
the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs
used in measuring fair value as follows</FONT>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Level <FONT STYLE="background-color: white">1-Inputs are unadjusted quoted prices in active markets for
identical assets or liabilities available at the measurement date.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Level <FONT STYLE="background-color: white">2-Inputs are unadjusted quoted prices for similar assets and
liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other
than quoted prices that are observable, and inputs derived from or corroborated by observable market data.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Level <FONT STYLE="background-color: white">3-Inputs are unobservable inputs which reflect the reporting
entity&rsquo;s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best
available information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The carrying values of
current assets and current liabilities in the Company&rsquo;s condensed consolidated balance sheets approximated their fair values as
of March 31, 2021 and December 31, 2020 due to their short-term nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 825-10 &ldquo;Financial Instruments&rdquo;,
allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair
value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value
option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent
reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Cash</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Cash consists
of cash on hand and cash in the bank. The Company maintains cash with financial institutions in the PRC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Credit Risk and Uncertainties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s cash is maintained with state-owned
banks within the PRC. Balances at state-owned banks within the PRC are covered by insurance up to RMB 500,000 (approximately $76,000)
per bank. Any balance over RMB 500,000 per bank in PRC will not be covered. At March 31, 2021, cash balances held by state-owned banks
within the PRC are RMB 1,205,456 (approximately $184,000), of which, RMB 172,460 (approximately $26,000) was not covered by such limited
insurance. The Company has not experienced any losses in such accounts and believes it is not exposed to any risks on its cash in bank
accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s operations are carried out
in PRC. Accordingly, the Company&rsquo;s business, financial condition and results of operations may be influenced by the political, economic
and legal environment in the PRC, and by the general state of the PRC&rsquo;s economy. The Company&rsquo;s operations in PRC are subject
to specific considerations and significant risks not typically associated with companies in North America. The Company&rsquo;s results
may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency
conversion and remittance abroad, and rates and methods of taxation, among other things.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments which potentially subject
the Company to concentrations of credit risk consist principally of trade accounts receivable. A portion of the Company&rsquo;s sales
are credit sales which is to the customer whose ability to pay is dependent upon the industry economics prevailing in Hebei province,
China; however, concentrations of credit risk with respect to trade accounts receivable is limited due to short term payment terms. The
Company also performs ongoing credit evaluations of its customers to help further reduce credit risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Accounts Receivable and Allowance for Doubtful
Accounts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are presented net of an allowance
for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses. The Company reviews the accounts receivable
on a periodic basis and makes general and specific allowances when there is doubt as to the collectability of individual balances. In
evaluating the collectability of individual receivable balances, the Company considers many factors, including the age of the balance,
a customer&rsquo;s payment history, its current credit-worthiness and current economic trends. Accounts are written off after exhaustive
efforts at collection.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management believes that
the accounts receivable are fully collectable. Therefore, no allowance for doubtful accounts is deemed to be required on its accounts
receivable at March 31, 2021 and December 31, 2020. The Company historically has not experienced significant uncollectible accounts receivable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Inventory</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">Inventory
consists of raw materials. Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out
(FIFO) method.</FONT>&nbsp;A reserve is established when management determines that certain inventory may not be saleable. If inventory
costs exceed expected net realizable value due to obsolescence or quantities in excess of expected demand, the Company will record reserves
for the difference between the cost and the estimated net realizable value. The Company did not record any inventory reserve at March
31, 2021 and December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Prepaid Expenses and Other Current Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid expenses and other current assets primarily
consist of prepaid utilities and prepaid service fees, which are recognized as expenses over the related service periods. As of March
31, 2021 and December 31, 2020, prepaid expenses and other current assets amounted to $60,949 and $21,017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Property and Equipment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are carried at cost and
are depreciated on a straight-line basis over the estimated useful lives of the assets. The estimated useful lives are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; white-space: nowrap; width: 31%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; white-space: nowrap; width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 36%; text-align: center">Useful Life</TD>
    <TD STYLE="padding-bottom: 1.5pt; white-space: nowrap; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 28%; text-align: center">Estimated Residual Value Rate</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap">Laboratory equipment</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">3 - 5 Years</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">5%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap">Office equipment and furniture</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">3 - 5 Years</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">5%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap">Vehicles</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">4 - 5 Years</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">5%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap">Leasehold improvements</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">Shorter of the remaining lease terms or estimated useful life</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">0%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap">Software</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">1 - 2 Years</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">0%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cost of repairs and maintenance is expensed
as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation
are removed from the accounts, and any resulting gains or losses are included in income or loss in the period of disposition. The Company
examines impairment of fixed assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Impairment of Long-lived Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with ASC Topic 360, the Company
reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may
not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future
cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset&rsquo;s
estimated fair value and its book value. There were no triggering events requiring assessment of impairment as of March 31, 2021 and December
31, 2020. For the three months ended March 31, 2021 and 2020, no impairment of long-lived assets was recognized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Value Added Tax</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to value added tax (&ldquo;VAT&rdquo;)
on revenues earned for services provided in the PRC. The amount of VAT liability is determined by applying the applicable tax rates to
the invoiced amount of services provided (output VAT) less VAT paid on purchases made with the relevant supporting invoices (input VAT).
The Company reports revenue net of PRC&rsquo;s value added tax for all the periods presented in the consolidated statements of operations
and comprehensive loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Government Grants
and Deferred Grant Income</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Government grants related to purchased long-live
assets, most of which are laboratory equipment for research and development, are recorded as deferred grant income initially and recognized
as grant income on a systematic basis over the useful lives of the assets. Government grants that are to compensate incurred costs, expenses
or losses are recognized in the current period. The Company applies the presentation method consistently to the similar government grants
in the condensed consolidated financial statements. Government grants that are related to operating activities are included in operating
income (loss), otherwise, they are recorded in other income (expense).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Grants and subsidies
received from Chinese government are recognized when the proceeds are received or collectible and related milestones have been reached
and all contingencies have been resolved. For the three months ended March 31, 2021 and 2020,&nbsp;grant income&nbsp;amounted to $123,467
and $526,703, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred grant income represents grants collected
but not earned as of each of the balance sheet date. This is primarily composed of receipts of the government subsidies for acquisition
of lab equipment and reimbursement on office rent and research and development expense. As of March 31, 2021 and December 31, 2020, deferred
grant income amounted to $488,113 and $612,356, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Accrued Liabilities and Other Payables</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued liabilities and other payables primarily
consist of accrued and unpaid interest related to notes payable, taxes payable, and accrued liabilities for other miscellaneous items.
As of March 31, 2021 and December 31, 2020, accrued liabilities and other payables amounted to $62,938 and $37,432, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Deferred Revenue</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">Payments
received prior to services being performed are recorded as deferred revenue until such time as the services are performed. As of March
31, 2021 and December 31, 2020, deferred revenue amounted to $167,201 and $88,508, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Revenue Recognition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">The
Company recognizes revenue under Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 606, Revenue from Contracts with Customers
(&ldquo;ASC 606&rdquo;).&nbsp;</FONT>The core principle of the revenue standard is that a company should recognize revenue to depict the
transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled
in exchange for those goods or services. The following five steps are applied to achieve that core principle:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Step 1: Identify the contract with the customer</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Step 2: Identify the performance obligations in the contract</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Step 3: Determine the transaction price</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Step 4: Allocate the transaction price to the performance obligations in the contract</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Step 5: Recognize revenue when the company satisfies a performance obligation</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Revenue Recognition
(continued)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">In
order to identify the performance obligations in a contract with a customer, a company must assess the promised goods or services in the
contract and identify each promised goods or service that is distinct. A performance obligation meets ASC 606&rsquo;s definition of a
&ldquo;distinct&rdquo; goods or service (or bundle of goods or services) if both of the following criteria are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The customer can benefit from the goods or service either on its own or together with other resources
that are readily available to the customer (i.e., the goods or service is capable of being distinct).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The entity&rsquo;s promise to transfer the goods or service to the customer is separately identifiable
from other promises in the contract (i.e., the promise to transfer the goods or service is distinct within the context of the contract).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If a goods or service
is not distinct, the goods or service is combined with other promised goods or services until a bundle of goods or services is identified
that is distinct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transaction price is the amount of consideration
to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected
on behalf of third parties (for example, some sales taxes). The consideration promised in a contract with a customer may include fixed
amounts, variable amounts, or both. Variable consideration is included in the transaction price only to the extent that it is probable
that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable
consideration is subsequently resolved. From time to time, the variable consideration may include fees for services performed. The Company
uses the expected value method to estimate the amount of variable consideration to be included in the transaction price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transaction price is allocated to each performance
obligation on a relative standalone selling price basis. The transaction price allocated to each performance obligation is recognized
when that performance obligation is satisfied, at a point in time or over time as appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company&rsquo;s revenues
are derived from providing general laboratory testing services and immunology and hematology testing services for patients and other customers.
Revenues related to its service offerings are recognized at a point in time when service is rendered. <FONT STYLE="background-color: white">Any
payments received in advance of the performance of services are recorded as&nbsp;deferred revenue&nbsp;until such time as the services
are performed. Except for deferred revenue, the Company did not have any other contract liability nor contract asset as of March 31, 2021
and December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not offer promotional payments,
customer coupons, rebates or other cash redemption offers to its customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has concluded that its government
grants are not within the scope of ASC Topic 606 as they do not meet the definition of a contract with a customer. The Company has concluded
that the grants meet the definition of a contribution and are non-reciprocal transactions, and has also concluded that Subtopic 958-605,
Not-for-Profit-Entities-Revenue Recognition does not apply, as it is a business entity and the grants are with governmental agencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the absence of applicable guidance under US
GAAP, effective January 1, 2018, the Company developed a policy for the recognition of grant revenue when the related costs are incurred
or the related long-live assets are purchased, and the right to payment is realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company believes this policy is consistent
with the overarching premise in ASC Topic 606, to ensure that revenue recognition reflects the transfer of promised goods or services
to customers in an amount that reflects the consideration that it expects to be entitled to in exchange for those goods or services, even
though there is no exchange as defined in ASC Topic 606.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company believes the recognition of revenue
as costs are incurred or long-live assets are purchased, and amounts become realizable is analogous to the concept of transfer of control
of a service over time under ASC Topic 606.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Disaggregation of
Revenues</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the following table,
revenues are disaggregated by segment for the three months ended March 31, 2021 and 2020:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the three months ended<BR>
March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">Revenue Stream</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">Revenue Stream Detail</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%; text-align: left">General laboratory testing</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">945,648</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">42,887</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 42%; text-align: justify">Providing general laboratory testing services, including genomics, proteomics, routine blood/urine testing, COVID-19 PCR/antibody testing etc., to patients and other customers.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">301,857</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Providing immunology and hematology testing services, mainly related to cell therapy, including tumor biomarkers and immunophenotyping, to customers.</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Total revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,247,505</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">42,887</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operating Lease</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company determines
if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&rsquo;s right to use an underlying
asset for the lease term and lease liabilities represent the Company&rsquo;s obligation to make lease payments arising from the lease.
Right-of- use assets and lease liabilities are recognized at the commencement date based on the present value of the remaining future
minimum lease payments. As the interest rate implicit in the Company&rsquo;s leases is not readily determinable, the Company utilizes
its borrowing rates set by the Central Bank of the People&rsquo;s Republic of China, determined by class of underlying asset, to discount
the lease payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company leases premises
for offices under non-cancellable operating leases. Operating lease payments are expensed over the term of lease. The Company leases do
not include options to extend nor any restrictions or covenants. The Company has historically been able to renew its office leases. Under
the terms of the lease agreements, the Company has no legal or contractual asset retirement obligations at the end of the lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Income Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes using the
asset/liability method prescribed by ASC 740, &ldquo;Income Taxes.&rdquo; Under this method, deferred tax assets and liabilities are determined
based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in
effect in the period in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax
assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets
will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes
the enactment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company follows the
accounting guidance for uncertainty in income taxes using the provisions of ASC 740 &ldquo;Income Taxes&rdquo;. Using that guidance, tax
positions initially need to be recognized in the financial statements when it is more likely than not the position will be sustained upon
examination by the tax authorities. As of March 31, 2021 and December 31, 2020, the Company had no significant uncertain tax positions
that qualify for either recognition or disclosure in the financial statements. Tax year that remains subject to examination is the years
ended December 31, 2017 through December 31, 2020. The Company recognizes interest and penalties related to significant uncertain income
tax positions in income tax expense. However, no such interest and penalties were recorded as of March 31, 2021 and December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B></B></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Loss per share</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company computes
loss per share in accordance with ASC 260, &ldquo;Earnings per Share&rdquo; (&ldquo;ASC 260&rdquo;). ASC 260 requires companies with complex
capital structures to present basic and diluted earnings per share (&ldquo;EPS&rdquo;). Basic EPS is measured as net income divided by
the weighted average common shares outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of potential
common shares (e.g. convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented,
or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e. those that increase income per share or decrease
loss per share) are excluded from the calculation of diluted EPS. As of March 31, 2021 and 2020, there were no dilutive shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Foreign Currency Translation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reporting currency of the Company is U.S.
Dollars. The functional currency of the parent company, Senlang, and Senlang HK, is the U.S. dollar and the functional currency of Senlang
BJ, SenlangBio, and SenlangBio Clinical Laboratory is the Chinese Renminbi (&ldquo;RMB&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Monetary assets and liabilities denominated in
currencies other than the reporting currency are translated into the reporting currency at the rates of exchange prevailing at the balance
sheet date. Revenue and expenses are translated using average rates during each reporting period, and shareholders&rsquo; equity is translated
at historical exchange rates. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported
on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheet.
Translation adjustments resulting from the process of translating the local currency financial statements into U.S. dollars are included
in determining comprehensive income/loss. Transactions denominated in foreign currencies are translated into the functional currency at
the exchange rates prevailing on the transaction dates. Assets and liabilities denominated in foreign currencies are translated into the
functional currency at the exchange rates prevailing at the balance sheet date with any transaction gains and losses that arise from exchange
rate fluctuations on transactions denominated in a currency other than the functional currency are included in the results of operations
as incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the Company&rsquo;s revenue transactions
are transacted in the functional currency of the Company. The Company does not enter into any material transaction in foreign currencies.
Transaction gains or losses have not had, and are not expected to have, a material effect on the results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Asset and liability accounts at March 31, 2021
and December 31, 2020 were translated at 6.5527 RMB and 6.5306 RMB to $1.00, respectively, which were the exchange rates on the balance
sheet dates. Equity accounts were stated at their historical rates. The average translation rates applied to the statements of operations
for the three months ended March 31, 2021 and 2020 were 6.4843 RMB and 6.9823 RMB to $1.00, respectively. Cash flows from the Company&rsquo;s
operations are calculated based upon the local currencies using the average translation rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Commitment and Contingencies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company
is subject to contingencies, such as legal proceedings and claims arising out of its business, that cover a wide range of matters. Liabilities
for such contingencies are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably
estimated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Segment Reporting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The&nbsp;Company uses &ldquo;the management approach&rdquo;
in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company&rsquo;s
chief operating decision maker for making operating decisions and assessing performance as the source for determining the Company&rsquo;s
reportable segments. The Company&rsquo;s chief operating decision maker is its Chief Executive Officer (&ldquo;CEO&rdquo;), who reviews
operating results to make decisions about allocating resources and assessing performance for the entire Company. The Company has determined
that it has two reportable business segments: general laboratory testing segment, and immunology and hematology testing segment. These
reportable segments offer different types of services and products, have different types of revenue, and are managed separately as each
requires different operating strategies and management expertise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Related Parties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Parties are considered to be related to the Company
if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with
the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal
owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly
influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully
pursuing its own separate interests. The Company discloses all significant related party transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 3 &ndash; <U>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Recent Accounting
Standards</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the FASB issued ASU No. 2018-13,&nbsp;<I>Fair
Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement</I>. The objective
of ASU 2018-13 is to improve the effectiveness of disclosures in the notes to the financial statements by removing, modifying, and adding
certain fair value disclosure requirements to facilitate clear communication of the information required by generally accepted accounting
principles. The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after
December 15, 2019 with early adoption permitted upon issuance of this ASU. The adoption of ASU 2018 &ndash; 13 did not have a material
impact on the Company&rsquo;s condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued&nbsp;ASU 2016-13,&nbsp;<I>Financial
Instruments - Credit Losses (&ldquo;Topic 326&rdquo;).&nbsp;</I>The ASU introduces a new accounting model, the Current Expected Credit
Losses model (&ldquo;CECL&rdquo;), which requires<I>&nbsp;</I>earlier recognition of credit losses and additional disclosures related
to credit risk.&nbsp;The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses
at the time the financial asset is originated or acquired. ASU 2016-13 is effective for annual period beginning after December 15, 2022,
including interim reporting periods within those annual reporting periods. The Company expects that the adoption will not have a material
impact on the Company&rsquo;s condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2019, the FASB issued ASU 2019-12,
<I>Simplifying the Accounting for Income Taxes, as part of its Simplification Initiative to reduce the cost and complexity in accounting
for income taxes. </I>This standard removes certain exceptions related to the approach for intra period tax allocation, the methodology
for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also
amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The guidance is effective for interim
and annual periods beginning after December 15, 2020, with early adoption permitted. The adoption of ASU 2019-12 did not have a material
impact on the Company&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other accounting standards that have been issued
or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial
statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated
to its consolidated financial condition, results of operations, cash flows or disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 4 &ndash;&nbsp;<U>VARIABLE INTEREST ENTITY
AND OTHER CONSOLIDATION MATTERS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 26, 2021, Senlang
BJ entered into VIE Agreements with SenlangBio and 13 shareholders of SenlangBio. The key terms of these VIE Agreements are summarized
in &ldquo;NOTE 1 &ndash; ORGANIZATION AND NATURE OF OPERATIONS&rdquo; above. As a result of the VIE Agreements, the Company classifies
SenlangBio as a VIE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A VIE is an entity that has either a total equity
investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose
equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected
residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has
a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE. Senlang BJ is deemed to
have a controlling financial interest and be the primary beneficiary of SenlangBio, because it has both of the following characteristics:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Power to direct activities of a VIE that most significantly impact the entity&rsquo;s economic performance,
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">Obligation to absorb losses of the entity that could potentially be significant to the VIE or right to
receive benefits from the entity that could potentially be significant to the VIE.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the VIE Agreements, SenlangBio pays
service fees equal to all of its net income to Senlang BJ. At the same time, Senlang BJ is entitled to receive all of SenlangBio&rsquo;s
expected residual returns. The VIE Agreements are designed so that SenlangBio operates for the benefit of the Company. Accordingly, the
accounts of SenlangBio are consolidated in the accompanying financial statements pursuant to ASC 810-10, Consolidation. In addition, its
financial positions and results of operations are included in the Company&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 4 &ndash;&nbsp;<U>VARIABLE INTEREST ENTITY
AND OTHER CONSOLIDATION MATTERS (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, as all of these VIE agreements are
governed by PRC law and provide for the resolution of disputes through arbitration in the PRC, they would be interpreted in accordance
with PRC law and any disputes would be resolved in accordance with PRC legal procedures. The legal environment in the PRC is not as developed
as in other jurisdictions, such as the United States. As a result, uncertainties in the PRC legal system could further limit the Company&rsquo;s
ability to enforce these VIE agreements. Furthermore, these contracts may not be enforceable in China if PRC government authorities or
courts take a view that such contracts contravene PRC laws and regulations or are otherwise not enforceable for public policy reasons.
In the event the Company is unable to enforce these VIE agreements, it may not be able to exert effective control over SenlangBio and
its ability to conduct its business may be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the Company&rsquo;s main current operations
are conducted through SenlangBio and subsidiary of SenlangBio. Current regulations in China permit SenlangBio to pay dividends to the
Company only out of its accumulated distributable profits, if any, determined in accordance with its article of association and PRC accounting
standards and regulations. The ability of SenlangBio to make dividends and other payments to the Company may be restricted by factors
including changes in applicable foreign exchange and other laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following consolidated
financial information of the VIE and VIE&rsquo;s subsidiary as a whole as of March 31, 2021 and December 31, 2020 and for the three months
ended March 31, 2021 and 2020 was included in the accompanying condensed consolidated financial statements of the Company. Transactions
between the VIE and VIE&rsquo;s subsidiary are eliminated in the financial information presented below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">December 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">Cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">188,887</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">18,935</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">636,746</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,271</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Recoverable VAT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,755</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">335,150</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">105,743</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,962</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Prepaid expenses and other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,949</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,017</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Security deposit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,012</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating lease right-of-use assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,406</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">320,123</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Property and equipment, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,268,076</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,567,522</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total Assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,920,405</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,483,992</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,373,480</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">918,752</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Notes payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">244,174</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">245,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">564,192</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">310,330</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Salary payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,329</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">105,810</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accrued leasehold improvements liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">261,106</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">315,583</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accrued liabilities and other payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,938</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,432</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167,201</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,508</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred grant income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">183,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">260,679</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating lease obligation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">151,167</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">155,470</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred grant income - noncurrent portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">304,617</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">351,677</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Operating lease obligation - noncurrent portion</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">52,377</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">105,566</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total Liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,467,077</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,894,807</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total shareholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">453,328</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">589,185</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 4 &ndash;&nbsp;<U>VARIABLE INTEREST ENTITY
AND OTHER CONSOLIDATION MATTERS (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,247,505</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">42,887</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Loss from operations</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(90,663</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(208,256</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(135,280</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(208,672</TD><TD STYLE="text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>NOTE 5 &ndash;&nbsp;<U>PROPERTY AND EQUIPMENT,
NET</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">At March 31, 2021 and
December 31, 2020, property and equipment consisted of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">December 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Laboratory equipment</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,261,276</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,268,929</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Electronic equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">235,628</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,212</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tools and furniture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,053</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">198,361</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Vehicles</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63,104</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63,317</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Leasehold improvements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,244,852</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,252,449</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Software</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">26,737</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">26,858</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,030,650</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,044,126</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,762,574</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,476,604</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Property and equipment, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,268,076</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,567,522</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For the three months
ended March 31, 2021 and 2020, depreciation expense of property and equipment amounted to $297,458 and $252,099, respectively, of which,
$14,586 and $0 was included in cost of revenue, $96,998 and $107,137 was included in research and development expenses, and $185,874 and
$144,962 was included in general and administrative expense, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 6 &ndash; <U>NOTES PAYABLE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">From time to time, the
Company acquires loans from various entities to fund its operations. These loans are due within one year and are unsecured and uncollateralized.
<FONT STYLE="background-color: white">At March 31, 2021 and December 31, 2020, short-term borrowings consisted of the following</FONT>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">December 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Loan from China Construction Bank, due on February 17, 2021 with annual interest rate of 4.1025%, extended to May 17, 2021 with annual interest rate of 3.8525% and repaid on the extended date (See Note 14)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">457,827</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">459,376</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Loan from a third-party company, due on February 8, 2021 with annual interest rate of 4.35%, extended through October 2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">457,827</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">459,376</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Loan from a third-party company, due on October 31, 2021 with annual interest rate of 4.35%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">457,826</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,373,480</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">918,752</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended March 31, 2021, interest
expense related to borrowings amounted to $13,647 and have been included in interest expense on the accompanying unaudited condensed consolidated
statements of operations and comprehensive loss. The Company had neither borrowing activity nor interest expense in the first quarter
of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As&nbsp;of March 31, 2021 and December 31, 2020,
the related accrued and unpaid interest for borrowings was $8,907 and $2,942, respectively, and have been included in accrued liabilities
and other payables on the accompanying condensed consolidated balance sheets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>NOTE 7 &ndash;&nbsp;<U>RELATED PARTY TRANSACTIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notes Payable - Related Party</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">From time to time, the
Company acquires loans from Hebei Senlang Taihe Biological Technology Co. Ltd. (&ldquo;Taihe&rdquo;) to fund its operations. These loans
are due within one year and are unsecured and uncollateralized. The annual interest rate for these loans is 4.35%. SenlangBio&rsquo;s
largest shareholder is the former executive director and currently holds 80% of equity interest of Taihe.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2021 and December 31, 2020, the
outstanding principal amounted to $244,174 and $245,000, respectively, and were recorded as &ldquo;Notes payable &ndash; related party&rdquo;
on the accompanying condensed consolidated balance sheets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended March 31, 2021 and
2020, interest expense related to related party borrowings amounted to $2,683 and $1,860, respectively, and have been included in interest
expense &ndash; related party on the accompanying condensed consolidated statements of operations and comprehensive loss. As&nbsp;of both
March 31, 2021 and December 31, 2020, the related interest for related party borrowings was paid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>NOTE 8 &ndash;&nbsp;<U>INCOME TAXES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><B>British
Virgin Islands</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the current laws
of BVI, Senlang is not subject to tax on income or capital gain. In addition, payments of dividends by the Company to its shareholders
are not subject to withholding tax in the BVI.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Hong Kong</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Senlang HK is incorporated in Hong Kong and is
subject to Hong Kong Profits Tax on the taxable income as reported in its statutory financial statements adjusted in accordance with relevant
Hong Kong tax laws. The applicable tax rate is 16.5% on its taxable income generated from operations in Hong Kong. The Company did not
make any provisions for Hong Kong profit tax as there were no assessable profits derived from or earned in Hong Kong since inception.
Additionally, payments of dividends by the subsidiary incorporated in Hong Kong to the Company are not subject to any Hong Kong withholding
tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>United States</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company and its subsidiaries
have no presence in the United States and does not conduct business in the United States, therefore no United States income tax should
be imposed upon the Company and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>PRC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Senlang BJ, SenlangBio and SenlangBio Clinical
Laboratory are subject to PRC Enterprise Income Tax (&ldquo;EIT&rdquo;) on the taxable income in accordance with the relevant PRC income
tax laws. The EIT rate for companies operating in the PRC is 25%. <FONT STYLE="background-color: white">In the year ended December 2020,
Senlang BJ, SenlangBio and SenlangBio Clinical Laboratory were each recognized as small low-profit enterprise and received a preferential
income tax rate of 10%. In the year ending December 2021, Senlang BJ, SenlangBio and SenlangBio Clinical Laboratory are each expected
to be recognized as small low-profit enterprise and are expected to receive a preferential income tax rate of 10%.</FONT> The Company
did not have any income taxes expense for the years ended December 31, 2020 since it incurred losses in the periods. As of March 31, 2021,
income tax returns for the tax years ended December 31, 2017 through December 31, 2020 remain open for statutory examination by PRC tax
authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Below is a reconciliation of the statutory tax
rate to the effective tax rate for the three months ended March 31, 2021 and 2020:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the three months ended<BR>
March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">PRC statutory income tax rate</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">25.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">25.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Effect of income tax exemptions and reliefs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15.0</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15.0</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Effect of non-deductible expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Valuation allowance</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(36.8</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(10.1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Effective tax rate</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(26.7</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.0</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The Company&rsquo;s approximate net deferred
tax assets as of March 31, 2021 and December 31, 2020 were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Deferred tax assets:</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March 31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">December 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 0.125in">Net operating loss carryforward</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,426,050</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,340,709</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Valuation allowance</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,426,050</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,340,709</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Net deferred tax assets</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>NOTE 8 &ndash;&nbsp;<U>INCOME TAXES (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>PRC (continued)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">The Company
provided a valuation allowance equal to the deferred income tax assets as of March 31, 2021 and December 31, 2020 because it was not known
whether future taxable income will be sufficient to utilize the loss carryforward. The potential tax benefit arising from the loss carryforward
will begin to expire in 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of March 31, 2021
and December 31, 2020, the Company had no significant uncertain tax positions that qualify for either recognition or disclosure in the
financial statements. As of March 31, 2021, income tax returns for the tax years ended December 31, 2017 through December 31, 2020 remain
open for statutory examination by PRC tax authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The uncertain tax positions are related to tax
years that remain subject to examination by the relevant tax authorities. Based on the outcome of any future examinations, or as a result
of the expiration of statute of limitations for specific jurisdictions, it is reasonably possible that the related unrecognized tax benefits
for tax positions taken regarding previously filed tax returns, might materially change from those recorded as liabilities for uncertain
tax positions in the Company&rsquo;s consolidated financial statements as of March 31, 2021 and December 31, 2020. In addition, the outcome
of these examinations may impact the valuation of certain deferred tax assets (such as net operating losses) in future periods. The Company&rsquo;s
policy is to recognize interest and penalties accrued on any unrecognized tax benefits, if any, as a component of income tax expense.
The Company does not anticipate any significant increases or decreases to its liability for unrecognized tax benefit within the next twelve
months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to the PRC Tax Administration and Collection
Law, the statute of limitations is three years if the underpayment of income taxes is due to computational errors made by the taxpayer.
The statute of limitations will be extended to five years under special circumstances, which are not clearly defined, but an underpayment
of income tax liability exceeding RMB100,000 (approximately $15,000) is specifically listed as a special circumstance. In the case of
a transfer pricing related adjustment, the statute of limitations is ten years. There is no statute of limitations in the case of tax
evasion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Accounting for Uncertainty in Income Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The tax authority of
the PRC government conducts periodic and ad hoc tax filing reviews on business enterprises operating in the PRC after those enterprises
complete their relevant tax filings. Therefore, the Company&rsquo;s tax filings results are subject to change. It is therefore uncertain
as to whether the PRC tax authority may take different views about the Company&rsquo;s tax filings, which may lead to additional tax liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 740 requires recognition and measurement of
uncertain income tax positions using a &ldquo;more-likely-than-not&rdquo; approach. The management evaluated the Company&rsquo;s tax positions
and concluded that no provision for uncertainty in income taxes was necessary as of December 31, 2020 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>NOTE 9 &ndash;&nbsp;<U>EQUITY</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The equity structures as of March 31, 2021 was
presented after giving retroactive effect to the reorganization of the Company that was completed in April 2021. Immediately before and
after the reorganization, the shareholders of SenlangBio controlled Senlang. Therefore, the reorganization is accounted for as a transaction
of entities under common control at carrying value and for accounting purpose, the reorganization was accounted for as a recapitalization.
The consolidated financial statements are prepared on the basis as if the Reorganization became effective as of the beginning of the first
period presented in the accompanying consolidated financial statements of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 15, 2020, Senlang was incorporated
in the British Virgin Islands. As of the date of this report, its authorized share capital consists of 50,000 ordinary shares with a par
value of $1.00 per share. As of the date of this report, 10,001 ordinary shares were issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Statutory Reserve</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Senlang BJ, SenlangBio and SenlangBio Clinical
Laboratory operate in the PRC and are required to reserve 10% of their net profit after income tax, as determined in accordance with the
PRC accounting rules and regulations. Appropriation to the statutory reserve by the Company is based on profit arrived at under PRC accounting
standards for business enterprises for each year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The&nbsp;profit arrived
at must be set off against any accumulated losses sustained by the Company in prior years, before allocation is made to the statutory
reserve. Appropriation to the statutory reserve must be made before distribution of dividends to shareholders. The appropriation is required
until the statutory reserve reaches 50% of the registered capital. This statutory reserve is not distributable in the form of cash dividends.
Senlang BJ, SenlangBio and SenlangBio Clinical Laboratory did not make any appropriation to statutory reserve during the three months
ended March 31, 2021 and 2020.&nbsp;As of both March 31, 2021 and December 31, 2020, the Company did not have any statutory reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>NOTE 10 -&nbsp;<U>CONCENTRATIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Customers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information as
to each customer that accounted for 10% or more of the Company&rsquo;s revenues for the three months ended March 31, 2021 and 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">Customer</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">A</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">43</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">*</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>B</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>C</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>D</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>E</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Less than 10%</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Two customers, whose outstanding receivable accounted
for 10% or more of the Company&rsquo;s total outstanding accounts receivable at March 31, 2021, accounted for 97% of the Company&rsquo;s
total outstanding accounts receivable at March 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One customer, whose outstanding receivable accounted
for 10% or more of the Company&rsquo;s total outstanding accounts receivable at December 31, 2020, accounted for 98.1% of the Company&rsquo;s
total outstanding accounts receivable at December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Suppliers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information as
to each supplier that accounted for 10% or more of the Company&rsquo;s purchase for the three months ended March 31, 2021 and 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">Supplier</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">A</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">40</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">*</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>B</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>C</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>D</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">*</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Less than 10%</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Two suppliers, whose outstanding payable accounted
for 10% or more of the Company&rsquo;s total outstanding accounts payable at March 31, 2021, accounted for 35.7% of the Company&rsquo;s
total outstanding accounts payable at March 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Three suppliers, whose outstanding payable accounted
for 10% or more of the Company&rsquo;s total outstanding accounts payable at December 31, 2020, accounted for 77.8% of the Company&rsquo;s
total outstanding accounts payable at December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>NOTE
11 &ndash;&nbsp;<U>SEGMENT INFORMATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended March 31, 2021 and
2020, the Company operated in two reportable business segments - (1) general laboratory testing segment, and (2) immunology and hematology
testing segment. The Company&rsquo;s reportable segments are strategic business units that offer different services and products. They
are managed separately based on the fundamental differences in their operations. Information with respect to these reportable business
segments for the three months ended March 31, 2021 and 2020 was as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>NOTE 11 &ndash;&nbsp;<U>SEGMENT
INFORMATION (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Revenues</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 0.125in">General laboratory testing</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">945,648</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">42,887</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">301,857</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,247,505</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">42,887</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">Cost of revenues</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">347,911</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,117</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">89,498</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">437,409</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,117</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">597,737</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,770</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">212,359</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">810,096</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28,770</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">Operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">59,480</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,969</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">841,279</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">186,057</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">900,759</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">237,026</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">Other (expense) income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(16,330</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,860</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Other income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,072</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">130</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">372</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">226</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,444</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total other expense, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(16,104</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(416</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">Income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,513</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28,513</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">Net income (loss)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">509,840</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,127</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(645,120</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(187,545</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(135,280</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(208,672</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">Depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,970</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,456</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">293,488</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">248,643</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">297,458</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">252,099</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0in">Capital expenditure</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,376</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,874</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">56,205</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,791</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">57,581</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,665</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>NOTE 11 &ndash;&nbsp;<U>SEGMENT
INFORMATION (continued)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">Identifiable long-lived tangible assets at March 31, 2021 and December 31, 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">December 31, <BR>2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">General laboratory testing</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">59,669</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">62,447</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,208,407</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,505,075</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; padding-bottom: 1.5pt">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,268,076</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,567,522</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">Total assets at March 31, 2021 and December 31, 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">809,399</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">163,560</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,111,006</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,320,432</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; padding-bottom: 1.5pt">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,920,405</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,483,992</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have long-lived assets located
outside the PRC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>NOTE 12 &ndash;&nbsp;<U>COMMITMENTS
AND CONTINCENGIES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Contingencies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">From
time to time, the Company may be subject to certain legal proceedings, claims and disputes that arise in the ordinary course of business.
Although the outcomes of these legal proceedings cannot be predicted, the Company does not believe these actions, in the aggregate, will
have a material adverse impact on its financial position, results of operations or liquidity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Operating Leases Commitment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company is a party
to leases for office space. Rent expense under all operating leases amounted to approximately $55,000 and $54,000 for the three months
ended March 31, 2021 and 2020, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Supplemental cash flow information related to
leases for the&nbsp;three months ended March 31, 2021 and 2020 is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Cash paid for amounts included in the measurement of lease liabilities:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 0.125in">Operating cash flows paid for operating lease</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">59,039</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">54,687</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Right-of-use assets obtained in exchange for lease obligation:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Operating lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the lease term
and discount rate for the Company&rsquo;s operating lease as of March 31, 2021:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Operating Lease</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">Weighted average remaining lease term (in years)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1.02</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted average discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.75</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>NOTE 12 &ndash;&nbsp;<U>COMMITMENTS
AND CONTINCENGIES (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Operating Leases Commitment (continued)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table summarizes the maturity of lease liabilities under
operating lease as of March 31, 2021:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">For the Twelve-month Period Ending March 31:</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Operating Lease</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">2022</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">162,681</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,999</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">2024 and thereafter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total lease payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">215,680</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Amount of lease payments representing interest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,136</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Total present value of operating lease liabilities</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">203,544</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">151,167</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Long-term portion</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">52,377</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">203,544</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Variable Interest
Entity Structure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt; background-color: white">In
the opinion of management, (i) the corporate structure of the Company is in compliance with existing PRC laws and regulations; (ii) the
Contractual Arrangements are valid and binding, and do not result in any violation of PRC laws or regulations currently in effect; and
(iii) the business operations of WFOE, VIE and VIE&rsquo;s subsidiary are in compliance with existing PRC laws and regulations in all
material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt; background-color: white">However,
there are substantial uncertainties regarding the interpretation and application of current and future PRC laws and regulations. Accordingly,
the Company cannot be assured that PRC regulatory authorities will not ultimately take a contrary view to the foregoing opinion of its
management. If the current corporate structure of the Company or the Contractual Arrangements is found to be in violation of any existing
or future PRC laws and regulations, the Company may be required to restructure its corporate structure and operations in the PRC to comply
with changing and new PRC laws and regulations. In the opinion of management, the likelihood of loss in respect of the Company&rsquo;s
current corporate structure or the VIE Agreements is remote based on current facts and circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>NOTE 13 &ndash;&nbsp;<U>RESTRICTED
NET ASSETS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of March 31, 2021,
the Company&rsquo;s operations are conducted through its PRC subsidiary, VIE and VIE&rsquo;s subsidiary, which can only pay dividends
out of their retained earnings determined in accordance with the accounting standards and regulations in the PRC and after they have met
the PRC requirements for appropriation to statutory reserve. In addition, most of the Company&rsquo;s businesses and assets are denominated
in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place either through the People&rsquo;s
Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People&rsquo;s Bank of
China. Approval of foreign currency payments by the People&rsquo;s Bank of China or other regulatory institutions requires submitting
a payment application form together with suppliers&rsquo; invoices, shipping documents and signed contracts. These currency exchange control
procedures imposed by the PRC government authorities may restrict the ability of the Company&rsquo;s PRC subsidiary to transfer their
net assets to the Lonlon Biotech Ltd. (the &ldquo;Parent Company&rdquo;) through loans, advances or cash dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Schedule I of Article
5-04 of Regulation S-X requires the condensed financial information of the parent company to be filed when the restricted net assets of
consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. For purposes
of this test, restricted net assets of consolidated subsidiaries shall mean that amount of the registrant&rsquo;s proportionate share
of net assets of its consolidated subsidiaries (after intercompany eliminations) which as of the end of the most recent fiscal year may
not be transferred to the parent company in the form of loans, advances or cash dividends without the consent of a third party. The restricted
net assets of the Company&rsquo;s PRC subsidiary amounted to approximately $453,000 and $589,000 as of March 31, 2021 and December 31,
2020, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>NOTE 13 &ndash;&nbsp;<U>RESTRICTED
NET ASSETS (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company&rsquo;s PRC
subsidiary&rsquo; net assets as of March 31, 2021 and December 31, 2020 exceeded 25% of the Company&rsquo;s consolidated net assets. Accordingly,
Parent Company&rsquo;s condensed financial statements have been prepared in accordance with Rule 5-04 and Rule 12-04 of SEC Regulation
S-X, and are as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Condensed Financial
Information of the Parent Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Parent Company&rsquo;s
condensed financial statements have been prepared using the same accounting principles and policies described in the notes to the consolidated
financial statements, with the only exception being that the Parent Company accounts for its subsidiaries using the equity method. Refer
to the consolidated financial statements and notes presented above for additional information and disclosures with respect to these financial
statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: center">Parent Company&rsquo;s Condensed Balance Sheets</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">December 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>NON-CURRENT ASSETS:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Investment in subsidiaries</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">453,328</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">589,185</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total Non-current Assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">453,328</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">589,185</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.25in">Total Assets</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">453,328</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">589,185</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">LIABILITIES AND SHAREHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total Liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and Contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">SHAREHOLDERS&rsquo; EQUITY:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><P STYLE="margin: 0pt 0 0pt 0.125in; text-indent: -0.125in">Ordinary shares, $1.00 par value; 50,000 shares authorized; 10,001 shares issued and outstanding at March 31,
2021 and December 2020 *</P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0">10,001</P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0">10,001</P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,946,197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,946,197</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accumulative deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,515,294</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,380,014</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accumulated other comprehensive income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,424</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,001</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total Shareholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">453,328</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">589,185</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.25in">Total Liabilities and Shareholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">453,328</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">589,185</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">The shares amounts are presented on a retroactive basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: center">Parent Company&rsquo;s Condensed Statements of Operations and Comprehensive Loss</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended&nbsp;March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Operating expense</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income attributable to Parent Company only</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; text-align: left; padding-bottom: 1.5pt">Share of loss from investment in subsidiaries</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(135,280</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(208,672</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(135,280</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(208,672</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Unrealized foreign currency translation loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(577</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,085</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Comprehensive loss</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(135,857</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(255,757</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LONLON BIOTECH LTD. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Unaudited)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTE 13 &ndash;&nbsp;<U>RESTRICTED NET ASSETS (continued)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Condensed Financial
Information of the Parent Company (continued)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: center">Parent Company&rsquo;s Condensed Statements of Cash Flows</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; text-align: left; padding-left: 0.125in">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(135,280</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(208,672</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Adjustments to reconcile net loss to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Share of loss from investment in subsidiaries</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">135,280</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">208,672</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">NET CASH PROVIDED BY OPERATING ACTIVITIES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">NET INCREASE IN CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">CASH - beginning of period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">CASH - end of period</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Basis of Preparation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The condensed financial
information of the Parent Company has been prepared using the same accounting policies as set out in the consolidated financial statements
except that the Company used the equity method to account for investment in its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain information and
footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally accepted in
the United States of America have been condensed or omitted. The Parent Company only financial information has been derived from the Company&rsquo;s
consolidated financial statements and should be read in conjunction with the Company&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Investment in Subsidiaries</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company and its subsidiaries
were included in the consolidated financial statements where the inter-company balances and transactions were eliminated upon consolidation.
For purpose of the Parent Company&rsquo;s stand-alone financial statements, its investments in subsidiaries were reported using the equity
method of accounting.&nbsp;Such investment is presented as &ldquo;Investment in subsidiaries&rdquo; on the condensed balance sheets and
the subsidiaries&rsquo; loss is presented as &ldquo;Share of loss from investment in subsidiaries&rdquo; in the condensed statements of
operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 14 &ndash; <U>SUBSEQUENT EVENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">In
May 2021, the Company repaid a short-term loan from China Construction Bank in the principal amount of $457,827.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">In
May 2021, the Company borrowed a short-term loan from a related party company in the principal amount of $763,044. The new loan bears
interest rate at 4.35% per annum and is due on October 31, 2021.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 26, 2021, Senlang BJ entered into a series
of contractual arrangements, or VIE agreements with SenlangBio and 13 equity holders of SenlangBio, through which the Company obtained
control and became the primary beneficiary of SenlangBio. As a result, SenlangBio became the Company&rsquo;s VIE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 13, 2021, the Company entered into a Share
Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;), by and among the Company, Avalon GloboCare Corp., a Delaware corporation (&ldquo;Avalon&rdquo;),
the holders of the share capital of Senlang (the &ldquo;Senlang Shareholders&rdquo;), the ultimate beneficial owners of the Senlang Shareholders
(the &ldquo;Senlang Beneficial Shareholders&rdquo; and, together with the Senlang Shareholders, the &ldquo;Senlang Owners&rdquo;) and
a representative of the Senlang Owners (the &ldquo;Senlang Representative&rdquo;). Pursuant to the Purchase Agreement, Avalon will acquire
all of the issued and outstanding share capital of the Company in consideration of 81 million shares of the common stock, par value $0.0001
per share, of Avalon (the &ldquo;Acquisition&rdquo;).</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Acquisition, on June 13,
2021, an institutional investor (the &ldquo;Investor&rdquo;) entered into an agreement with the related to the purchase of registered
capital of the SenlangBio (the &ldquo;SenlangBio Capital Increase Agreement&rdquo;) pursuant to which the Investor will acquire an aggregate
of up to 13.5% of the equity ownership of the SenlangBio for an aggregate purchase price of RMB 200,000,000 (approximately $30 million)
(the &ldquo;Equity Financing&rdquo;), which funds will be invested in the SenlangBio in three installments of RMB 67,000,000 (approximately
$10 million), RMB 67,000,000 (approximately $10 million) and RMB 66,000,000 (approximately $10 million), the first to be upon the closing
of the Acquisition, the second to be within three months after the closing and the third to be within six months after the closing. In
addition, pursuant to a Securities Exchange Agreement (the &ldquo;Exchange Agreement&rdquo;), by and among the Company, SenlangBio, Avalon
and the Investor, dated June 13, 2021, the Investor has the right, exercisable between the six-month and five year-anniversaries of the
respective initial closing and installment closings, to elect to exchange, from time to time, all or part of its then-owned equity ownership
of SenlangBio for shares (the &ldquo;Exchange Shares&rdquo;) of Avalon Common Stock at a fixed exchange price of US$1.21 per share of
Avalon Common Stock, which was the market price of the Avalon Common Stock as of the date of the Exchange Agreement under Nasdaq rules.
In addition, the Exchange Agreement provides that the Investor may only exchange up to 10% of its total investment amount in any 30-day
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These unaudited condensed consolidated financial
statements were approved by management and available for issuance on June 24, 2021. The Company evaluated subsequent events through the
date these unaudited condensed consolidated financial statements were issued.</P>

<P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">F-26</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>6
<FILENAME>ea143147ex99-4_avalonglob.htm
<DESCRIPTION>THE COMPANY'S UNAUDITED PRO FORMA CONSOLIDATED COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE YEAR ENDED DECEMBER 31, 2020 AND THE THREE MONTHS ENDED MARCH 31, 2021, THE UNAUDITED PRO FORMA CONSOLIDATED COMBINED BALANCE SHEET AS OF MARCH
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED PRO FORMA CONSOLIDATED COMBINED FINANCIAL
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On June 13, 2021, Avalon
entered into a share purchase agreement (the &ldquo;Purchase Agreement&rdquo;) with Senlang. Pursuant to the Purchase Agreement, subject
to the satisfaction of the conditions to closing, including approval by the Avalon stockholders pursuant to the rules of the Nasdaq Stock
Market, Avalon will acquire all of the issued and outstanding securities of Senlang in consideration of 81,000,000 shares of Avalon common
stock. The following unaudited pro forma consolidated combined financial statements present the historical consolidated financial statements
of Avalon GloboCare Corp. and Subsidiaries (&ldquo;Avalon&rdquo;) and the historical consolidated financial statements of Lonlon Biotech
Ltd. and Subsidiaries (&ldquo;Senlang&rdquo;), adjusted as if Avalon had acquired Senlang.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The unaudited pro forma
consolidated combined balance sheet combines the historical consolidated balance sheet of Avalon and the historical consolidated balance
sheet of Senlang as of March 31, 2021, giving effect to the acquisition as if they had been consummated on March 31, 2021. The unaudited
pro forma consolidated combined statement of operations and comprehensive loss for the three months ended March 31, 2021 combines the
historical consolidated statement of operations and comprehensive loss of Avalon and the historical consolidated statement of operations
and comprehensive loss of Senlang, giving effect to the acquisition as if they had been consummated on January 1, 2020, the beginning
of the earliest period presented. The unaudited pro forma consolidated combined statement of operations and comprehensive loss for the
year ended December 31, 2020 combines the historical consolidated statement of operations and comprehensive loss of Avalon and the historical
consolidated statement of operations and comprehensive loss of Senlang, giving effect to the acquisition as if they had been consummated
on January 1, 2020, the beginning of the earliest period presented. The historical consolidated financial statements have been adjusted
in the unaudited pro forma consolidated combined financial statements to give pro forma effect to events that are: (1) directly attributable
to the acquisition; (2) factually supportable; and (3) with respect to the statement of operations, expected to have a continuing impact
on Avalon&rsquo;s results following the completion of the acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The unaudited pro forma
consolidated combined financial statements have been developed from and should be read in conjunction with:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The accompanying notes to the unaudited pro forma consolidated combined financial statements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The historical consolidated financial statements and related notes of Avalon as of March 31, 2021, for
the three months ended March 31, 2021 and for the year ended December 31, 2020, as well as &ldquo;Management&rsquo;s Discussion and Analysis
of Financial Condition and Results of Operations,&rdquo; included in Avalon&rsquo;s Quarterly Report on Form 10Q for the three months
ended March 31, 2021 and Annual Report on Form 10-K for the year ended December 31, 2020, which were filed with the Securities and Exchange
Commission; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The historical consolidated financial statements of Senlang as of March 31, 2021 and for the three months
ended March 31, 2021 and for the year ended December 31, 2020, which are contained elsewhere in this Form 8-K/A.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AVALON GLOBOCARE CORP. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNAUDITED PRO FORMA CONSOLIDATED COMBINED BALANCE
SHEET</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">As of March 31, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historical</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="14" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Forma</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avalon</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lonlon</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GloboCare Corp.</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Biotech Ltd.</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="8" STYLE="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Forma Adjustments</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Forma</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Subsidiaries</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Subsidiaries</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cr.</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Combined</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSETS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT ASSETS:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 49%; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,692,540</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,887</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,881,427</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">636,746</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">636,746</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent receivable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,471</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,471</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred financing costs</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">152,438</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">152,438</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverable VAT</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">343,755</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">343,755</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,743</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,743</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">295,731</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,949</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">449,498</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">806,178</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,164,180</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,336,080</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">449,498</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">449,498</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,260</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT ASSETS:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent receivable - noncurrent portion</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,174</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,174</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security deposit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,662</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,843</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,505</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred leasing costs</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,359</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,359</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use assets, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">241,729</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,406</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">508,135</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">439,962</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,268,076</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,708,038</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in real estate, net</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,644,950</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,644,950</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity method investment</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">532,199</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">532,199</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,556,672</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,556,672</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Non-current Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,121,035</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,584,325</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,556,672</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,262,032</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,285,215</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,920,405</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,006,170</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">449,498</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,762,292</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITIES AND SHAREHOLDERS&rsquo; EQUITY</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT LIABILITIES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued professional fees</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,445,225</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">650,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;d</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,095,225</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued research and development fees</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">432,500</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">432,500</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued payroll liability and directors&rsquo; compensation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,846</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,329</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">268,175</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">564,192</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">564,192</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued leasehold improvements liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">261,106</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">261,106</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities and other payables</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">344,453</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,938</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,175,995</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;e</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,583,386</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,373,480</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,373,480</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities and other payables - related parties</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,105</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,105</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,201</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,201</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred grant income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,496</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,496</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease obligation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">132,657</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,167</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">283,824</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note payable - related party</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">390,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,174</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">634,174</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,223,786</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,110,083</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,175,995</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,825,995</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,983,869</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-CURRENT LIABILITIES:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred grant income - noncurrent portion</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">304,617</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">304,617</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease obligation - noncurrent portion</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,337</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,377</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">161,714</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan payable - related party</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,305,249</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,305,249</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Non-current Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,414,586</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">356,994</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,771,580</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,638,372</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,467,077</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,175,995</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,825,995</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,755,449</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHAREHOLDERS&rsquo; EQUITY:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.25in; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 0.25in; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock, $0.0001 par value; 490,000,000 shares authorized; 84,943,564 shares issued and 84,423,564 shares outstanding 165,943,564 pro forma shares issued and 165,423,564 pro forma shares outstanding</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,494</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,100</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;b</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,594</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional paid-in capital</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,755,996</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,946,197</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,946,197</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,001,900</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;b</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">147,757,896</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,001</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: common stock held in treasury, at cost; 520,000 shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(522,500</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(522,500</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated deficit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(44,408,493</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,515,294</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">650,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,515,294</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;c</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(45,058,493</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statutory reserve</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,578</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,578</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated other comprehensive (loss) income</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(193,232</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,424</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,424</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(193,232</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total shareholders&rsquo; equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,646,843</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">453,328</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,618,622</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,525,294</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,006,843</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Liabilities and Shareholders&rsquo; Equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,285,215</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,920,405</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,794,617</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,351,289</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,762,292</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AVALON GLOBOCARE CORP. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNAUDITED PRO FORMA CONSOLIDATED COMBINED STATEMENT
OF OPERATIONS AND COMPREHENSIVE LOSS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Three Months Ended March 31, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Historical</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Pro Forma</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center">Avalon</TD><TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center">Lonlon</TD><TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="8" STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; white-space: nowrap; text-align: center">GloboCare Corp.</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; white-space: nowrap; text-align: center">Biotech Ltd.</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="8" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma Adjustments</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; white-space: nowrap; text-align: center">Pro Forma</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">and Subsidiaries</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">and Subsidiaries</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">Dr.</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">Cr.</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">Combined</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">REVENUES</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 49%; text-align: left; text-indent: -0.125in; padding-left: 0.25in">Real property rental</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">289,774</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">289,774</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">945,648</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">945,648</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">301,857</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">301,857</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Revenues</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">289,774</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,247,505</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,537,279</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">COSTS AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Real property operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">216,894</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">216,894</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">347,911</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">347,911</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">89,498</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">89,498</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Costs and Expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">216,894</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">437,409</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">654,303</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Real Property Opearting Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,880</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,880</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Gross Profit from General Laboratory Testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">597,737</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">597,737</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Gross Profit from Immunology and Hematology Testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">212,359</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">212,359</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Gross Profit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">72,880</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">810,096</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">882,976</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">OTHER OPERATING EXPENSES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,381,178</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,041</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,405,219</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Compensation and related benefits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562,006</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">86,204</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">648,210</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Research and development expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">213,188</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">565,331</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">778,519</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">406,188</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">406,188</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Other general and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">220,096</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">295,943</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">516,039</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Selling and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,707</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,707</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,439,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">c</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,439,000</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Grant income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(123,467</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(123,467</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Other Operating Expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,376,468</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">900,759</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,845,188</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">406,188</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,716,227</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">LOSS FROM OPERATIONS</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,303,588</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(90,663</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,845,188</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(406,188</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,833,251</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">OTHER (EXPENSE) INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,647</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,647</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Interest expense - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(45,149</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,683</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,832</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Loss from equity method investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18,514</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18,514</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Other income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">133</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">226</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">359</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Other Expense, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(63,530</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(16,104</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(79,634</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">LOSS BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,367,118</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(106,767</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,845,188</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(406,188</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,912,885</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">INCOME TAXES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28,513</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28,513</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">NET LOSS</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,367,118</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(135,280</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,845,188</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(406,188</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(4,941,398</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">COMPREHENSIVE LOSS:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">NET LOSS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(2,367,118</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(135,280</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(2,845,188</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(406,188</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(4,941,398</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">OTHER COMPREHENSIVE LOSS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Unrealized foreign currency translation loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,722</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(577</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,299</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in">COMPREHENSIVE LOSS</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,369,840</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(135,857</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,845,188</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(406,188</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(4,944,697</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">NET LOSS PER COMMON SHARE:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in">Basic and diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.03</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">)&nbsp;b</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in">Basic and diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">83,413,154</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">164,413,154</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AVALON GLOBOCARE CORP. AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNAUDITED PRO FORMA CONSOLIDATED COMBINED STATEMENT
OF OPERATIONS AND COMPREHENSIVE LOSS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Year Ended December 31, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Historical</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Pro Forma</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center">Avalon</TD><TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center">Lonlon</TD><TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">GloboCare Corp.</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">Biotech Ltd.</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="8" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma Adjustments</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">Pro Forma</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">and Subsidiaries</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">and Subsidiaries</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">Dr.</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">Cr.</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">Combined</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">REVENUES</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 49%; text-align: left; text-indent: -0.125in; padding-left: 0.25in">Real property rental</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">1,206,854</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">1,206,854</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Medical related consulting services - related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">170,908</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">170,908</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">649,932</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">649,932</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">440,183</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">440,183</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Revenues</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,377,762</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,090,115</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,467,877</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">COSTS AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Real property operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">851,754</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">851,754</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Medical related consulting services - related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,805</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,805</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">General laboratory testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,794</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,794</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Immunology and hematology testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">197,444</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">197,444</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Costs and Expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">987,559</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">541,238</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,528,797</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Real Property Opearting Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">355,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">355,100</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Gross Profit from Medical Related Consulting Services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,103</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,103</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Gross Profit from General Laboratory Testing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">306,138</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">306,138</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Gross Profit from Immunology and Hematology Testing</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">242,739</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">242,739</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Gross Profit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">390,203</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">548,877</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">939,080</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">OTHER OPERATING EXPENSES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,553,009</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73,397</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,626,406</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Compensation and related benefits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,156,150</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">292,439</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,448,589</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Research and development expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">883,855</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,813,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,697,105</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">925,438</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">925,438</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Other general and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,251,208</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">559,602</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,810,810</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Selling and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">163,145</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">163,145</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,756,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">c</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,756,000</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Grant income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(929,505</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(929,505</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Other Operating Expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,844,222</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,972,328</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">10,681,438</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">925,438</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">25,572,550</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">LOSS FROM OPERATIONS</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,454,019</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,423,451</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(10,681,438</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(925,438</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(24,633,470</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">OTHER (EXPENSE) INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,397</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,397</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Interest expense - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(168,762</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,169</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(179,931</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Loss from equity method investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(51,673</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(51,673</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Other (expense) income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,984</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,654</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(330</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Total Other Expense, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(225,419</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(18,912</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(244,331</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">LOSS BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,679,438</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,442,363</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,681,438</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(925,438</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,877,801</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">INCOME TAXES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">NET LOSS</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(12,679,438</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,442,363</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(10,681,438</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(925,438</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(24,877,801</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">COMPREHENSIVE LOSS:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">NET LOSS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(12,679,438</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(2,442,363</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(10,681,438</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(925,438</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(24,877,801</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in">OTHER COMPREHENSIVE INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.375in">Unrealized foreign currency translation gain</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">67,237</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">58,807</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">126,044</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in">COMPREHENSIVE LOSS</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(12,612,201</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,383,556</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(10,681,438</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(925,438</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(24,751,757</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">NET LOSS PER COMMON SHARE:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in">Basic and diluted</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="white-space: nowrap; border-bottom: Black 4pt double; text-align: right">(0.16</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="white-space: nowrap; border-bottom: Black 4pt double; text-align: right">(0.15</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">) b</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in">Basic and diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">79,508,149</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">160,508,149</TD><TD STYLE="white-space: nowrap; padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>[1]&nbsp;Basis of Pro Forma Presentation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The unaudited pro forma
consolidated combined financial statements have been prepared assuming the acquisition is accounted for as a business combination using
the acquisition method of accounting under Financial Accounting Standards Board (&ldquo;FASB&rdquo;) ASC 805, Business Combinations (&ldquo;ASC
805&rdquo;). For business combinations under ASC 805, acquisition-related transaction costs are not included as a component of consideration
transferred but are accounted for as expenses in the periods in which such costs are incurred. Acquisition-related transaction costs include
advisory, legal, accounting fee and others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The unaudited pro forma
consolidated combined financial statements reflect adjustments, based on available information and certain assumptions that Avalon believes
are reasonable, attributable to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquisition of Senlang, which will be accounted for as a business combination, with Avalon identified as the acquirer, and the issuance of shares of Avalon common stock as acquisition consideration. Avalon is considered the accounting acquirer since immediately following the closing: (i) Avalon stockholders will own a majority of the voting rights of the combined company; (ii) Avalon will designate a majority (nine of ten) of the initial members of the board of directors of the combined company; (iii) Avalon&rsquo;s senior management will hold the majority of the key positions in senior management of the combined company; and (iv) Avalon will continue to maintain its corporate headquarters in Freehold, New Jersey, United States. SenlangBio will continue to maintain operations in the Shijiazhuang High-tech Development Zone, Hebei Province, China;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Adjustments to conform the classification of certain assets
and liabilities in Senlang&rsquo;s historical consolidated balance sheet to Avalon&rsquo;s classification for similar assets and liabilities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Adjustments to conform the classification of expenses in Senlang&rsquo;s
historical consolidated statement of operations and comprehensive loss to Avalon&rsquo;s classification for similar expenses; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">The incurrence of acquisition-related expenses.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The pro forma adjustments
represent management&rsquo;s estimates based on information available as of the date of this filing and are subject to change as additional
information becomes available and additional analyses are performed. The pro forma financial statements are provided for illustrative
purposes only and are not intended to represent what Avalon&rsquo;s financial position or results of operations would have been had the
acquisition actually been consummated on the assumed dates nor do they purport to project the future operating results or financial position
of Avalon following the acquisition. The pro forma financial statements do not reflect future events that may occur after the acquisition,
including, but not limited to, the anticipated realization of ongoing savings from potential operating efficiencies, cost savings, or
economies of scale that Avalon may achieve with respect to the combined operations. Specifically, the pro forma statements of operations
do not include the synergies expected to be achieved as a result of the acquisition and any associated costs that may be incurred to achieve
the identified synergies. Additionally, Avalon cannot assure that additional charges will not be incurred in excess of those included
in the pro forma additional legal, accounting, and advisory fees of $650,000 related to the acquisition, Avalon&rsquo;s efforts to achieve
operational synergies, or that management will be successful in its efforts to integrate the operations. The pro forma statement of operations
also excludes the effects of costs associated with any restructuring and integration activities that may result from the acquisition.
Further, the pro forma financial statements do not reflect the effect of any regulatory actions that may impact the results of Avalon
following the acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Assumptions and estimates
underlying the pro forma adjustments are described in the accompanying notes, which should be read in conjunction with the unaudited pro
forma consolidated combined financial statements. In Avalon&rsquo;s opinion, all adjustments that are necessary to present fairly the
pro forma information have been made. The historical financial statements have been adjusted in the unaudited pro forma consolidated combined
financial statements to give effect to the acquisition. These adjustments are directly attributable to the acquisition, factually supportable
and, with respect to the unaudited pro forma consolidated combined statements of operations, expected to have a continuing impact on Avalon
following the acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>[2] Pro Forma Adjustments and Assumptions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><I>Pro Forma
Adjustments to the Consolidated Balance Sheet at March 31, 2021:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">Represents the reclassification of recoverable VAT and inventory into prepaid expenses and other current
assets.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects <FONT STYLE="background-color: white">the issuance of 81,000,000 shares of Avalon common stock at a price of $1.21 per share (which was the market price of the Avalon common stock as of the date of the Purchase Agreement under the rules of the Nasdaq Stock Market) as consideration for&nbsp;acquisition of Senlang and adjustments to state&nbsp;Senlang&rsquo;s&nbsp;assets acquired and liabilities assumed at fair value. A summary of the consideration paid and the preliminary fair value of the assets acquired and liabilities assumed is as follows:</FONT></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Preliminary consideration:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; padding-left: 0.25in">Avalon common stock issued to Senlang shareholders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">81,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 0.25in">Issued price</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1.21</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total consideration</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">98,010,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0in">Preliminary fair value of assets acquired:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in">Cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">188,887</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">636,746</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Recoverable VAT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,755</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">105,743</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,949</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Non-current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Security deposit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,843</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Operating lease right-of-use assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,406</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,268,076</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Intangible assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">97,556,672</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total preliminary fair value of assets acquired</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">101,477,077</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0in">Preliminary fair value of liabilities assumed:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1,373,480</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Notes payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(244,174</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(564,192</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Salary payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(102,329</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accrued leasehold improvements liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(261,106</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Accrued liabilities and other payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(62,938</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(167,201</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Deferred grant income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(183,496</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Operating lease obligation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(151,167</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Non-current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Deferred grant income - noncurrent portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(304,617</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Operating lease obligation - noncurrent portion</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(52,377</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total preliminary fair value of liabilities assumed</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,467,077</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0in">Net Assets acquired and liabilities assumed</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">98,010,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The acquisition consideration is allocated to
the acquired assets and assumed liabilities based on their estimated fair values, and any excess is initially allocated to identifiable
intangible assets mainly consisting of cell and gene engineering technologies with the ability to generate innovative and transformative
cellular immunotherapies for solid and hematologic cancers. The purchase price exceeded the fair value of net assets acquired by $97,556,672.
The Company allocated the $97,556,672 excess to intangible assets, which will be amortized over 10 years. The initial allocation is subject
to change upon the final valuation which is to be done at the time of closing. Such change could have a material impact on the Company&rsquo;s
financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c.</TD><TD STYLE="text-align: justify">Represents the elimination of Senlang&rsquo;s historical equity balances.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d.</TD><TD STYLE="text-align: justify">Represents the accrual of $650,000 in estimated legal, accounting, and advisory fees that are payable
as a result of the acquisition of Senlang, which were not reflected in either Avalon&rsquo;s or Senlang&rsquo;s historical financial statements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e.</TD><TD STYLE="text-align: justify">Represents the reclassification of accounts payable, accrued leasehold improvements liabilities, deferred
revenue, deferred grant income into accrued liabilities and other payables.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><I>Pro Forma
Adjustments to the Consolidated Statement of Operations and Comprehensive Loss for the Three Months Ended March 31, 2021:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">Represents a reclassification of general and administrative expenses into professional fees, compensation
and related benefits, and other general and administrative expenses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">The pro forma basic and diluted net loss per common share was computed by dividing pro forma net loss
attributable to Avalon by the historical weighted average number of shares of common stock outstanding after giving effect to the issuance
of 81,000,000 shares of Avalon common stock in connection with the acquisition of Senlang, as if the issuance had been completed on January
1, 2020.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents amortization of intangible assets acquired from this acquisition.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><I>Pro Forma
Adjustments to the Consolidated Statement of Operations and Comprehensive Loss for the Year Ended December&nbsp;31, 2020:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">Represents a reclassification of general and administrative expenses into professional fees, compensation
and related benefits, and other general and administrative expenses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">The pro forma basic and diluted net loss per common share was computed by dividing pro forma net loss
attributable to Avalon by the historical weighted average number of shares of common stock outstanding after giving effect to the issuance
of 81,000,000 shares of Avalon common stock in connection with the acquisition of Senlang, as if the issuance had been completed on January
1, 2020.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents amortization of intangible assets acquired from this acquisition.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>[3] Unaudited Pro Forma Adjustment Reflects
the Following Two Transactions:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Transaction 1:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Intangible assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">97,556,672</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,956,198</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accumulated other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,424</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,515,294</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Common stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,100</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">98,001,900</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transaction reflects (i) the elimination of
Senlang&rsquo;s historical equity balances; (ii) the issuance of 81,000,000 shares of Avalon common stock at a price of $1.21 per share
as consideration for acquisition of Senlang; (iii) and acquisition consideration exceeded the fair value of net assets acquired by $97,556,672,
which the Company allocated to intangible assets mainly consisting of cell and gene engineering technologies with the ability to generate
innovative and transformative cellular immunotherapies for solid and hematologic cancers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Transaction 2:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Accumulated deficit</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">650,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Accrued professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">650,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To accrue $650,000 estimated additional legal,
accounting, and advisory fees that are payable as a result of the acquisition of Senlang, which were not reflected in either Avalon&rsquo;s
or Senlang&rsquo;s historical financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">8</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>7
<FILENAME>ea143147ex99-5_avalonglob.htm
<DESCRIPTION>PRESS RELEASE DATED JUNE 28, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="ex99-5_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Avalon GloboCare CEO Provides Letter to Update
Shareholders About Acquisition of SenlangBio</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Previously Announced Execution of Definitive
Agreement to Acquire SenlangBio</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>SenlangBio Generated Revenue of USD $1.2 Million
for the Three Months Ended March 31, 2021 and Projects $5 Million to $7 Million in Revenue for the Full Year 2021</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>USD $30 Million of Committed Capital for SenlangBio
from an Institutional Healthcare Investor </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>This Transformative Acquisition is Expected
to Significantly Contribute to Growth and Development of Avalon </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FREEHOLD, N.J., June 28, 2021 (GLOBE NEWSWIRE)
-- Avalon GloboCare Corp. (NASDAQ: AVCO) (&ldquo;Avalon&rdquo; or &ldquo;the Company&rdquo;), a clinical-stage global developer of innovative
and transformative cell-based technologies and therapeutics, today provided the following letter to shareholders from its President and
Chief Executive Officer, David Jin, M.D., Ph.D.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;We
recently entered into a definitive purchase agreement to </I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>aquire
SenlangBio</I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>, a world-class cell therapy company. We believe
that the acquisition, which is subject to certain previously disclosed closing conditions, will significantly enhance Avalon&rsquo;s capabilities
in cell and gene therapy, expanding our therapeutic pipeline by adding 15 autologous and universal (&ldquo;off-the-shelf&rdquo;) cell
therapy programs. SenlangBio has applied its cellular therapeutics technology to develop a broad range of cellular therapy candidates
including CAR-T, CAR-</I></FONT><I><FONT STYLE="font-family: Symbol">gd</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">T
and armored tumor infiltrating lymphocytes, with potential applications to a wide array of hematologic malignancies and solid tumors.
This transformative acquisition will significantly contribute to sustainable and successful growth and development of Avalon.</FONT></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Importantly, this will be an all-stock transaction,
which clearly illustrates the confidence and commitment of SenlangBio and its principals. Avalon was also able to secure approximately
USD $30 million from an institutional healthcare investor for an approximately 13.5% equity interest in SenlangBio on favorable terms
and without warrants or other equity-linked or debt instrument related to the financing. This funding, which is contingent on the close
of the SenlangBio acquisition, should provide us with a substantial cash runway at SenlangBio for several years, as we advance a number
of clinical programs and execute on key milestones. In connection with the acquisition, we intend to integrate Avalon&rsquo;s and SenlangBio&rsquo;s
technology platforms and manufacturing/bio-processing infrastructure, which is expected to significantly reduce costs and accelerate the
clinical translation of cellular technologies.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>To date, over 300 patients have received one
of SenlangBio&rsquo;s 15 cell therapy candidates through investigator-initiated first-in-human clinical trials at 13 partnering hospitals,
covering 9 indications with significant unmet medical needs. Importantly, SenlangBio&rsquo;s clinical trials have thus far demonstrated
meaningful clinical benefit and favorable safety profiles among patients with solid tumors and hematological malignancies. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>SenlangBio&rsquo;s intellectual property includes
10 issued patents and 5 patents pending, as well as additional IP and trade secrets. Notably, SenlangBio will bring added capabilities
to Avalon with their 16,000 square-foot GMP facility, which supports in-house bio-manufacturing, bio-processing, and QA/QC processes.
Furthermore, SenlangBio has a revenue generating clinical laboratory that provides third-party clinical testing services including: general
biochemical, genomic and proteomic testing; as well as cell therapy related testing such as hematology, immunology, cancer biomarkers,
immuno-phenotyping, and more.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>For the year ended December 31, 2020 and the
three months ended March 31, 2021, SenlangBio generated revenue of USD $1.1 million and USD $1.2 million, respectively, and had a net
loss of USD $2.4 million and USD $135,000, respectively. As a vertically integrated leader in cellular medicine with a strong technology
platform that we believe can rapidly deliver life-saving cellular therapeutics to patients, I could not be more excited about the operational
and financial outlook for our business. I strongly believe we will be well positioned to execute on our organic growth strategy and drive
significant value for shareholders in the years ahead.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Additional Details About the Transaction</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 13, 2021, Avalon entered into a Share
Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;), by and among Avalon and the other parties named therein to acquire SenlangBio
(the &ldquo;Acquisition&rdquo;). The purchase price being paid by Avalon under the Purchase Agreement is an aggregate of 81 million shares
(the &ldquo;Acquisition Shares&rdquo;) of its common stock, par value US$0.0001 per share (the &ldquo;Avalon Common Stock&rdquo;). The
Acquisition is subject to the satisfaction of certain conditions to closing set forth in the Purchase Agreement, including approval by
the Avalon stockholders of the issuance of the Acquisition Shares pursuant to the rules of the Nasdaq Stock Market (&ldquo;Nasdaq&rdquo;)
and approval of the listing of the Acquisition Shares by Nasdaq. In connection with the Acquisition, Avalon will prepare and file with
the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;), a proxy statement and will seek the approval of its stockholders
with respect to the issuance of the Acquisition Shares pursuant to Nasdaq rules. Currently, the officers and directors of Avalon own in
the aggregate approximately 64.1% of the outstanding shares of Avalon Common Stock and are expected to vote in favor of the issuance of
the Acquisition Shares pursuant to Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Avalon has filed a Current Report on Form 8-K
with the SEC on June 14, 2021 which provides more detail on the terms of the Purchase Agreement and the transactions contemplated thereby
and a detailed description of the SenlangBio business. In addition, Avalon will file a Current Report on Form 8-K/A with the SEC on or
about June 28, 2021 which contains historical financial information with respect to SenlangBio and its operations, as well as certain
other financial information with respect to the proposed Acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Avalon GloboCare Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage,
vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector
cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and
outsourcing services to facilitate and enhance its clients&rsquo; growth and development, as well as competitiveness in healthcare and CellTech
industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&amp;D to automated bioproduction
and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK),
exosome technology (ACTEX&trade;), and regenerative therapeutics. For more information about Avalon GloboCare, please visit www.avalon-globocare.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the latest updates on Avalon GloboCare&rsquo;s developments, please follow
our twitter at @avalongc_avco</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Information about the Proposed Acquisition Transaction
and Where to Find It</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This communication relates to the proposed Acquisition
and may be deemed to be solicitation material in respect of the Acquisition. In connection with the Acquisition, Avalon will file relevant
materials with the SEC, including a proxy statement on Schedule 14A (the &ldquo;Proxy Statement&rdquo;). This communication is not a
substitute for the Proxy Statement or for any other document that Avalon may file with the SEC or send to Avalon&rsquo;s stockholders
in connection with the Acquisition. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS OF AVALON ARE URGED TO READ THE
PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY
WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT AVALON, SENLANGBIO, THE ACQUISITION AND RELATED MATTERS.
The Acquisition will be submitted to Avalon&rsquo;s stockholders for their consideration. Investors and security holders will be able
to obtain free copies of the Proxy Statement (when available) and other documents filed by Avalon with the SEC through the website maintained
by the SEC at http://www.sec.gov. Copies of the documents filed by Avalon with the SEC will also be available free of charge on Avalon&rsquo;s
website at&nbsp;www.avalon-globocare.com&nbsp;or by contacting Avalon&rsquo;s Investor Relations contact at PR@Avalon-GloboCare.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Participants in the Solicitation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Avalon and its directors and certain of its executive
officers and employees may be deemed to be participants in the solicitation of proxies from Avalon&rsquo;s stockholders with respect to
the Acquisition under the rules of the SEC. Information about the directors and executive officers of Avalon and their ownership of shares
of Avalon&rsquo;s common stock is set forth in its Annual Report on Form&nbsp;10-K&nbsp;for the year ended December 31, 2020, which was
filed with the SEC on March 30, 2021 and in subsequent documents filed with the SEC, including the Proxy Statement. Additional information
regarding the persons who may be deemed participants in the proxy solicitations and a description of their direct and indirect interests
in the Acquisition, by security holdings or otherwise, will also be included in the Proxy Statement and other relevant materials to be
filed with the SEC when they become available. You may obtain free copies of this document as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cautionary Notes Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This communication contains &ldquo;forward-looking statements&rdquo;
within the meaning of the Private Securities Litigation Reform Act of 1995. Avalon generally identifies forward-looking statements by
terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;could,&rdquo; &ldquo;intends,&rdquo; &ldquo;target,&rdquo; &ldquo;projects,&rdquo; &ldquo;contemplates,&rdquo; &ldquo;believes,&rdquo;
&ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo; &ldquo;potential&rdquo; or &ldquo;continue&rdquo; or the negative of these terms or other
similar words, including statements regarding [projected full year 2021 revenue of SenlangBio and the Acquisition. These statements are
only predictions. Avalon has based these forward-looking statements largely on its then-current expectations and projections about future
events and financial trends as well as the beliefs and assumptions of management. Forward-looking statements are subject to a number of
risks and uncertainties, many of which involve factors or circumstances that are beyond Avalon&rsquo;s control. Avalon&rsquo;s actual
results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not
limited to: (i) risks associated with Avalon&rsquo;s ability to obtain the stockholder approval required to consummate the Acquisition
in accordance with Nasdaq rules and the timing of the closing of the Acquisition, including the risks that a condition to closing would
not be satisfied within the expected timeframe or at all or that the closing of the Acquisition will not occur; (ii) the outcome of any
legal proceedings that may be instituted against the parties and others related to the Purchase Agreement; (iii) the occurrence of any
event, change or other circumstance or condition that could give rise to the termination of the Purchase Agreement, (iv) unanticipated
difficulties or expenditures relating to the Acquisition, the response of business partners and competitors to the announcement of the
Acquisition; and (v) those risks detailed in Avalon&rsquo;s most recent Annual Report on Form&nbsp;10-K&nbsp;and subsequent reports filed
with the SEC, as well as other documents that may be filed by Avalon from time to time with the SEC. Accordingly, you should not rely
upon forward-looking statements as predictions of future events. Avalon cannot assure you that the events and circumstances reflected
in the forward-looking statements will be achieved or occur, and actual results could differ materially from those projected in the forward-looking
statements. The forward-looking statements made in this communication relate only to events as of the date on which the statements are
made. Except as required by applicable law or regulation, Avalon undertakes no obligation to update any forward-looking statement to reflect
events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contact Information: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Avalon GloboCare Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4400 Route 9, Suite 3100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Freehold, NJ 07728</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PR@Avalon-GloboCare.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Crescendo Communications, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tel: (212) 671-1020 Ext. 304</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">avco@crescendo-ir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !  5X# 2(  A$! Q$!_\0
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M\"K(OF*& P?$?)&1]W(+$\\5ZI\*?^#AW]B;Q_XCMM$\8Z5\3/@UI=RZQ_\
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M/_A$M1_XG_@34=2T/0=.EOOA_P#$;PG<ZQX&\;>'))!8ZAH>K.XA%Y96$UN
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M&O@_X6^ O -O\0M(CGA\/?$7Q[I7P[\+:,WQ&\6>$Q,M_P"#WUJ:WT/0-?\
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M-'%S\6=+\-:1KWA#3X[*&"2/1]-C\,6=YHU^95UNRU"4ZA;WD%Y;VL\0!G_
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5LK%GR0#T2BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &S ?0# 2(  A$! Q$!_\0
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MVCB/>ER(!%,C)+"[Q2(QY_X->#=._:Y_;7^/O[0?Q7M$\2^$/V-_B;)^SO\
MLK^!]2O9-3\+>$/'6AZ%IFL?&+XY3>'WABT^;XBZWK.K:7X1\/:W>B[NO#6@
M^&;E-'N;.ZUJ\D/ZR1QL0'\Q_F4!LNQ.5R%P3C&.=PZLS;MP*G> ?EW_ ,/8
M/A9W_90_X*2?^('?'L?^ZZ:/^'L'PL_Z-0_X*2?^('?'O_YG*_4GRC_ST?\
M,_XT>6?^>C_F?\: /RV_X>P?"S_HU#_@I)_X@=\>_P#YG*/^'L'PL_Z-0_X*
M2?\ B!WQ[_\ F<K]2?+/_/1_S/\ C1Y9_P">C_F?\:+V_+[] /RV_P"'L'PL
M_P"C4/\ @I)_X@=\>_\ YG*/^'L'PL_Z-0_X*2?^('?'O_YG*_4GRS_ST?\
M,_XTTHV<!VP#@G>1CC/(]\XX]O6@#\N/^'L'PL_Z-0_X*2?^('?'O_YG*/\
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M4RSZEJ\NG'3=+LXVN]1O;>U1YAYTG[8/P!-W^S[IUCXU\0WVH_M6>'=8\6_
M6TT_X9_%B_;X@:#X?TK0M8U:_BE@\%1VOA6.UT_Q#HVI$^/+KPG(]G?1SF.6
MS>>:#R']A3PUXNO?V<?&/PZ^-/@?XL:3I</Q.^-?@[2/"_QYO=0UWQ'JGP5U
MKQ5K<'A*PN-6UC7?$.LZSH%WX1U2'3[:\U[6+C5'MT>&[F;RT ^;OV=?A/\
MM1>$O@7^T%\,?C3H7Q-M;C]F'X:_$#]G/]E'XA^!?$=C=?$GXR>#1HVLZAX<
M^-'@R*"6[N?"WC__ (1-OAY\-M'FU"X34;+5/"NO'SGMM2#R<\4H*I3F](4O
MK$+-^\IJ,G%O76-6LX1Y;6ITVG'2X0FIJE4BI)U%&DU):IPO=VTM?E3?64K:
MO1'Z^^']3GU_1M+UHZ?K^B?VC:0W;:-K]J+#6]/-Q%$QL]8L8I[B.UU"%CY<
MT"7<J1?-M<K\PS];UZXTB_\ #UC_ &/XDU$>(-3FTQ-0TBR>[M- $.GWNH2:
MCXFN9I8)--T2=K..PBO8K:Y*:E<V$!@D6Y,T?\SWPY\.?M6:3\./C-\2/CF_
M[;OPV\4>"/\ @F9^S9IW@?QE\3_'.J6WA[PG^U5IFA>-/#OQL@\':,/'TFA:
MEXLUN]U+P<VJZMXIMM96\G%QK&A:I:7$ A6]^S+X/^-?A7XF?L[^(O"FE_MI
M)!J?[7/C?QI^T5\*]'^(_P 7_B;\+_A)\#?%G[,OB?POX,T"[\1_$[QI=ZWX
MWT>/XJV?ASQ/X1U.PAM;_0+_ %3Q9%_8,L=G#?R:PC[1KE=HO#0Q'+)I*-YU
M(.#;O:5Z%U?6U2'NN^NFBIRJ2T<:JI<JU;?LZ-1M:;?O9*]NCUZ+^G4^?L D
MDN$)94#$F/YR0HY+%02S;2RLJ-DA47[H^</@I^U?\#_VBO$WQ5\&?"+QGKOB
M?Q)\#]=C\)_%6POOA_\ %;P./"/B:>2]\K0[J]\>>#_"VG:EJ8M["6^DLM$O
M-1NX=*N--U>54TK6=(O+W\H/^"77A;]K+PA\2/@]%\:?!O[7NFV/B']@O1[#
MXX>)_P!H[Q+J?BG3KS]I?PQ\9=:NM+_M)M1\6:W9:;XM7X=ZWJ$$UYX1TK1]
M+U72'MH]32>\M;9[7SWQAX&_:H\1P_MLZO\ #KX0?M)^"?$(_;.C^,WP\T?6
M?#.N:%X9^/WA.V^%</A+3-"NM=^'_P 4?"'CK1-$E\5Z2+BQ\1Z1J%S'X9O/
M['\2>)?"7B;1!<:0^+ER5()>_#V?-*2;NI4ZL:=*R[5'.7/=-M125TF.,')U
M(2:C:>%Y7=:Q<<1.LFV^GLX;-)J33UY3]Q/A?\??AK\7/&_QQ^'_ ,/];U34
MO%7[/'CK2?AQ\7=-N]"\0:.?#OC+7/!V@^.[&QM+C5]/L8?$4%QX8\1Z)?1:
MII"3:4$N'^SW=QN4+[CB4#8)9G&YU+?,S<8R6;<-I ))5N%;E H!!_FN^*OP
MU_:E\8>*_P!N30K+]EG]IFPUSXW_ !/^"VH^!_&.A_$_Q5X7\%>&-?\ !W[!
M>C?#FS\37OB_X8>._ OC?XN>&/#'QN\)W&AD27GAK2I]6?PIXYUY)+ RZ<8[
M?1?VY)/%>@>/_$?PY_;UOOB!H\__  30O+>SN/%,NI?#;2]8T#2-5T?]K.ZL
M?"NA>,M+\.7VE7<5X+OX@:?K&D7T>JZ@XO=+6TNECN+?K5%1ER\Z6RYKJ\G)
MV;EK9-MW=DMM%;?)RLH.*NJKLHRT]FE%OIJDHII7>\EN?O)??'WX<:?\>M#_
M &:I]:UT?%_Q-\-M?^*VC:)+X7\6MH%SX#\,:WI?A_6M4B\;/I5OX.NKR'5M
M9TRSFT/3_$5YXAMGN(KB\TFTM'@GNNH_X6OX-MOB@WP9FO+FP\?3>%3XWT;2
M=0L+NQL_$GAFUU#^RM:O?"6I3QQZ;K\OA:]FTN'Q5IFF.]YH']N:)/?116FH
MQ7!_G@T_]G/]L;Q9\7M&\0>)OA[^U#X-^*&H_LP_M;?!WXY_M$VWC*R\3>&M
M(^)7C'XN_#K7_ ?B+X.>%-7^)UC)-X+\3^%?#K06]A\-4\%:G;:)#]@%UI&O
MV(O;SZZ^&B?&;QGJ7_!.GPOXT\)2?#7XQ^!?BW\7OBAX_P#";^(/%GBR_P!*
M_9]L?"7B_P 'VOB#7+7Q]KWBCQW\.=+^(LVN^$K72O WC?Q5XIU?1;PW6AGQ
M%K\^BW%U'G"BW\3@O9M1NI-RDG6Q*6K?2G"E+1-<]62=ERH')*223:JWJ+2S
MBE2PUU/HGS2TVT3ZWM^WZ2!P.1DYQCH1V(/IC'T/%/K/MP"Z, <8QR1D$INZ
M>@#8^IK0J(OF2>FL8O3N^:Z^5D:.VEG?2_S[!1115"&2?ZN3_<;_ -!-?F;^
MQI_R>G_P5)_[++\ _P#U07A^OTRD_P!7)_N-_P"@FOS-_8T_Y/3_ ."I7_99
MO@&/_, ^'C_44 ?IK1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4$K!&5C
M_#U.0 B$KEFSUY&!C'7VYGJ"5,Y.Y<D# ;IM4'<.^003G@XZT ?FC_P37\^R
MM?VW](OHFM=2L/\ @H5^TA+=6S\M';:S=>&=7TV==H(>*[L+F&:)A@,C%B>#
M7Z:@@]#GZ5^4_P 6?#GQG_8X_:1\<?M0?!WX5>+/V@/V?OVBAX9'[3_P=^&\
M<%W\7?A;\0/!>FKH>@?M _"3PC('/Q1TSQ-X>:#PS\5_A]IU_I?BBW.A>&O%
M?A:#Q-+)KFDVUV+_ (+/_P#!,.SAM#XH_:Z^'WPZU2ZMY)F\,?%"S\5_#?QE
M9K%(D,BZEX3\8Z!I.O:>Z2G:Z7EE&V73DG)H _4NBORZ_P"'UG_!*%N1^WE^
MS[QP<>+GQD?]N5'_  ^J_P""47_1^7[/W_A7/_\ (5 'ZB$9!'K44D*R$,20
M1G!7AADY.&ZJ>2 5P0#P<X(_,#_A]5_P2B_Z/R_9^_\ "N?_ .0J/^'U7_!*
M+_H_+]G[_P *Y_\ Y"HLGOV:^3M?[[+[@_K[S])M,\,:)HELUEHVFV6DV+75
M[?-8Z;:06-D;S4KF:]U*Y^R6J16ZRZC>W$]Y?NL:F[NIII[CS)9&:KXTVWR2
M=Y8D$DGKM! &#GY0&8E>A9F/<BOS+'_!:O\ X)1#_F_']GT_7Q<Y_P#;*@_\
M%J_^"4G;]O+]GL?]S8Y_]M/2IE&,_B5_O\][-7W>XK*[?62L]]59*V_:,=K;
M(_37['&SX)<JNTG)# D!<,=RG+9&-QRV!][(7$GV*+"@%@%[ @ C+'!&.1\V
M.<X 7&,<_F+_ ,/K?^"4)X'[>7[/G/IXM<'_ -(J/^'U7_!*+_H_+]G[_P *
MY_\ Y"IM)M.VJ=UTL]=5:ROJ^G76]E9_\!?^ N;7W.<VO\3WTM^G'V&(,'RV
MX# )V],$'(Q@D\9XQD# %*MC"O3=PQ;).3DKM/)R>5SN[,6<L&+MG\QO^'U7
M_!*+_H_+]G[_ ,*Y_P#Y"IH_X+6?\$H@2/\ AO+]G\]_^1KD. O+<BQP<]Z.
M6.FFT>5?X7>ZWVU>]]_2QM9+2VWEK?\ /Y^9^D^M^%M \2Z3J.@>(](T[Q!H
M&KVDNGZOH>MV-KJNDZI83H(YK/4=/OHI[6\MY8P4EBN(I$=20RD 8YCX?_"S
MX<?";PW9^"_A=X&\+?#SPCIL]S/I_A?P9H6E^&]!LY[J:6>[N+?3=+M;>UBF
MGGE>6601[G=V)R&8'X&E_P""TW_!*F!]D_[=?P"@89RDWB>:-B!C+8>P!V\@
M@XP1R.*KM_P6J_X)/GG_ (;P_9\&3U_X2N0YZ_\ 3E196:V32B[:725DO1+9
M:=]]163LFM%JEYI)?E&*]$C].3:0*H0?,1C"Y^\!@,#U!5U4"1<8D"C?DC-(
MMA$5PQDP2<J6'/#*"QQDN Q829W;CN)+<G\R%_X+6?\ !*#.?^&\/V?"PZ'_
M (2N0$#Z?8??K[T__A]=_P $H?\ H_']GS_PK)/_ )!H22;:5FU%-^4)<T?N
ME[RM;7>XWYO\>\91_P#29R7I)V/TS-G"N[YV.,93L 0JC*9"L H4 $%0NY0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P">.E2A@>ASC!_,9'YBEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD? S4M:\,_M7ZO)\-UUS_@GAX]^(WQZ\&?"31?"_BO\ 9M^('Q0_:LT/P/\
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M_@J3_P!EE^ ?K_T0+P^?\XK]+O\ EE+]' Z\@+_CD<>F.U?FC^QI_P GI_\
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MLI-,^'R67A&W7Q+%J"^*O$<C>(+0^$HH]=^QC#&<90$#H&)8#C;P"2!\N1[
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M:?<V)\9G6[R;^S98-*6W-[<?6'E1\?(,#;@<X&W.W Z#;GY<#@8 Q@8BDC0
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M;"VU#Q6UW+:6\<RV(N2T7UD(H\$E0,G/!.1USDYSDDMN]223S2^5$,$(JX
MQP !T Q@ #HHZ $@8!(H;25[Z=_P[=_(#Y13QY^V"&^("/\ L^?!F.+2?#&E
M:A\-W7]HG6G;Q?XJGFLUUOP]XG0_!A/^$,TG3XWU'[%XEMI/$SZA-:VZ/H=H
MMTYM\9_B)^VXGV@?\,T? V5H_ -OJENX_:<UZ-)_B41;->>#)8F^!;M;^&T+
M3F#QF6EN2+=#)X907.8?L?RH\@[1D'(/7# DY^H.?H:001#I&HQCG'/!8CGK
MU=S[EF)Y)I@?'5I\1?VV7&CB_P#V:/@9:O<>&=;NM;%M^T]KUVNE^+X)+O\
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M:-Z?WE_[Z'^-?EI_P[L^.?\ TE/_ &]__!K\"?\ YS%'_#NSXY_])3_V]_\
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M&]/[R_\ ?0_QK\M/^'=GQS_Z2G_M[_\ @U^!/_SF*/\ AW9\<_\ I*?^WO\
M^#7X$_\ SF*!GZE[T_O+_P!]#_&D,B*I8L HZG_/7\*_+7_AW9\<_P#I*?\
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M !1110 ASCC_ "._XXZ>]?GE_P %'?VM?%_[(/P4\*^*?ASX<T/Q/\4?B_\
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M"TBBB4+7Q-_P4@)'P/\ AL1P1^UM^R 01U!'[0_@ @@]000"",$$9!S7W]0
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M\%" 0/F^"?[#^[CEO^)=\=Q\QZGCC)SQQ0!^E2=&Z<,PXQVX' Z< <?CWI]
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M&U'Q!<PVWB/XE^%M)N'\:_$*S^R:I!I?C33=0TV_MKCPGJEU-]6O^RS)H_\
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M/XW^)]A+I_COQS\)O#=S:W%GX1\3>(UEDFFG\R_L;.9II].L+.2YO6N/R/\
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M)O"^FZSIFLZ]IU^J&:35/&L][:W^K22V\%J;_3(9EAE>601_(_@3_@FM\)O
MUEJ/AY/C+^U/XM\":[XQ\;>/O$WPX\9?&)M6\&>)O$WQ!DU>?Q5>>(+&S\.Z
M9J5]:ZE?ZW=ZE_9(U6/3(-06VG@LT\HJWQ9X-_:O^)?Q=^#?P#_:6UVU\.VW
M[0OPL_X*#W'[&?C6Q^'OAK7O &E_$3P!K/Q?F^$_C#3M1^%'BOX@?$OQ%X-A
MU?0HM*^*5GX7\0^-/&6M>%KSPY_:UCJPL[[4'?\ >..-U,B"1CM.P;B6)57"
M9+$+EF^1W &=Y;^ QDZ5*$H.7/%ISA2ISLU9^RFIRTZWG5YEZMW:L@A/FE":
M5U%W@U]E.DJ:;Z[Q;?JNI^8GB#_@D+^R7XG\%VWP^OY?C9:^$Y?AY\-/A=XJ
MT[2/C!XFT63XB^$_@WXBB\3?"?\ X3F_TYX+^_U?X;WZSV_A+6]*N='U'3M,
MO;O3VFG@>,1?I/X:\.'0(-3B?6]>UQ]1US4]8\_Q!>0WUS8+J$YFCT>PECM;
M8QZ-I:G[/I5O-]HN8+4>7-=W#%FKI$7*88=W&#Z%C^N,<C\*D_S^?6L];R;Z
MOF^=FFWYN[OYLT?O2YGNU:X4444P"BBB@ K\T_@)_P I//\ @H/_ -D3_8?_
M /3?\=Z_2ROS3^ G_*3S_@H/_P!D3_8?_P#3?\=Z /TLHHHH **** "BBB@
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MA,9).4R1@\CD>G6DE9W3:_B=M5424EMLK:?CT \_D\ >"9[A+E_"7AI+A/%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH K7$"3!2X9@I!V@D!@"<A@/O*<\J>#CUKX?^.W[!WP<^,_Q'L_C=HVL_
M$SX!_M"66E6^@7/Q\_9X\9/\-_B-XE\.6BD:?X7^(I-CJ7A3XJ>'-.8(^D:9
M\1= \13:"$D70I].BNKM9_NFDVKZ>OUYZX/;/M0!^6)_8C_;2W,+?_@K+^TD
MD.XB$3_ O]EVYD5!]P23'X:QM/WQ)Y:!\XDR0I"?\,0_MM]_^"M/[17_ (8+
M]EH?^\Y-?J?M!.<#/KW_ #_I00#UH _+'_AB+]MK_I+3^T7_ .&#_9:_^=Q1
M_P ,1?MM?]):?VB__#!_LM?_ #N*_4W8OI^I_P :-B^GZG_&@#\LO^&(OVVO
M^DM/[1?_ (8/]EK_ .=Q1_PQ%^VU_P!):?VB_P#PP?[+7_SN*_4W8OI^I_QH
MV+Z?J?\ &@#\LO\ AB+]MK_I+3^T7_X8/]EK_P"=Q1_PQ%^VU_TEI_:+_P##
M!_LM?_.XK]3=B^GZG_&C8OI^I_QH _++_AB+]MK_ *2T_M%_^&#_ &6O_G<4
M?\,1?MM?]):?VB__  P?[+7_ ,[BOU-V+Z?J?\:-B^GZG_&@#\LO^&(OVVO^
MDM/[1?\ X8/]EK_YW%(?V(OVV!RW_!6G]HS_ ,,+^RTHZ?\ 9./Q_#)Z$U^I
MVQ?3]3_C2./D( [C\MP)H _G>O/ ?[?$'_!0[0_V.E_X*E_',^#M8_8^U[]H
MI_$7_"@OV9_^$CB\3Z7\6])\ P:,LO\ P@BV<>DR:5J,M[,'T]I_MT$,2-%%
M*S5]IG]B/]M@*"/^"M7[1? Y)^ O[+39 !.?^2< 9XZ]/SKD]2"C_@N?X(
M'_&KGQA@#H,_M*^&5)QT&1&BDXZ*H["OUKFDVJQP21G.U@,*01C+G ^8XPP(
MS\K##9";LFWI&,7)OM83=DY;\J3:[W=OS/R^/[%'[:J'+_\ !6O]HH  $_\
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M_BKP=JWBW1M(A\1+X;\426.A:UIEEC5+/4=7T:-K9HKZ&0U&<:B?([Z/[O\
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MW^^:?,Z=+MK#72S'5RYUH2I3PU25-P2LX-VE&I"I%]-G>VF\%K\-_#OVY/\
M@GM\7OVM_B3'XDT?XV>!=#\!V.E_"Z_\*>!?B'\.O%OBD> _B5\+/B;IWCL>
M+O#/_")_$'P9HU[_ ,)KIMF/#^LR^+],\0:UX<2VM+CP7J>B"XU*.Y\>US_@
MFU^U[KOA+QEH\_QW_9UM-:\7?\%+O G[?L][;_"_XL-ID>@^"/$'ASQ5%\*)
MK:7XF?:GO;[5_"NF6S>)Q<K:VVCS74,6A_;H;6_7[3_X>3? _&/^%:_M7[L
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M=^?E2Y*>K]G&K?X/Y96]4^Q=-S<J>+B<YYRLSX_]#'--^U77_/Q<_P#?YO\
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M*X:NW-UI-[7^YBDZ,4Y.--1C%R;Y(-64HQW<5NYKRT9>%Q=C.+N89.<&>3T
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M[.?@'X*_ 7P-?6GQHTG]FCQAJNE_$+Q=XYB\?V?PV^//A+7/&'BCXK^%-/\
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MV?#O\AU%%%6(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ)Q"P[9E'ZN?YU,GW%_W5_D*@4CRSSU:7'OP]3I]Q?\ =7^0K^AH?"EVY_\
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M?2+^6[GMY]&N;QKZ.(0WD,8<G[6;]A_]HQ,%_P#@J%^UUR0JX\ _LIC<2 0
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M^\3V^;D?7@C^O6B_E+_P%AROR^]?YD](V,')P,8_/CC/&?3WJ+>_^S_WR?\
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MV'P_\)ZC)X/_ .$/T[X;?%RS\(^)_CQ\,?CI!XK^'TDL/BOQ3^T5\=?'&F_
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M,DG8*?P(_P#9J3S)?[J_Y_X%3#E?E]Z_S+!_P_0_UZ'VI N,X)QZ$YQ]*3<
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MNG7KZOS#^P,-?>:76SBW]UF?#1^(W_!6W.#\)/\ @G/P"?\ DO?[1G3GJ/\
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MQY_:+Z_A\">E?<X53M.X$=2>!Q@],DXZ'L<#.>AI2(V'#$8ZD,/0G^Z.P)_
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M47[K:3MU3VZ5_:-3FI0@HRC5E[*G.+N[\BE=V;2=VT[V3:NE9GZD_"']ICX
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MBB@ HHHH **** "BBB@ K\OO#'_*2_\ :W_[-H_92_\ 4M^,U?J#7Y?>&/\
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M8../NGK0@RP*H$3>< ,7 CP2,S'!E/3,I"[F! 4;2*L("!TQR<CMUP,< \@
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MXB@?Q#?W5W<^#='\ Z[X$TW3M+N5DO)-7::&>'Y>\'_\%*OBEX9_9^^)5O\
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MU3=__ */_IN)^<S^.3[RE9>DG_F+1116A(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!4<E X
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M>AS^=1,023YS+[ #C\US7P;_ ,(3_P %@._C'_@F-_X;#]JL?^]P-._X0?\
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MO7KGCUYKX(_X0G_@L!_T.7_!,8?]TO\ VJS_ .]R'\OQ]$_X0K_@L&.GC/\
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M_GE_X%+_ #"R[+[E_D&!Z#\A1@>@_(444<\_YY?^!2_S"R[+[E_D&!Z#\J7
M/49HHHYY?S2_\"?^8679?<O\A,#T'Y"C ]!^0HHHYY_SR_\  I?YA9=E]R_R
M(4 ^7@?> Z=C"#_,9IJ_ZQ_^N>>G?/\ ]8?EGK11711;<%=MZK=M_F.25I:+
MX?\ (F))5OKC\,BE3[H_'^9HHK?I\Q]/F.HHHI""BBB@ HHHH **** "BBB@
7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex99-3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &S ?0# 2(  A$! Q$!_\0
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MVCB/>ER(!%,C)+"[Q2(QY_X->#=._:Y_;7^/O[0?Q7M$\2^$/V-_B;)^SO\
MLK^!]2O9-3\+>$/'6AZ%IFL?&+XY3>'WABT^;XBZWK.K:7X1\/:W>B[NO#6@
M^&;E-'N;.ZUJ\D/ZR1QL0'\Q_F4!LNQ.5R%P3C&.=PZLS;MP*G> ?EW_ ,/8
M/A9W_90_X*2?^('?'L?^ZZ:/^'L'PL_Z-0_X*2?^('?'O_YG*_4GRC_ST?\
M,_XT>6?^>C_F?\: /RV_X>P?"S_HU#_@I)_X@=\>_P#YG*/^'L'PL_Z-0_X*
M2?\ B!WQ[_\ F<K]2?+/_/1_S/\ C1Y9_P">C_F?\:+V_+[] /RV_P"'L'PL
M_P"C4/\ @I)_X@=\>_\ YG*/^'L'PL_Z-0_X*2?^('?'O_YG*_4GRS_ST?\
M,_XTTHV<!VP#@G>1CC/(]\XX]O6@#\N/^'L'PL_Z-0_X*2?^('?'O_YG*/\
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M4RSZEJ\NG'3=+LXVN]1O;>U1YAYTG[8/P!-W^S[IUCXU\0WVH_M6>'=8\6_
M6TT_X9_%B_;X@:#X?TK0M8U:_BE@\%1VOA6.UT_Q#HVI$^/+KPG(]G?1SF.6
MS>>:#R']A3PUXNO?V<?&/PZ^-/@?XL:3I</Q.^-?@[2/"_QYO=0UWQ'JGP5U
MKQ5K<'A*PN-6UC7?$.LZSH%WX1U2'3[:\U[6+C5'MT>&[F;RT ^;OV=?A/\
MM1>$O@7^T%\,?C3H7Q-M;C]F'X:_$#]G/]E'XA^!?$=C=?$GXR>#1HVLZAX<
M^-'@R*"6[N?"WC__ (1-OAY\-M'FU"X34;+5/"NO'SGMM2#R<\4H*I3F](4O
MK$+-^\IJ,G%O76-6LX1Y;6ITVG'2X0FIJE4BI)U%&DU):IPO=VTM?E3?64K:
MO1'Z^^']3GU_1M+UHZ?K^B?VC:0W;:-K]J+#6]/-Q%$QL]8L8I[B.UU"%CY<
MT"7<J1?-M<K\PS];UZXTB_\ #UC_ &/XDU$>(-3FTQ-0TBR>[M- $.GWNH2:
MCXFN9I8)--T2=K..PBO8K:Y*:E<V$!@D6Y,T?\SWPY\.?M6:3\./C-\2/CF_
M[;OPV\4>"/\ @F9^S9IW@?QE\3_'.J6WA[PG^U5IFA>-/#OQL@\':,/'TFA:
MEXLUN]U+P<VJZMXIMM96\G%QK&A:I:7$ A6]^S+X/^-?A7XF?L[^(O"FE_MI
M)!J?[7/C?QI^T5\*]'^(_P 7_B;\+_A)\#?%G[,OB?POX,T"[\1_$[QI=ZWX
MWT>/XJV?ASQ/X1U.PAM;_0+_ %3Q9%_8,L=G#?R:PC[1KE=HO#0Q'+)I*-YU
M(.#;O:5Z%U?6U2'NN^NFBIRJ2T<:JI<JU;?LZ-1M:;?O9*]NCUZ+^G4^?L D
MDN$)94#$F/YR0HY+%02S;2RLJ-DA47[H^</@I^U?\#_VBO$WQ5\&?"+QGKOB
M?Q)\#]=C\)_%6POOA_\ %;P./"/B:>2]\K0[J]\>>#_"VG:EJ8M["6^DLM$O
M-1NX=*N--U>54TK6=(O+W\H/^"77A;]K+PA\2/@]%\:?!O[7NFV/B']@O1[#
MXX>)_P!H[Q+J?BG3KS]I?PQ\9=:NM+_M)M1\6:W9:;XM7X=ZWJ$$UYX1TK1]
M+U72'MH]32>\M;9[7SWQAX&_:H\1P_MLZO\ #KX0?M)^"?$(_;.C^,WP\T?6
M?#.N:%X9^/WA.V^%</A+3-"NM=^'_P 4?"'CK1-$E\5Z2+BQ\1Z1J%S'X9O/
M['\2>)?"7B;1!<:0^+ER5()>_#V?-*2;NI4ZL:=*R[5'.7/=-M125TF.,')U
M(2:C:>%Y7=:Q<<1.LFV^GLX;-)J33UY3]Q/A?\??AK\7/&_QQ^'_ ,/];U34
MO%7[/'CK2?AQ\7=-N]"\0:.?#OC+7/!V@^.[&QM+C5]/L8?$4%QX8\1Z)?1:
MII"3:4$N'^SW=QN4+[CB4#8)9G&YU+?,S<8R6;<-I ))5N%;E H!!_FN^*OP
MU_:E\8>*_P!N30K+]EG]IFPUSXW_ !/^"VH^!_&.A_$_Q5X7\%>&-?\ !W[!
M>C?#FS\37OB_X8>._ OC?XN>&/#'QN\)W&AD27GAK2I]6?PIXYUY)+ RZ<8[
M?1?VY)/%>@>/_$?PY_;UOOB!H\__  30O+>SN/%,NI?#;2]8T#2-5T?]K.ZL
M?"NA>,M+\.7VE7<5X+OX@:?K&D7T>JZ@XO=+6TNECN+?K5%1ER\Z6RYKJ\G)
MV;EK9-MW=DMM%;?)RLH.*NJKLHRT]FE%OIJDHII7>\EN?O)??'WX<:?\>M#_
M &:I]:UT?%_Q-\-M?^*VC:)+X7\6MH%SX#\,:WI?A_6M4B\;/I5OX.NKR'5M
M9TRSFT/3_$5YXAMGN(KB\TFTM'@GNNH_X6OX-MOB@WP9FO+FP\?3>%3XWT;2
M=0L+NQL_$GAFUU#^RM:O?"6I3QQZ;K\OA:]FTN'Q5IFF.]YH']N:)/?116FH
MQ7!_G@T_]G/]L;Q9\7M&\0>)OA[^U#X-^*&H_LP_M;?!WXY_M$VWC*R\3>&M
M(^)7C'XN_#K7_ ?B+X.>%-7^)UC)-X+\3^%?#K06]A\-4\%:G;:)#]@%UI&O
MV(O;SZZ^&B?&;QGJ7_!.GPOXT\)2?#7XQ^!?BW\7OBAX_P#";^(/%GBR_P!*
M_9]L?"7B_P 'VOB#7+7Q]KWBCQW\.=+^(LVN^$K72O WC?Q5XIU?1;PW6AGQ
M%K\^BW%U'G"BW\3@O9M1NI-RDG6Q*6K?2G"E+1-<]62=ERH')*223:JWJ+2S
MBE2PUU/HGS2TVT3ZWM^WZ2!P.1DYQCH1V(/IC'T/%/K/MP"Z, <8QR1D$INZ
M>@#8^IK0J(OF2>FL8O3N^:Z^5D:.VEG?2_S[!1115"&2?ZN3_<;_ -!-?F;^
MQI_R>G_P5)_[++\ _P#U07A^OTRD_P!7)_N-_P"@FOS-_8T_Y/3_ ."I7_99
MO@&/_, ^'C_44 ?IK1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4$K!&5C
M_#U.0 B$KEFSUY&!C'7VYGJ"5,Y.Y<D# ;IM4'<.^003G@XZT ?FC_P37\^R
MM?VW](OHFM=2L/\ @H5^TA+=6S\M';:S=>&=7TV==H(>*[L+F&:)A@,C%B>#
M7Z:@@]#GZ5^4_P 6?#GQG_8X_:1\<?M0?!WX5>+/V@/V?OVBAX9'[3_P=^&\
M<%W\7?A;\0/!>FKH>@?M _"3PC('/Q1TSQ-X>:#PS\5_A]IU_I?BBW.A>&O%
M?A:#Q-+)KFDVUV+_ (+/_P#!,.SAM#XH_:Z^'WPZU2ZMY)F\,?%"S\5_#?QE
M9K%(D,BZEX3\8Z!I.O:>Z2G:Z7EE&V73DG)H _4NBORZ_P"'UG_!*%N1^WE^
MS[QP<>+GQD?]N5'_  ^J_P""47_1^7[/W_A7/_\ (5 'ZB$9!'K44D*R$,20
M1G!7AADY.&ZJ>2 5P0#P<X(_,#_A]5_P2B_Z/R_9^_\ "N?_ .0J/^'U7_!*
M+_H_+]G[_P *Y_\ Y"HLGOV:^3M?[[+[@_K[S])M,\,:)HELUEHVFV6DV+75
M[?-8Z;:06-D;S4KF:]U*Y^R6J16ZRZC>W$]Y?NL:F[NIII[CS)9&:KXTVWR2
M=Y8D$DGKM! &#GY0&8E>A9F/<BOS+'_!:O\ X)1#_F_']GT_7Q<Y_P#;*@_\
M%J_^"4G;]O+]GL?]S8Y_]M/2IE&,_B5_O\][-7W>XK*[?62L]]59*V_:,=K;
M(_37['&SX)<JNTG)# D!<,=RG+9&-QRV!][(7$GV*+"@%@%[ @ C+'!&.1\V
M.<X 7&,<_F+_ ,/K?^"4)X'[>7[/G/IXM<'_ -(J/^'U7_!*+_H_+]G[_P *
MY_\ Y"IM)M.VJ=UTL]=5:ROJ^G76]E9_\!?^ N;7W.<VO\3WTM^G'V&(,'RV
MX# )V],$'(Q@D\9XQD# %*MC"O3=PQ;).3DKM/)R>5SN[,6<L&+MG\QO^'U7
M_!*+_H_+]G[_ ,*Y_P#Y"IH_X+6?\$H@2/\ AO+]G\]_^1KD. O+<BQP<]Z.
M6.FFT>5?X7>ZWVU>]]_2QM9+2VWEK?\ /Y^9^D^M^%M \2Z3J.@>(](T[Q!H
M&KVDNGZOH>MV-KJNDZI83H(YK/4=/OHI[6\MY8P4EBN(I$=20RD 8YCX?_"S
MX<?";PW9^"_A=X&\+?#SPCIL]S/I_A?P9H6E^&]!LY[J:6>[N+?3=+M;>UBF
MGGE>6601[G=V)R&8'X&E_P""TW_!*F!]D_[=?P"@89RDWB>:-B!C+8>P!V\@
M@XP1R.*KM_P6J_X)/GG_ (;P_9\&3U_X2N0YZ_\ 3E196:V32B[:725DO1+9
M:=]]163LFM%JEYI)?E&*]$C].3:0*H0?,1C"Y^\!@,#U!5U4"1<8D"C?DC-(
MMA$5PQDP2<J6'/#*"QQDN Q829W;CN)+<G\R%_X+6?\ !*#.?^&\/V?"PZ'_
M (2N0$#Z?8??K[T__A]=_P $H?\ H_']GS_PK)/_ )!H22;:5FU%-^4)<T?N
ME[RM;7>XWYO\>\91_P#29R7I)V/TS-G"N[YV.,93L 0JC*9"L H4 $%0NY0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P">.E2A@>ASC!_,9'YBEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD? S4M:\,_M7ZO)\-UUS_@GAX]^(WQZ\&?"31?"_BO\ 9M^('Q0_:LT/P/\
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M_@J3_P!EE^ ?K_T0+P^?\XK]+O\ EE+]' Z\@+_CD<>F.U?FC^QI_P GI_\
M!4K_ +++\ __ %07A^@:VUT?2WK_ )'Z:T444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5^5O_!2?_DHG_!,[_M)!\(O_5;_ !1K]4J_*W_@I/\ \E$_X)G?
M]I(/A%_ZK?XHT ?J/&,EAZDC\S<4VYL8+F,Q3I%+&[ES'-%%-&2<,/DE1TW(
M4#(Q4E6 -/B^^?\ >_K<5:QT]N1^1'\B:&D]'JOZ?YI 846B6MLDL5M!:6R3
MG;(MO9VD"R* VU9$B@6.91ND(69)%4N^%PQ!E.E1-MWPV;(@"11FSMV$4*IY
M:6\8=&2.%$+!415&&;.<FM? SG'.<Y]\8_EQ2T=6^K;DWW;44W\U&*?2RVWN
MK)*UM+6MY7;M]\F_GZ)8YTFW\N:,06BQ7";)XEL[7RIE!;8DD0B"30QABJ1S
M;R%Y)9ADL;28I')GALIUV@,);&"1G5598H0\@=S!&'.U'8F, *C!,BMNDP..
M!QC'M@@C'MD#CIQ1KO=W[W=_S'_7]?UT796PYM)2Z$:726MRT: ;KBT@G"[F
M!81+<),L8;8NXQ@,Q55)V10B.P;"(B-FAMB+7"VH6"%/LR\*PMV*GR,!5P8?
M+(9%X)6M,A22.A(!R/J2#]03GZGO4(4LG/)#'KW!&&].O+4K*[=M6N5ONNS]
M>O5]6^AT\EHUTW4M?^WDGZ_CX]\2?B1X4^%/A^'7_$JSS#6_$.E^&]#\/Z%I
M8U3Q'XW\8^(',6E^'O#FA0Q(^M>(M3D@,S,\B06.F6%[JVJ7=EI.GWEQ%\M3
M_P#!1C]D>#X:>+?C'+XH^(Z^ /!?Q@G_ &?O&'B2']G/X^?:-)^*4&I1^'V\
M)W6EQ_#'^W;J&PUIXO#E[K5KI]UX=T[6I;33]2U.TN[JSBD;^UE87_AKX[_L
M0?&K6M772?A-\+?BM\2=)^)=[<^7%I&D7WQ7^&MWX*^'OB;Q!=2 VVEZ-IOB
MJ0:1/J]V]O;V5SX@@\Z^MHY6E/Y'W/[)G[0S_!CX\^+G^!O[8<7Q*\3?\%,=
M6^.7A;X+:+\8_#6G> =7^$]]\>?#WQ+M?&-WX'M_B'#X(VS>%-'U&+4K:7;J
M[^*&L9AI]T@C6.\/3I5'2=2HJ;JU*,7-WM%5,32P\F]59K"7FW)6?*K]TW&+
ME%IOW7*<6[?%*,JD+:?\P\Z<5!/OKS=?Z3[*UMKBSL[JWTR*V@NK2$V\5UH8
ML;B"TN%2=8I[*>U2>QN,2!)M.N+6WDBN-\-S"DRL%N36T4[QI-IZ7"AG6*.Y
MM8I52*;R_P#5QS0O'"@CA=&"G<JB-'C821M%_/\ ?$[]F+]L#Q)\0/COXMT[
MP]\>="^)EWJ_[4&H2?%SX?\ QCO-(\._%S]GSQUX#\467P"^"7A#PB_Q!M]-
M\)?$+P?XNU;PRRZHFB:!/X5N/#6IZTGB:Z77I8D^8?$GPW_:6^#WPK^,VD>*
M_ _QA\%:+\4?!/\ P3!L_#?@[XQ?M$W>B^#OC3\?O ^@?$>V_:\\%>)/'MI\
M4-7\5^ ].\9:-:^#$\>>)?"E]IH\36_A>UU'2;#6+JRU'2]57LN:FYPE'G<Z
M<J=&-FG*;6(E5M=VDG4E'KK#5*RNJ=YI:N3C33;=KN,J<^:^N[O=I;=+)6/Z
M1OC9\8?AE^S;\,?%_P :OBY=7GAWX??#[3Y-;\6^)-&\$>)?&.H:/ICS!9M8
MGT7P1H6N^));6W8![R]L=/N54[[F[>"*+=)P?@_]K'X%?$+XHZ/\$?#6J^,[
M_P >Z_\ "S0?C5%X?U7X0?$_1])L/AUXF\RYT'5_$>N^(?!NG^%_"EY>O;CR
M_#_B35=.\4QW8A1](BN&"7'YJ^"_@YXCT;_@CU\9_@C\%_ _Q1^)GQ-\0^#?
MB[X-3PIJGB&36?%5WX]^(%ZTUUI^C^+O'WCWQ'!K7@CPW:ZM::7H/B*\\7S'
M5/#FA6-[/90:A>7.G6W%_#GX>?\ !1GX1_#WXV_LH_#?P)XWUA?C!^S7JGCC
MX%_MM_$'Q#X-T[XG?"+]H#5_"M_;I\#/VC;C2M4O=0\:7GA2XMK/3_ 'QN\'
M6,ECH5C=V?AZ;PDMMI$.IW,55[*5>%2;DJ49RPL7)1]K4I8=XJHFFT_<ITJM
ME>[<K1DI6A4SI-U8TG9+GLG)V=K5E1CS+567.F]+.G&=[VT_?4V^)1*UKOFE
M1@;AK0&X56+.T3MME8PNTC$0M(J)*Q."LA>WKM8122N5T^!9RT 6Z-A!OC==
MRV\H<64D@:W):5$D,1A#H T,$BL_\[MM^R?\>(=6\$ZEX7^"_P"UIX#_ &<M
M?_:(_9UUW5OV77_:)O=7UOP'IVA>!?B%8?M(^*?$.NS_ !7-UK/P[\?ZAKG@
MW2(_!5IXGU&#6]9\/W7C+3M(\-/?3P'XV^)WPG^-/B?P7^R_\$/CMI/Q5T2?
MX8?#'6Y?B?X<UCX^:U9_$WX0>$+#]H&^\3^#_$_PKTGPA\7/#=]\9/&7CKX3
M^&F\ ^*](\9:]XDDL?"$-B]GJ4^MQ36&N:*,>:E!3:G6E%M+9<U6C:-UOI5:
MLE'2ZT>D$JKC.5-:4XTU5E-[P@\-4Q-GS*]U"DX2U;YDU+5W?]5?PZ^)/@OX
MEQ^+8/#%O/:W_P /O&VH^"_%WA[6](&CZWX2\8:=:65ZJ:EI4D6+9M0T+6-(
M\0:!J-O-<0:MX:UO2-2T^ZFM[KRX?45T]-R.D-D&#.^5LX209-CRE"$0@NVQ
M3DX95!?=(%D'Y]_LZ:8GB;]M?]LSXT>$YVD^$>N_#?\ 9#^"7AYXXIA8ZU\5
M?@9<?M&:Y\3M=L[FX!^V3:9H'Q<^&7@+4;Z/S674?!,MA)>3&QCBB_1B,@LZ
M=@<CC^ZV!D^HPH //&><TG%VA)-RBX7N[[Z*Z]>9WZ:[=KBVW.[O*,]7972U
MT^3_ !,U]+26,131VTT9(8)):0.J%4=4*QR(\2LJR/&&5 54X!&Z0O&NC6L,
M8BBM-.CB$GFB,6%J(UFP<R*D<: .0=K-C<R\,QR=VYC'3W/YG)_6BEU;ZMW?
MFVDK_<DODBNWDDEY)--+[TON^_GSHVGY?_0M/(,2Q[/[.LL&#DJDA-N0PB,C
M^5&-L2B67*,S@@CTZ.!B8EM8M^)9F2T@C$DZNC6]P62-1)+"PE(=MTBRS,0R
M[5"[Q12 " 0.F>W.?YBD* D=L-N^N>H^A.,^OXT/7?K_ %_5K!TM=VV^ZR]5
MHELT92Z9$ZSY6 "Z.ZY5;>$Q71X4O<@J1<2E55/,G\Q]JX)()S9^RN#DR MC
M !! .W."JAL* IZ*, EF !-7L#T'0CIV/4?0]_6EP,8[8QCVHZI]4I):O:22
MDM];V6]]M+/4.EM-V]EO+1_>ONZ6N[LD_P!7)_N-_P"@FOS-_8T_Y/3_ ."I
M/_99?@'_ .J"\/U^F4G^KD_W&_\ 037YF_L:?\GI_P#!4G_LLOP#_P#5!>'Z
M /TUHHHH **** "BBB@ I,@=2!^-!_#J.ON1G\?3WQ5"=L2E=QRQ#*O.3@8R
M  V1[8]*3VWMY@: (/0@_2BLN641\,&0DCAE8G /56"KC)(7D<8SWX86EWHA
MW*68A05.^0'[S E>D:D,6]<G/!(AU$U/EU<(\S^]+U;NQ-I?-V-;(/0@YZ<C
MFEK(BD5T\V.3S4V*VY064AAF,ANQ8<DD'!]\8O12YV98G*KD>F[O[G=P?0$?
MB4YJ<$TV^]_G_7R*M:WGJ6:*B,C9(5"<'&><''7MCU'WO\*52Q&"5#<\$<_B
M,CL1T/?K6@B2BBB@ HHHH **** "BBB@ HIH=2<!@2>U._KTH **874$@D @
M]^_ .?UH\Q/[PYZ4 /HHII8 XY)X_4@?US] : '44@.?S(_(D?KC-+0 449Y
M/7C]?I1TZT %% (/0Y^E)D @9Y.<#UQUH 6BBD!!) ()'49YXZ_ED9H 6ORL
M_P""E8=/'/\ P37OG1EL;'_@I!\&3>WA!^S60O? _P 3--L?M4H&R$7FH3PV
M-L9"OG7<L<"9D=17ZI$@#).!ZG\J^6/VP/V:=*_:O^!GB[X/WWB?5/ FN7EY
MHGB[X<?$;0XUN-8^&WQ4\%:G;>(_AYXZLK,SV_\ :2Z!XDT^QGU/17N[2'7=
M$;4M&>XLQ?O=Q@'U!"P7S V /,?:3G+ 8R3GK@D<_7T-6*_(SPG_ ,%)-3^"
MVF1>#_\ @HA\#OB?^SI\5="AAL-6^)'@;X=^//C#^S!\5[BQACBN?&WPJ^(_
M@/0=>ET*RUIP-2F^'_CJPT3QCX9_M"'3[G^WX;4:Y<]4/^"S7_!.]01_PN?Q
M0=@PQ_X45\?.Q"Y_Y)ITR1SSUH _4FBORV_X?-_\$[O^BS^)^1G_ )(5\>^A
MZ?\ --*/^'SG_!.[_HL_B?\ \,7\>_\ YVE 'ZDT5^6W_#YO_@G=_P!%G\3_
M /ABOCW_ /.TI?\ A\U_P3O_ .BS>*/_  Q7Q[_^=I0!^I%-< J<G X.?3!!
M]Z_+G_A\U_P3O_Z+-XH_\,5\>_\ YVE)_P /F_\ @G?G'_"YO%&?3_A17Q[_
M /G:4 ?I9?Z+::I:W.GZA;07NGWT4MM>Z=>VT%U87EI<*%GM+NVG26&>"5,I
M+')$RLN,J",U;6$H )!(WW?F;;U(QDE0 I4$)M50N0S<;L#\R?\ A\U_P3O_
M .BS>*/_  Q7Q[_^=I2?\/F_^"=W!_X7/XGX/_1"OCWZ'C_DFGO6;@FI1=[3
MG[1_XMK;OOZ!_7XH_3A+?G<"3C)&T#.#G YZ<'."#P2.,9KF_%'@?POXZTC4
M/#7CCPSX?\9^&-52*/4?#GBS0M)\1>'[]8I&D1;[1]9MKZPO%1FCV^?;2&,Q
M$QE3R?SK'_!9K_@G?DG_ (7/XH.<?\T*^/?;C_HFE*O_  69_P"">&0/^%S^
M*/F;:,_ KX]@;CSC/_"M..#W^O2K45'EY791U_#;I_2!O5=59)_<N_FC]*](
MT;3-#TZQTC1M-LM'TO3K:*STW2M,M+;3].TZSM8O*@LM/L;.*"TL[6%5"QV]
MO!%%$.%0Y!%HVLC,2)&VY.%9 W7ECG(R001GI\WIS7Y@Q?\ !:;_ ()QW%S<
M6EO\==9GN[);4WUE!\&/CA->6(OHVELS?6L?PZ:XM/M<:2/;"XCC\]89FBWB
M-RM@_P#!9S_@G@,9^,OBCG(S_P *+^/.,C&>?^%:^]#5^:_O)IMKLEO?O;?=
MOLFP[_>_Z9^G*P[-RL^"V3OV[6 P  #S@9!&/<GV/%Z[\,_ 7BO7/#WB?Q-X
M'\'>)/$O@^>2Y\'^)_$/A70=;\0^%KF=E>YG\-:WJ=E<ZAH<TK0P;IM-FM'=
MD#,Y*IY7Y\_\/F_^"=_7_A<OB@] #_PHKX]=3V'_ !;7MW^O<9I?^'S?_!._
M_HLWBC_PQ?QZ]O\ JFN><C'U^N)BHQ245;E5HKR?O::6UO?7YVU#9.+ZN-]]
M'/2%O\36GZ=?TOM])M;2WCMK6"*SMH9))$MK:**WAW33R7,A$4$<<0>:YEEF
MDV(/,EN)&EWG!&N@."S?>)8X/8' Q]/E'Z"ORY_X?.?\$[_^BS>* /7_ (45
M\>L?3_DFG^<4?\/G/^"=W_19_$X_[H7\>OZ?#0U?5KJM_P"O^' _4FBORU/_
M  6<_P""=P_YK/XF]>?@9\>1^A^&H/;KT_(TO_#YS_@G=_T6?Q/_ .&+^/1_
M4?#0C\C0!^I-%?EM_P /F_\ @G=_T6?Q/QU_XL5\>_\ YVE'_#YS_@G=_P!%
MG\3_ /AB_CW_ /.TH _4FBORV_X?.?\ !.[_ *+/XG_\,7\>_P#YVE'_  ^;
M_P""=_;XS>*#GT^!/Q\/\OAG0!^H<KJ8V 8$L&48.>1P1QW'((ZYR.O%?FC^
MQM&S?MC?\%0[]59[*;XY?!&RCNE1A;M<:?\ L_\ AA;^!)P"DL]G+<(ES$IW
MP.\8D"EUSQ.L?\%0_"?Q0LF\.?L,_!;XS?M8_%?4X9+/P]*_PT^(?PG^ OA;
M57B'V?6/B_\ &WX@>%M%T'PQX;TF[)EU.VT*R\0>*;L+/8Z/H<LT@9?J#]BK
M]F76/V9/A/?Z%XW\86?Q+^-GQ+\9^)?C'^T'\3M/TDZ!IGCOXQ^/)8Y_$VH:
M'H+W-W+H?A/18+6Q\+^$=,GNKFZB\/Z+9/>2"]DN3( ?9"@*-H[$CKGKS[=B
M#[9[TZFIC&/0MGD'!))QQQQGI2Y (&>3G ]<=: %HINY2=N1GTSZ4Z@ HHIK
M,5!.,@#/!]_Z#F@!KX*L"#A1V./X>Q[8ZY[<&OR;_P""B/QG^)?A_P".?_!/
MO]ESP9XSU?X3>$?VQ/CQXZ\&?%+XL>&;J'3O%NG>&?AG\+]2^(%C\,O!VN7E
MO<6?ASQ'\6=2A.F0ZPJMK%MI.CZK#H2'4;F.:#]9"X(((VX"GYNAW#ICKP>O
MKC%>)_&SX#_"[]H3P@? 7Q?\#:+X[\+)KNB^*M-M]5EN;:]T#Q9X9NTU#PWX
MN\)ZUILMEKGA3Q?H%_&+C1/%'A_4M.U?2KB5VM[@JSQ2\\XOGHU)0YJ=/$4:
ME:'6I"-*M!M:KX*E2G-W:OR.WG-2,ITZD(3]G.44HU/Y6I0;UU^*$9PVWGT/
MP1_;+^-/[1W[&OQ3_:D_9Q_9T^)>M^*/!>L?\$ROC5^UCH-Q\8O$?B_XB:]^
MS5X^^%OC71O!T4NA>+GO7\77.D?%31?%U^?#.A^*-;O3:^,/!MO=Z;.-+CU?
M3K[QNZ^!_P 3_!_QK^''P_;X2> OBYX%TG]@/5/VN[KX%_#+XB_M'VGB/QS\
M>-#\7^$[2P\1_#K5=4\>W9TOQOJT]KI]I%&[G2-9TN[\067]F3:GJT5W'^XX
M_P""<7[*[?#'XJ?"BY\$^*M1T3XZZ;I>B?&3Q3JWQ@^+&L?%;XCZ!HBS1Z7X
M;\6_&*_\7S?$S5O#%C!=7MA%X>;Q-#I"V-U?69LF2[E<4K;_ ()M_LO6GB_0
M?'IT/XJ7OBCPS\++?X):5=ZG^T9\>[^-/A;:7MOJD'A>[M;SXA75MJ-LFIVM
MOJ/VZ]@FU&74K6"^DG$R)L5"E4A*]6:JSE+%1E45E_'I8^.'GTNL/[;"1::5
M_9:72L\/95.9J%64*<H0IJ$EI2C)X6.(:6MISA#&.G9N*EB%M=\OY7^-_P!I
M?XC?M*?'#_@EG\5/AEXM^'VJ?$&S_:,_:G^%FN>&M%U3XW?#OX?:1KEK^RLW
MB6^\(?'GX5>,+2R\7:/XW\*>(;4W+:#K=E<W]GI45CK.C7SVVJ3O%Z/X7_X+
M"_%[XH_ 37?C-\)_@9\.+BY^ O[*G@;]J;]I?P?XO\9>*-/N)].\5:QX_P!.
MO? OP>U:VTD6D^IV5A\,/%&MVOB3Q8LFF3--IVC7=G;7OVNZ7] '_P""9'[)
MD_B3P?XTD\'>/H_&W@CQUXU^)VD>,[;X\_&V'Q9?_$/X@^&+7P5XC\:^*/$4
M/CV'5/%OB)O!UA9>#] U;Q)=ZC<^'?"T']B>'UTFR>2%Z/AG_@EI^Q9X.\+_
M  ^\&Z!\*=5LO#/PTT2Y\*:/I4OQ6^*UT-?\%WGB*7Q4_@'XE7%WXRN;CXJ>
M X?$UQ<ZYI_@_P"(+>(?#NFWM]J)M-+2/4+T7*IQJ0C)V]^=1SJI6O*4H4>9
MWMH[TYW>J=[)ZZ-PJ\]&4)\L(15-0?V81]KR=%:7+*FIK;FC)+N?$R_\%9?C
MO);?&+QY=?LV>!K'X3> OCQX2_9S\)VVF^-/'?C?XM>+_&?QITCX2ZW\"_$*
M>#= \#VT4FG3V/C_ %V?X@>$=,N+KQ+9W.FZ7IOAJZU6ZOIG'Z0?L3_M ?&+
M]H/X7^(?$'QR^!?BGX$>.?"WQ \1>!Y-*\2>'/$O@^R\?:'I7V>30_B=X1\-
M>-5B\9Z%X5\66MR9;+2?%<$>M6%Y;:A973SBV6YERH_^">?[+">'/VC?"%_\
M.+WQ)X:_:Q\66_CGXX:1XQ^(?Q"\56VO>,K"$0:3XI\.-KOB>^N/AYJ^BPVM
M@VB7O@&7PY<:5/HGAV73'L9-#TZ:#Z4^%?PJ\-_"+PU;>$?"O]O3:9;2M/<Z
MMXN\8>)?'_BS6+LPP6J7FN>,O&&J:MXGUV\M[:VBLXKW6+^\N?L<,-N3&D2B
MMZ5X0<9Q<YNDE&>EHSTNM+;M5'ULJRUOM*IUO<O5G=5:\G91Y>647R6TNDXN
MF[[^VH1Z:GJZ$E%+=<?UX_3%.J(.!$&P<  8[\';3MZ@XSV8D]AM*@@^_P P
MJSJ'T4P." 3QGL>HY(YQ]#3P0>G^<<']: "BH_-3U(Z<D>HR*<'0G 89- #J
M*0$'.#G!P?KZ44 ?)&M>/OVQ;2_FC\/_ +.WP7UBPC^'.DZK;W5]^T7K>C7-
MS\5;C3+*36O YM1\$]26W\*Z;K#ZA86/CGSKBZU2QMK?4&\*V,ERUE#)IGCW
M]L:XOI8=8_9\^"]AIP^'-QJ]IJ5E^T+K^I2R_%1+!9K/P9+IP^"]LT7A*YU%
MQ9R^-8[RXN[6US?'PO,P%HWUB(HP00H&,8VY ^7.!@$# R< C ].!2>5&.-H
MYZ]<G@KR<Y/!()[CKT% 'QQ8?$7]MJX/AY+[]F?X&V37GA/7M0\3O#^T]KMZ
MNB^-;5_$*Z!X<TN)?@3;-KFBZNEKX8FU+Q+(^E7&C#6-3@BT'56TB.2]U+;Q
M[^V"]O\ #)KK]GSX+07>LP:Y)\688_VC-;EA\ R6TZKX=C\*S'X,(_CN/6+8
M2SZA-<P^%/['DC\B*/4\F5?K/RH_[@X!'//!QG.>N=JDYZE5/500OEIG.WH0
M1DD@$="!G ('&<=..E 'R'X8^(O[9]Y??#9/%W[.?P2T'2]9US4;;XJ7FC?M
M)ZWX@NO WA^._ABTK5?"EI-\$-'3QWJ-YIIN;RZTFYN?"B6ES#'90W]V)&N8
ML^P^(W[;LMMI[ZA^S-\"XKJ;QV^E:DMK^T]XAE@MOAX(F*>,;3S_ ("PRW/B
M*6;]W_PA4J6R0H59_$A=FCC^R_)B'\"XP1@C(P3DC!XP>X] !T  4QH>J@_G
M[\]?O<GYOO9YSD# !\33?$S]O!-,\02VG[+GP GUBT\06=GX;L'_ &J_$$5G
MKWAN;^V1=:[J%[_PS](^@ZC:"WT!(=!CMM7CO6U'46&KVZZ=$+S2U_XD_MO6
MC>/O^$;_ &9O@;K@TOQKI>G?#9-0_:<UW0W\7^ 9U\='5?%7BAA\!M47P7XA
MLI-,^'R67A&W7Q+%J"^*O$<C>(+0^$HH]=^QC#&<90$#H&)8#C;P"2!\N1[
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M:?<V)\9G6[R;^S98-*6W-[<?6'E1\?(,#;@<X&W.W Z#;GY<#@8 Q@8BDC0
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M;"VU#Q6UW+:6\<RV(N2T7UD(H\$E0,G/!.1USDYSDDMN]223S2^5$,$(JX
MQP !T Q@ #HHZ $@8!(H;25[Z=_P[=_(#Y13QY^V"&^("/\ L^?!F.+2?#&E
M:A\-W7]HG6G;Q?XJGFLUUOP]XG0_!A/^$,TG3XWU'[%XEMI/$SZA-:VZ/H=H
MMTYM\9_B)^VXGV@?\,T? V5H_ -OJENX_:<UZ-)_B41;->>#)8F^!;M;^&T+
M3F#QF6EN2+=#)X907.8?L?RH\@[1D'(/7# DY^H.?H:001#I&HQCG'/!8CGK
MU=S[EF)Y)I@?'5I\1?VV7&CB_P#V:/@9:O<>&=;NM;%M^T]KUVNE^+X)+O\
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M:-Z?WE_[Z'^-?EI_P[L^.?\ TE/_ &]__!K\"?\ YS%'_#NSXY_])3_V]_\
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M&]/[R_\ ?0_QK\M/^'=GQS_Z2G_M[_\ @U^!/_SF*/\ AW9\<_\ I*?^WO\
M^#7X$_\ SF*!GZE[T_O+_P!]#_&D,B*I8L HZG_/7\*_+7_AW9\<_P#I*?\
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M !1110 ASCC_ "._XXZ>]?GE_P %'?VM?%_[(/P4\*^*?ASX<T/Q/\4?B_\
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M"TBBB4+7Q-_P4@)'P/\ AL1P1^UM^R 01U!'[0_@ @@]000"",$$9!S7W]0
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M\%" 0/F^"?[#^[CEO^)=\=Q\QZGCC)SQQ0!^E2=&Z<,PXQVX' Z< <?CWI]
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M&U'Q!<PVWB/XE^%M)N'\:_$*S^R:I!I?C33=0TV_MKCPGJEU-]6O^RS)H_\
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M/XW^)]A+I_COQS\)O#=S:W%GX1\3>(UEDFFG\R_L;.9II].L+.2YO6N/R/\
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M)O"^FZSIFLZ]IU^J&:35/&L][:W^K22V\%J;_3(9EAE>601_(_@3_@FM\)O
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M /3?\=Z_2ROS3^ G_*3S_@H/_P!D3_8?_P#3?\=Z /TLHHHH **** "BBB@
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MA,9).4R1@\CD>G6DE9W3:_B=M5424EMLK:?CT \_D\ >"9[A+E_"7AI+A/%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*S5]IG]B/]M@*"/^"M7[1? Y)^ O[+39 !.?^2< 9XZ]/SKD]2"C_@N?X(
M'_&KGQA@#H,_M*^&5)QT&1&BDXZ*H["OUKFDVJQP21G.U@,*01C+G ^8XPP(
MS\K##9";LFWI&,7)OM83=DY;\J3:[W=OS/R^/[%'[:J'+_\ !6O]HH  $_\
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M_BKP=JWBW1M(A\1+X;\426.A:UIEEC5+/4=7T:-K9HKZ&0U&<:B?([Z/[O\
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MW^^:?,Z=+MK#72S'5RYUH2I3PU25-P2LX-VE&I"I%]-G>VF\%K\-_#OVY/\
M@GM\7OVM_B3'XDT?XV>!=#\!V.E_"Z_\*>!?B'\.O%OBD> _B5\+/B;IWCL>
M+O#/_")_$'P9HU[_ ,)KIMF/#^LR^+],\0:UX<2VM+CP7J>B"XU*.Y\>US_@
MFU^U[KOA+QEH\_QW_9UM-:\7?\%+O G[?L][;_"_XL-ID>@^"/$'ASQ5%\*)
MK:7XF?:GO;[5_"NF6S>)Q<K:VVCS74,6A_;H;6_7[3_X>3? _&/^%:_M7[L
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M=^?E2Y*>K]G&K?X/Y96]4^Q=-S<J>+B<YYRLSX_]#'--^U77_/Q<_P#?YO\
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M*X:NW-UI-[7^YBDZ,4Y.--1C%R;Y(-64HQW<5NYKRT9>%Q=C.+N89.<&>3T
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M[.?@'X*_ 7P-?6GQHTG]FCQAJNE_$+Q=XYB\?V?PV^//A+7/&'BCXK^%-/\
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MV?#O\AU%%%6(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ)Q"P[9E'ZN?YU,GW%_W5_D*@4CRSSU:7'OP]3I]Q?\ =7^0K^AH?"EVY_\
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M?2+^6[GMY]&N;QKZ.(0WD,8<G[6;]A_]HQ,%_P#@J%^UUR0JX\ _LIC<2 0
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M^\3V^;D?7@C^O6B_E+_P%AROR^]?YD](V,')P,8_/CC/&?3WJ+>_^S_WR?\
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MV'P_\)ZC)X/_ .$/T[X;?%RS\(^)_CQ\,?CI!XK^'TDL/BOQ3^T5\=?'&F_
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M,DG8*?P(_P#9J3S)?[J_Y_X%3#E?E]Z_S+!_P_0_UZ'VI N,X)QZ$YQ]*3<
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MNG7KZOS#^P,-?>:76SBW]UF?#1^(W_!6W.#\)/\ @G/P"?\ DO?[1G3GJ/\
MA1/3\QR,9--'Q$_X*V$''PC_ ."<I//R_P#"^?VC.<_]T*( R?QX'&0*^Z-B
MD@!S]"V"?IQ_3UIQC '+''NP]O5/I37'6?WO[7#WT^Q;5;.R:M;=6V;;$\@P
MC;?[W5P=VX7?([Z:?:VEWMHX[GPR/B'_ ,%;CU^$?_!.?/4$_'G]HO\ 3'P*
M//OG'\J7_A8?_!6[_HD?_!.?CIGX]?M%CMCJ?@5UZ].U?<N$X <9. .0?T'K
MVY_.EVC."PSCIQG/8]3Q^'/'/JGQWGMV^;"J_P#TX5M_6_\ PX?V!A>\UY>Z
ME\U_P3X8_P"%C?\ !7 'CX2?\$Y>./\ DO7[1?3)[_\ "B3_ /K]<\-_X6/_
M ,%;1][X2_\ !.8$$\#X]?M&8')(Q_Q8GTY[<]A7W00!G++D=<MSGKZ#K_DT
MW:C$?/SUQD#CU''KD9.?K1_KYQ"G9U,-%6NN2CRO?K9W^7S%'(,,EJYVN^JW
M[;6/AG_A8W_!7#I_PJ3_ ()R_C\>/VC!_/X$TO\ PL;_ (*W#[WPD_X)R@>W
MQY_:+Z_A\">E?<X53M.X$=2>!Q@],DXZ'L<#.>AI2(V'#$8ZD,/0G^Z.P)_
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M47[K:3MU3VZ5_:-3FI0@HRC5E[*G.+N[\BE=V;2=VT[V3:NE9GZD_"']ICX
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MBB@ HHHH **** "BBB@ K\OO#'_*2_\ :W_[-H_92_\ 4M^,U?J#7Y?>&/\
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M8../NGK0@RP*H$3>< ,7 CP2,S'!E/3,I"[F! 4;2*L("!TQR<CMUP,< \@
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MXB@?Q#?W5W<^#='\ Z[X$TW3M+N5DO)-7::&>'Y>\'_\%*OBEX9_9^^)5O\
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MU3=__ */_IN)^<S^.3[RE9>DG_F+1116A(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!4<E X
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M>AS^=1,023YS+[ #C\US7P;_ ,(3_P %@._C'_@F-_X;#]JL?^]P-._X0?\
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MO7KGCUYKX(_X0G_@L!_T.7_!,8?]TO\ VJS_ .]R'\OQ]$_X0K_@L&.GC/\
MX)BX]#\+_P!JW^GQSH_U#X@_Y\TU_P"!_G8?]O8'O+[Z:7RLS[XWKZ_S_P *
M3S$_O"O@@^"?^"P!''C'_@F,#_V3#]JS^GQQ!_6D'@C_ (+!#_F<O^"8O_AL
M/VK?Z_',T?ZA\0?\^:?WR_1!_;V [S^^G_F??.]3T.?SJ-L,P.\@ ],''0?C
MU /;J>HKX,_X0G_@L!W\8_\ !,;_ ,-A^U6/_>X&E_X0K_@L#V\9_P#!,<>W
M_"L/VK#_ .]R'\A_6C_4/B#_ )\T_P#R?_(/[>P/1R^^G_\ )'WAQ_SW;\E_
M^)I<8ZSN/P7_ .)KX-'@C_@L"3@>,/\ @F,<] /AA^U83_ZO _RIQ\#_ /!8
M(#)\8?\ !,A1ZGX7_M6$9].?CBN/S[=/0? G$"_Y=4OOE?[GJ/\ M[ ]YV]:
M7^9]YHR@<N7YZD?3C@ ?_KIV]?7]#_A7P1_PA/\ P6 _Z''_ ()C'_NF'[58
M_P#>XFC_ (0G_@L!V\8_\$QO_#8?M5__ #\*/]0^(/\ GS3^^7^0O[>P/>?W
MT_\ Y(^\#(>N5QPV%^^<8(^7);!.%;@X!(('-? 7_!2/XEZUX8_9F\4?!OX?
M&'4OV@?VN[35_P!FS]GSPC^ZGO\ 6?%/Q#L'T3Q'XK>Q#^=+X/\ AMX1U'5O
M%?CG6%C.G6&GV]E#/=VTU_:2->'PX_X*Z:H38W7Q4_X)Q^#K6Z1X9?$?ASX'
M_M(>)]=TG<,K<Z3I7B3X\V^@75]&S%T_M>">S=@//MI5&P^Q?LX_L)>&_@Y\
M0K_]H#XJ_$?QM^TY^U/KGA\^&;[XX_$V+2;&+PEX<NI(Y]2\)?!KX>^&[/3_
M  =\)O"5_/#;2WUEX=LY-5U:6&)]:UC4$C2!?7R3@7,Z6+5?,G&%.G.$U&+3
M<N5WLN:^NW1:7M;IQ8[.:$Z3C0DU*2<7%I/I;[+LEZO7;EU/K?X:^!M*^&'P
MV\ _##07>71/AQX)\*> =&D>%('DTOP=H&G>';!WAA)BC9[;3(B8X\(A;8@V
MJI;T5#E5/L*B5"5;("LQ)P>< X(' '3)QD9SUXXJ8=!T_#IQZ>WI7ZZE9[6O
M&-[?"N5**2^2[]-%8^63;3OT;L_)ZBT4450!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'I^(
M_F*CD)V_]]?IP.:**:_K[F)?Q%_A_4J@#*<?>9PWJ0B@J#[ DY'<'!R.*M(!
MY9.!G+]AV9@/T HHK"R<Z5TG==4N\C27Q/\ Q+\HCP 0.!T'84N!Z#\A117.
MISLO?ELOM2[>IG9=E]R_R# ]!^0HP/0?D***.>?\\O\ P*7^8679?<O\@P/0
M?D*,#T'Y"BBCGG_/+_P*7^8679?<O\@P/0?D*1A\I';IQQU/-%%'/+^:7_@3
M_P RDE=:+==%W]!<#T'Y"C '0 ?A111SS_FE_P"!2_S)LNR^Y?Y" #+<#K_[
M**7 ]!^0HHHYY_S2_P# I?YC:79=.B[+R# ]!^0HP/0?D***.>?\\O\ P*7^
M8K+LON7^08'H/R%&!Z#\A111SS_GE_X%+_,++LON7^08'H/R%&!Z#\A111SS
M_GE_X%+_ #"R[+[E_D&!Z#\A1@>@_(444<\_YY?^!2_S"R[+[E_D&!Z#\J7
M/49HHHYY?S2_\"?^8679?<O\A,#T'Y"C ]!^0HHHYY_SR_\  I?YA9=E]R_R
M(4 ^7@?> Z=C"#_,9IJ_ZQ_^N>>G?/\ ]8?EGK11711;<%=MZK=M_F.25I:+
MX?\ (F))5OKC\,BE3[H_'^9HHK?I\Q]/F.HHHI""BBB@ HHHH **** "BBB@
7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex99-5_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-5_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !# 0 # 2(  A$! Q$!_\0
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MT^+1WO?;:/J?O94<C,H 7[S, #C<%!.-Q7<A*@D!L,"-P/04XG@<\\?7J/\
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M^N):-I]M>Z[JD%K8RC3K"2YN9+"QL]+TS2M/BCDN9WN$M1<2L)W<#ZDC18Y
MQ5D+1[0#T'S@[>">2QSD]<C'/6W4,T9E"CY<!@Q#9*DJRLI*C&XJ1N7+ *X5
ML$ BOB<7C,1CL5B<;BJLJV*QE:5?$5I64JDY6NVDDM;7T5_,_HKAWA_*.$\B
MRGAOA_!PR[)LCP-/+,KP=.=2I'"9?1_A82G.M.I/V4-U>3EI:]M#^?;_ (+!
M:[XV_:6^.'[,G_!.3X.7&E2^+/'>H_\ "XO'LVJ-<3:'X>TC0DUU_"D_C"*T
ML=3:/P_##H'BW6]=LY;6&ZO+.TTG2X2X\26RR>_CX-?\%CO^$=C\,)\;_P!A
MZ/P_%HJZ#%I,'PZ\9?V=_8ZV*:>FGQVS>&T$-E%9KY,$,<V%B"(7( 8?</A;
M]CGX2>$_VH/B+^U[9_\ "2ZC\8OB7X?TCPOJEQKFMC5/#WA[1-)TW1-,DM/!
MFDRV*/H UFW\/:8FLG[7=I.$F-O';--(6^K%4A O"G;C*C(!([ C! )XR.>X
MK.-64>1)1?(W)73=V^KU7X6U2/4E1C+G]Z2YU9V:T5[Z73\_O9_/?_P1UUOQ
ME^S3\9?VE_\ @G%\79M-M_$_P]U[_A:W@)-,^UV^AW^FZM9Z3;>(CX534B^H
M'0-1TB\\%^*-'L)9YY+?[9K]U.R74EY;VG]"0(/2ODOQ#^QG\(O$W[5?PQ_;
M&O!XCTWXQ?"[P;J_@;3Y]$U>"Q\/^)M!U;2/%&BQ6OC'2O[,:76O[$M?&&N3
M:/,+ZVE2YET]KLW,.C:?"GUH,]\?A_\ 7J)S<Y.;23D[NVU_FWN7"*A%13;4
M59-[V/S>_P""JW[.%S^TC^QY\0]+\.02#XD_"];+XQ?#2\M@3??\)!X$D;5=
M4T>U5$,DDOB3PI%K^B62!T6/6KO2;_YY-/B4_D=\.OC=J?\ P5E_:$_8#^'M
M]87K> _V?_AO#\>/VG1+;7 L;GXI^&[N7P];Z$7F2W@N++7M9\/Z#=6A%R\[
M:)XYU.Y3;?>'GC3^HJXA:56"K&Q9"A$N2C*0QV. #O1FVJZ$8,;2#G.T_('[
M,?[#/P)_9&U_XK>(_@WI&K6>H_&#Q''KWB.37-1M-0&DV<%WJ%[:>%?"YM=*
MT^73?"^G7>JW]U8V-U-J%UYCQPSWLD<<;1;PJ0C2<'\3NXRZP;5FEI:UM5OK
M?8YIPFZOM%HHZ<O2:6J;ZM]'JEMHS[%48.X@ D$8!R.69B3T')/7'4GUXYKQ
MGXGT3P3X8U[QCXDNXK#0/"NB:QXDUJ]G:)(K72]!TZXU>_G9IG2/=#;64DJ;
MF&TQE\@(Q'45Y'\>/@SX9_:%^$7CWX+^,M1\1:5X6^(N@S^'->OO">JG1=?C
MTRYF@ENH;#4?(N5@6]2#[%?*\$J7.FW%Y9.HCNG(Y6N96?=/[FG^AV)VU]5]
MZ:_4_F[_ &(_ ?[?_P"TK\2?VB/^"A'[/OBSX%> [CX]^.?$?A"RN_C7H'B;
MQ1J#^"_"FIV,.FZ%X6>QLKU--\.Z;::5X8\-W,JK<//J/@>WM)XQ)ILWD[W_
M  44_9^_X*6P_"K0_P!I/XS_ !)_9X\:S?LH^)=,^)GAMOA+X:\2^'_&FFB7
M5M#L;Z^6]NO#MA'>:/83Q6FO:YI>]<Z-9ZC%$US<^6K_ -&'P3^#W@?]G_X4
M>!/@S\-],?2/!'P[T&W\.^'[2:X:\O'M;>26:;4-3O7CB:]UC5[R>YU;6;UH
MT-YJM[>7)&9:W/%OAO1/'&@^)/!/B33EU3P]XFT;5O#GB"Q=HC%>Z/KUI<6%
M_8RDEWA:2UODN VU)D_=2P[@QQT*JY/6,=(J*LG>RTWOVTOV.9THQ2]Z7Q.6
MZW?RVOJ>>?LV_&SP]^T7\#_A3\;?"LD4NC_$SP9I'B9HHLRG2=8N81!XD\.W
M%RF8&O\ PQXEL=:\.ZFD;R(EWI@2)Y8U$K^[DC@9&20!R.2#D@>N "3[ GI7
MS#^RQ^S7\/?V0_A-8?"#X7:EXNU/P/IVN^)?$MD_C'Q!'K]_;3>*+O\ M.;3
M["^^RZ>D.F6$A:&ST\6D60\]_<S37LDSR_1SW<<CDH5 @8J)&*20B7S%A8,4
M?"RI+YEKL:1)$E\W<H5=U8S2NO)W7XE\SOTU23^7ZZL_!S_@@6K+\#?VC00<
MM^T5K3+@%LI)X9TUD<;<_*V=N3@!PT;8D1T7]\-ZE6 ()3Y& Y*O@85L="<@
MC/4,I&0RY_(:;_@C!^Q5;ZEK&H:3/\>/#*:UJ]WJMUIGA/XV>*?#^C-J$LQN
M[B*VL=-,"[(YHG6.U8R/Y;SB-&@C?9]#_LS_ /!/_P" _P"R=XZU;XE?#;6?
MC'>:UJGA#4?!]W#\1/BOXH\8>'H]$O\ 5/#6K3W<.B:TXLK/4H[KPCI?V?4I
M!]JLK2:_MED2"[5:TG^\E*;T<[MI;)O>S;8H?NXQ@K-122O>[L[ZV2\_Z10_
MX*:?LU:Y^U/^Q=\7?A7X3M6O/&\=CI/C'P79[4/]K^(O!-];ZS#H@)1]K^(=
M-AU'08V !\Z_4!T# US?_!-C]M_P+^U3\$O"OA_5=>@TC]H7X;^&M+\)?&'X
M::Z1I/C:U\1^%K*#1-6\2Q>&[I;?4Y-)UB[M&OKM4M&N/#FJW5UX;UE;6_L!
M')^C4LJ7""-EEC!\N1PZ <!HG$; J^_>6" P;MSI*(9@\18?F9^TU_P2K_98
M_:=\7Q_%+S?&OP<^,4EX^J3?$OX)Z]I?A37]=U-3(&U37[&XTG5=#U/4)+B4
M-J&O:59:)XGNR[+=>)0Y+!1DN2-*6D$_BZK2WDK.RO\ @+7GE46LY+;H];Z6
MUNKNW3OW/OGXI?%3X=?!SP?K/Q"^*'C+P]X%\&^'X8YM3U_Q)J$&GVL;RB3R
M["V2>19+[6-01?LVE:3:0W&HZA=2);6-M<SR"(_C)_P30A\5?M3?M??M2_\
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MU:-2LA+.OS;68]6VYQDGYL@ [_G^_P#-2[(V=&,:;E8E7P=ZEAM.ULY&5.W
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+ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
